pgkioclmmcissqgobqdofivgxczkmspsjmmqtqyq length 6 375623 page 375623 

<!DOCTYPE html>

<html id="doc" lang="en" class="page-article">
<head id="Head1">
    <!-- charset must appear in the first 1024 bytes of the document -->
    <meta http-equiv="Content-Type" content="text/html; charset=utf-8" />

<script>
      var SCM = SCM || {};
      if (SCM.AMA && SCM.AMA.DataLayerAsync) {
        SCM.AMA.DataLayerAsync.push("arrSisAffinity", "", "array");
        SCM.AMA.DataLayerAsync.push("SubStatus", "no", "string");
      }

      var googletag = window.googletag || {};
      googletag.cmd = googletag.cmd || [];

          
          if (typeof Storage !== "undefined")
          {
              var targetingParamStr = localStorage.getItem("bcDFPTargetingParams");
              if (targetingParamStr)
              {
                  var targetingParameters = JSON.parse(targetingParamStr);     // set page-level targeting parameters
                  jQuery.each(targetingParameters, function (index, param) {
                      googletag.cmd.push(function () {
                          window.googletag.pubads().setTargeting(param.key, param.value);
                      });
                  });
              }
          }
          
      if (!googletag.pubads) {
        (function () {
          var gads = document.createElement('script');
          var useSSL = 'https:' == document.location.protocol;
          gads.src = (useSSL ? 'https:' : 'http:') +
            '//securepubads.g.doubleclick.net/tag/js/gpt.js';
              gads.setAttribute("async", "");
              gads.setAttribute("defer", "");
          var node = document.getElementsByTagName('script')[0];
          node.parentNode.insertBefore(gads, node);
          })();

        var App = App || {};
        App.Ads = App.Ads || {};
        App.Ads.adPath = App.Ads.adPath || '/6479/' + 'ama.jama';
        App.Ads.Mappings = App.Ads.Mappings || {};
        App.Ads.slots = App.Ads.slots || [];
        App.Ads.fromGoogle = !('yes' === 'yes');

        App.isCollection = App.isCollection || !!document.getElementsByClassName('pg_collection').length;

        
        googletag.cmd.push(function () {

          googletag.pubads()
            .setTargeting('environment', ['newjama'])
            .setTargeting('site', ['ama.jama'])
            .setTargeting('sect', ['scholarly'])
            .setTargeting('sub', ['no'])
            .setTargeting('device', ['cis5550-crawler'])
            .setTargeting('usaphys', ['no'])
            .setTargeting('memberstat', ['no'])
            .setTargeting('pracset', [''])
            .setTargeting('specialty', ['other'])
            .setTargeting('occupation', [''])
            .setTargeting('useraffinity', [''])
            .setTargeting('direct', ['yes'])
            .setTargeting('bot', ['yes'])
            .setTargeting('datacenter', ['no'])
            .setTargeting('selfMPA', [''])
            .setTargeting('selfSpecialty', ['']);

          if (App.isCollection) {
            googletag.pubads().setTargeting('collection', ['']);
          }

          var testParam = getQueryVariable('test');

          if (testParam) {
            googletag.pubads().setTargeting('test', [testParam]);
          }

          function getQueryVariable(variable) {
            var query = window.location.search.substring(1);
            var vars = query.split('&');
            for (var i = 0; i < vars.length; i++) {
              var pair = vars[i].split('=');
              if (decodeURIComponent(pair[0]) == variable) {
                return decodeURIComponent(pair[1]);
              }
            }
          }

          googletag.pubads().disableInitialLoad();
          googletag.enableServices();
        });
      }
</script>


<meta name="viewport" content="width=device-width, initial-scale=1" /><meta name="format-detection" content="telephone=no" /><link rel="shortcut icon" href="//cdn.jamanetwork.com/UI/app/img/favicons/jama/favicon.ico">
<link rel="icon" type="image/png" href="//cdn.jamanetwork.com/UI/app/img/favicons/jama/favicon-192x192.png" sizes="192x192">
<link rel="apple-touch-icon" sizes="180x180" href="//cdn.jamanetwork.com/UI/app/img/favicons/jama/apple-touch-icon-180x180.png">
<meta http-equiv="X-UA-Compatible" content="IE=Edge" />
    
    <link rel="stylesheet" href="//cdn.jamanetwork.com/UI/app/dist/app.min.css?v=638488852237037766">
    
    
    
    
    <link href="//cdn.jsdelivr.net/chartist.js/latest/chartist.min.css" type="text/css" rel="stylesheet" />
    

    <meta property="og:title" content="CONSERVE Guidelines for Trials Modified Due to Extenuating Circumstances" />
    <meta property="og:type" content="Article" />
    <meta property="og:url" content="https://jamanetwork.com/journals/jama/fullarticle/2781397" />
    <meta property="og:image" content="https://cdn.jamanetwork.com/ama/content_public/journal/jama/938737/jsc210001f1_1626283660.46193.png?Expires=2147483647&amp;Signature=sS4okGoHTdEko57DWMe3i~9Bjtn0XzFZlhV83cZEPhcH46bkFwOAjJ-sjjpy57R1-vUg2Bjq9v~B6TYvRevQxkMQ-ExeXjw5eZ8zHsdC95XVJeKG8yIr8dB7XJeENlTMum-L1~FZQvDDS6WFWx2EDjtca9oNsRCxZuQEabi6epoqznmN~kbMQqfxT9KycnyN1J0L47q9EJjobALksj0nHzeupq-leaWCLie~5V5N24bkW-sQV82AaPMH8-T6Oos0Ad6AgOZen~z8shHaq7TvDtswXHXBCk-Q3~hNRvc0zcAm1A4-BmcuwhDodXtfADuykNnQb3UiPeMeV2m0OuJKLA__&amp;Key-Pair-Id=APKAIE5G5CRDK6RD3PGA" />
    <meta property="og:image" content="https://cdn.jamanetwork.com/ama/content_public/journal/jama/938737/jsc210001t1_1626283660.49195.png?Expires=2147483647&amp;Signature=08HhHjGep2EpK2r8Ekopt~GVQaqKN-zStiQxX-teowElh3AV~ZnekAMFmpbGT-VfM6f~WlEVjz5qf03yTOcZ-jLJNzbtYUJTy4FBZqHo5f8ZGmtIF661007EgOtnCvstyVz7KjLt1T9mc-DlbzyJQvCpodx0Q4cvNsmmGTfXroBE41ukP8Lj9g2PIS91vss2WqAeJL~JI6894umg4hs65XG407qRFxmlzQAm0kE2wnBU9S3Z2JXfCsrYRtnkXy5qY6H5fbVU3tRCq5jZwgv6uKQlnlLqBxc1qT-7f7RoXDD3UPc2G5~nO96yyZBT88TUMDu~flqnHQZ7Yge4kaXTig__&amp;Key-Pair-Id=APKAIE5G5CRDK6RD3PGA" />
    <meta property="og:description" content="This Special Communication describes CONSERVE, a guideline developed to improve the transparency, quality, and completeness of reporting of trials and trial protocols that undergo important modifications in response to extenuating circumstances such as the COVID-19 pandemic." />
        <meta property="fb:pages" content="87087958340" />
        <meta property="fb:pages" content="122228711814384" />
        <meta property="fb:pages" content="1648414928738217" />
        <meta property="fb:pages" content="117506346528" />
        <meta property="fb:pages" content="97538728726" />
        <meta property="fb:pages" content="114116793520" />
        <meta property="fb:pages" content="100679858757" />
        <meta property="fb:pages" content="759822190741773" />
        <meta property="fb:pages" content="100265333750" />
        <meta property="fb:pages" content="234770525256" />
        <meta property="fb:pages" content="98784919862" />
        <meta property="fb:pages" content="120829458202" />
        <meta property="fb:pages" content="124842870398" />
        <meta property="fb:pages" content="110245330325636" />
        <meta name="twitter:card" content="summary_large_image" />
        <meta name="twitter:site" content="@JAMA_current" />
        <meta name="twitter:image" content="https://cdn.jamanetwork.com/ama/content_public/journal/jama/938737/jsc210001f1_1626283660.46193.png?Expires=2147483647&amp;Signature=sS4okGoHTdEko57DWMe3i~9Bjtn0XzFZlhV83cZEPhcH46bkFwOAjJ-sjjpy57R1-vUg2Bjq9v~B6TYvRevQxkMQ-ExeXjw5eZ8zHsdC95XVJeKG8yIr8dB7XJeENlTMum-L1~FZQvDDS6WFWx2EDjtca9oNsRCxZuQEabi6epoqznmN~kbMQqfxT9KycnyN1J0L47q9EJjobALksj0nHzeupq-leaWCLie~5V5N24bkW-sQV82AaPMH8-T6Oos0Ad6AgOZen~z8shHaq7TvDtswXHXBCk-Q3~hNRvc0zcAm1A4-BmcuwhDodXtfADuykNnQb3UiPeMeV2m0OuJKLA__&amp;Key-Pair-Id=APKAIE5G5CRDK6RD3PGA" />




<script type="application/ld+json">
    {
  "@context": "https://schema.org/",
  "@type": "Article",
  "headline": "Guidelines for Reporting Trial Protocols and Completed Trials Modified Due to the COVID-19 Pandemic and Other",
  "author": "Aaron M. Orkin, MD, MSc, MPH",
  "url": "https://jamanetwork.com/journals/jama/fullarticle/2781397",
  "datePublished": "2021-07-20",
  "description": "This Special Communication describes CONSERVE, a guideline developed to improve the transparency, quality, and completeness of reporting of trials and trial protocols that undergo important modifications in response to extenuating circumstances such as the COVID-19 pandemic.",
  "publisher": {
    "@type": "Organization",
    "name": "JAMA Network",
    "logo": {
      "@type": "ImageObject",
      "url": "//cdn.jamanetwork.com/UI/app/img/favicons/jama/favicon.ico"
    }
  },
  "image": [
    "https://cdn.jamanetwork.com/ama/content_public/journal/jama/938737/jsc210001f1_1626283660.46193.png?Expires=2147483647&Signature=sS4okGoHTdEko57DWMe3i~9Bjtn0XzFZlhV83cZEPhcH46bkFwOAjJ-sjjpy57R1-vUg2Bjq9v~B6TYvRevQxkMQ-ExeXjw5eZ8zHsdC95XVJeKG8yIr8dB7XJeENlTMum-L1~FZQvDDS6WFWx2EDjtca9oNsRCxZuQEabi6epoqznmN~kbMQqfxT9KycnyN1J0L47q9EJjobALksj0nHzeupq-leaWCLie~5V5N24bkW-sQV82AaPMH8-T6Oos0Ad6AgOZen~z8shHaq7TvDtswXHXBCk-Q3~hNRvc0zcAm1A4-BmcuwhDodXtfADuykNnQb3UiPeMeV2m0OuJKLA__&Key-Pair-Id=APKAIE5G5CRDK6RD3PGA",
    "https://cdn.jamanetwork.com/ama/content_public/journal/jama/938737/jsc210001t1_1626283660.49195.png?Expires=2147483647&Signature=08HhHjGep2EpK2r8Ekopt~GVQaqKN-zStiQxX-teowElh3AV~ZnekAMFmpbGT-VfM6f~WlEVjz5qf03yTOcZ-jLJNzbtYUJTy4FBZqHo5f8ZGmtIF661007EgOtnCvstyVz7KjLt1T9mc-DlbzyJQvCpodx0Q4cvNsmmGTfXroBE41ukP8Lj9g2PIS91vss2WqAeJL~JI6894umg4hs65XG407qRFxmlzQAm0kE2wnBU9S3Z2JXfCsrYRtnkXy5qY6H5fbVU3tRCq5jZwgv6uKQlnlLqBxc1qT-7f7RoXDD3UPc2G5~nO96yyZBT88TUMDu~flqnHQZ7Yge4kaXTig__&Key-Pair-Id=APKAIE5G5CRDK6RD3PGA"
  ],
  "articleSection": [
    "Introduction",
    "Methods",
    "CONSERVE Guideline Development Procedure and Panel",
    "Rapid Review",
    "Consensus-Based Meetings and Surveys",
    "Global Survey of Trials Community",
    "Results",
    "Scope of CONSERVE",
    "CONSERVE Checklists",
    "Extenuating Circumstances",
    "Important Modifications",
    "Responsible Parties",
    "Interim Data",
    "Discussion",
    "Conclusions",
    "Article Information"
  ],
  "keyWords": "guidelines, clinical trial protocol document, covid19 (disease), coronavirus pandemic, extension"
}
</script>
<meta name="citation_author" content="Aaron M. Orkin" /><meta name="citation_author_institution" content="Division of Emergency Medicine, Department of Family and Community Medicine, University of Toronto, Toronto, Ontario, Canada" /><meta name="citation_author_institution" content="Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada" /><meta name="citation_author" content="Peter J. Gill" /><meta name="citation_author_institution" content="Hospital for Sick Children, Department of Paediatrics, University of Toronto, Toronto, Ontario, Canada" /><meta name="citation_author" content="Davina Ghersi" /><meta name="citation_author_institution" content="National Health and Medical Research Council, Canberra, Australia" /><meta name="citation_author" content="Lisa Campbell" /><meta name="citation_author_institution" content="Clinical Trials Unit, Medicines and Healthcare Products Regulatory Agency, London, England" /><meta name="citation_author" content="Jeremy Sugarman" /><meta name="citation_author_institution" content="Berman Institute of Bioethics, Johns Hopkins University, Baltimore, Maryland" /><meta name="citation_author" content="Richard Emsley" /><meta name="citation_author_institution" content="Department of Biostatistics and Health Informatics, Institute of Psychiatry, Psychology, and Neuroscience, King’s College London, London, England" /><meta name="citation_author" content="Philippe Gabriel Steg" /><meta name="citation_author_institution" content="Université de Paris, AP-HP, Paris, France" /><meta name="citation_author" content="Charles Weijer" /><meta name="citation_author_institution" content="Departments of Medicine, Epidemiology and Biostatistics, and Philosophy, Western University, London, Ontario, Canada" /><meta name="citation_author" content="John Simes" /><meta name="citation_author_institution" content="National Health and Medical Research Council Clinical Trials Centre, University of Sydney, Sydney, Australia" /><meta name="citation_author" content="Tanja Rombey" /><meta name="citation_author_institution" content="Department of Health Care Management, Technische Universität Berlin, Berlin, Germany" /><meta name="citation_author" content="Hywel C. Williams" /><meta name="citation_author_institution" content="University of Nottingham, Nottingham, England" /><meta name="citation_author_institution" content="National Institute for Health Research, Nottingham, England" /><meta name="citation_author" content="Janet Wittes" /><meta name="citation_author_institution" content="WCG Statistics Collaborative, Washington, DC" /><meta name="citation_author" content="David Moher" /><meta name="citation_author_institution" content="Centre for Journalology, Clinical Epidemiology Program, Ottawa Hospital Research Institute, School of Epidemiology and Public Health, University of Ottawa, Ottawa, Ontario, Canada" /><meta name="citation_author" content="Dawn P. Richards" /><meta name="citation_author_institution" content="Clinical Trials Ontario, Toronto, Ontario, Canada" /><meta name="citation_author" content="Yvette Kasamon" /><meta name="citation_author_institution" content="Office of Oncologic Diseases, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland" /><meta name="citation_author" content="Kenneth Getz" /><meta name="citation_author_institution" content="Tufts Center for the Study of Drug Development, Boston, Massachusetts" /><meta name="citation_author" content="Sally Hopewell" /><meta name="citation_author_institution" content="Oxford Clinical Trials Research Unit, Centre for Statistics in Medicine, University of Oxford, Oxford, England" /><meta name="citation_author" content="Kay Dickersin" /><meta name="citation_author_institution" content="Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland" /><meta name="citation_author" content="Taixiang Wu" /><meta name="citation_author_institution" content="Chinese Clinical Trial Registry, Sichuan University, Chengdu, China" /><meta name="citation_author" content="Ana Patricia Ayala" /><meta name="citation_author_institution" content="Gerstein Science Information Centre, University of Toronto, Toronto, Ontario, Canada" /><meta name="citation_author" content="Kenneth F. Schulz" /><meta name="citation_author_institution" content="FHI 360, Durham, North Carolina" /><meta name="citation_author_institution" content="School of Medicine, University of North Carolina at Chapel Hill" /><meta name="citation_author" content="Sabine Calleja" /><meta name="citation_author_institution" content="Gerstein Science Information Centre, University of Toronto, Toronto, Ontario, Canada" /><meta name="citation_author" content="Isabelle Boutron" /><meta name="citation_author_institution" content="Centre of Research in Epidemiology and Statistics, Université de Paris, Inserm, Paris, France" /><meta name="citation_author" content="Joseph S. Ross" /><meta name="citation_author_institution" content="Department of Internal Medicine, Yale School of Medicine, New Haven, Connecticut" /><meta name="citation_author_institution" content="The BMJ, London, England" /><meta name="citation_author" content="Robert M. Golub" /><meta name="citation_author_institution" content="Deputy Editor, JAMA" /><meta name="citation_author_institution" content="Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois" /><meta name="citation_author" content="Karim M. Khan" /><meta name="citation_author_institution" content="Canadian Institutes of Health Research Institute of Musculoskeletal Health and Arthritis, Ottawa, Ontario, Canada" /><meta name="citation_author" content="Cindy Mulrow" /><meta name="citation_author_institution" content="University of Texas Health Science Center, San Antonio" /><meta name="citation_author" content="Nandi Siegfried" /><meta name="citation_author_institution" content="Alcohol, Tobacco, and Other Drugs Research Unit, South African Medical Research Council, Cape Town, South Africa" /><meta name="citation_author" content="Joerg Heber" /><meta name="citation_author_institution" content="Lawrence Berkeley National Laboratory, Berkeley, California" /><meta name="citation_author" content="Naomi Lee" /><meta name="citation_author_institution" content="The Lancet, London, England" /><meta name="citation_author" content="Pamela Reed Kearney" /><meta name="citation_author_institution" content="Office of Extramural Research, Division of Human Subjects Research, National Institutes of Health, Bethesda, Maryland" /><meta name="citation_author" content="Rhoda K. Wanyenze" /><meta name="citation_author_institution" content="Department of Disease Control and Environmental Health, School of Public Health, Makerere University, Kampala, Uganda" /><meta name="citation_author" content="Asbjørn Hróbjartsson" /><meta name="citation_author_institution" content="Centre for Evidence-Based Medicine Odense (CEBMO) and Cochrane Denmark, University of Southern Denmark, Odense, Denmark" /><meta name="citation_author" content="Rebecca Williams" /><meta name="citation_author_institution" content="ClinicalTrials.gov, National Library of Medicine, National Institutes of Health, Bethesda, Maryland" /><meta name="citation_author" content="Nita Bhandari" /><meta name="citation_author_institution" content="Centre for Health Research and Development, Society for Applied Studies, New Delhi, India" /><meta name="citation_author" content="Peter Jüni" /><meta name="citation_author_institution" content="Applied Health Research Centre, St Michael’s Hospital, University of Toronto, Toronto, Ontario, Canada" /><meta name="citation_author" content="An-Wen Chan" /><meta name="citation_author_institution" content="Women’s College Research Institute, Department of Medicine, University of Toronto, Toronto, Ontario, Canada" /><meta name="citation_author" content="CONSERVE Group" /><meta name="citation_author" content="Aaron M. Orkin" /><meta name="citation_author_institution" content="for the CONSERVE Group" /><meta name="citation_author" content="Peter J. Gill" /><meta name="citation_author_institution" content="for the CONSERVE Group" /><meta name="citation_author" content="Davina Ghersi" /><meta name="citation_author_institution" content="for the CONSERVE Group" /><meta name="citation_author" content="Lisa  Campbell" /><meta name="citation_author_institution" content="for the CONSERVE Group" /><meta name="citation_author" content="Jeremy Sugarman" /><meta name="citation_author_institution" content="for the CONSERVE Group" /><meta name="citation_author" content="Richard  Emsley" /><meta name="citation_author_institution" content="for the CONSERVE Group" /><meta name="citation_author" content="Philippe Gabriel Steg" /><meta name="citation_author_institution" content="for the CONSERVE Group" /><meta name="citation_author" content="Charles Weijer" /><meta name="citation_author_institution" content="for the CONSERVE Group" /><meta name="citation_author" content="John Simes" /><meta name="citation_author_institution" content="for the CONSERVE Group" /><meta name="citation_author" content="Tanja Rombey" /><meta name="citation_author_institution" content="for the CONSERVE Group" /><meta name="citation_author" content="Hywel C. Williams" /><meta name="citation_author_institution" content="for the CONSERVE Group" /><meta name="citation_author" content="Janet Wittes" /><meta name="citation_author_institution" content="for the CONSERVE Group" /><meta name="citation_author" content="David Moher" /><meta name="citation_author_institution" content="for the CONSERVE Group" /><meta name="citation_author" content="Dawn P. Richards" /><meta name="citation_author_institution" content="for the CONSERVE Group" /><meta name="citation_author" content="Yvette Kasamon" /><meta name="citation_author_institution" content="for the CONSERVE Group" /><meta name="citation_author" content="Kenneth Getz" /><meta name="citation_author_institution" content="for the CONSERVE Group" /><meta name="citation_author" content="Sally Hopewell" /><meta name="citation_author_institution" content="for the CONSERVE Group" /><meta name="citation_author" content="Kay Dickersin" /><meta name="citation_author_institution" content="for the CONSERVE Group" /><meta name="citation_author" content="Taixiang Wu" /><meta name="citation_author_institution" content="for the CONSERVE Group" /><meta name="citation_author" content="Ana Patricia Ayala" /><meta name="citation_author_institution" content="for the CONSERVE Group" /><meta name="citation_author" content="Kenneth F. Schulz" /><meta name="citation_author_institution" content="for the CONSERVE Group" /><meta name="citation_author" content="Sabine Calleja" /><meta name="citation_author_institution" content="for the CONSERVE Group" /><meta name="citation_author" content="Isabelle Boutron" /><meta name="citation_author_institution" content="for the CONSERVE Group" /><meta name="citation_author" content="Joseph S. Ross" /><meta name="citation_author_institution" content="for the CONSERVE Group" /><meta name="citation_author" content="Robert M. Golub" /><meta name="citation_author_institution" content="for the CONSERVE Group" /><meta name="citation_author" content="Karim M. Khan" /><meta name="citation_author_institution" content="for the CONSERVE Group" /><meta name="citation_author" content="Cindy Mulrow" /><meta name="citation_author_institution" content="for the CONSERVE Group" /><meta name="citation_author" content="Nandi Siegfried" /><meta name="citation_author_institution" content="for the CONSERVE Group" /><meta name="citation_author" content="Joerg Heber" /><meta name="citation_author_institution" content="for the CONSERVE Group" /><meta name="citation_author" content="Naomi Lee" /><meta name="citation_author_institution" content="for the CONSERVE Group" /><meta name="citation_author" content="Pamela Reed Kearney" /><meta name="citation_author_institution" content="for the CONSERVE Group" /><meta name="citation_author" content="Rhoda K. Wanyenze" /><meta name="citation_author_institution" content="for the CONSERVE Group" /><meta name="citation_author" content="Asbjørn Hróbjartsson" /><meta name="citation_author_institution" content="for the CONSERVE Group" /><meta name="citation_author" content="Rebecca  Williams" /><meta name="citation_author_institution" content="for the CONSERVE Group" /><meta name="citation_author" content="Nita Bhandari" /><meta name="citation_author_institution" content="for the CONSERVE Group" /><meta name="citation_author" content="Peter Jüni" /><meta name="citation_author_institution" content="for the CONSERVE Group" /><meta name="citation_author" content="An-Wen Chan" /><meta name="citation_author_institution" content="for the CONSERVE Group" /><meta name="citation_author" content="Veronique Kiermer" /><meta name="citation_author_institution" content="for the CONSERVE Group" /><meta name="citation_author" content="Jacqueline  Corrigan-Curay" /><meta name="citation_author_institution" content="for the CONSERVE Group" /><meta name="citation_author" content="John  Concato" /><meta name="citation_author_institution" content="for the CONSERVE Group" /><meta name="citation_title" content="Guidelines for Reporting Trial Protocols and Completed Trials Modified Due to the COVID-19 Pandemic and Other Extenuating Circumstances: The CONSERVE 2021 Statement" /><meta name="citation_firstpage" content="257" /><meta name="citation_lastpage" content="265" /><meta name="citation_doi" content="10.1001/jama.2021.9941" /><meta name="citation_keyword" content="guidelines" /><meta name="citation_keyword" content="clinical trial protocol document" /><meta name="citation_keyword" content="covid-19" /><meta name="citation_keyword" content="coronavirus pandemic" /><meta name="citation_keyword" content="extension" /><meta name="citation_abstract" content="&lt;h3&gt;Importance&lt;/h3&gt;&lt;p&gt;Extenuating circumstances can trigger unplanned changes to randomized trials and introduce methodological, ethical, feasibility, and analytical challenges that can potentially compromise the validity of findings. Numerous randomized trials have required changes in response to the COVID-19 pandemic, but guidance for reporting such modifications is incomplete.&lt;/p&gt;&lt;h3&gt;Objective&lt;/h3&gt;&lt;p&gt;As a joint extension for the CONSORT and SPIRIT reporting guidelines, CONSERVE (CONSORT and SPIRIT Extension for RCTs Revised in Extenuating Circumstances) aims to improve reporting of trial protocols and completed trials that undergo important modifications in response to extenuating circumstances.&lt;/p&gt;&lt;h3&gt;Evidence&lt;/h3&gt;&lt;p&gt;A panel of 37 international trial investigators, patient representatives, methodologists and statisticians, ethicists, funders, regulators, and journal editors convened to develop the guideline. The panel developed CONSERVE following an accelerated, iterative process between June 2020 and February 2021 involving (1) a rapid literature review of multiple databases (OVID Medline, OVID EMBASE, and EBSCO CINAHL) and gray literature sources from 2003 to March 2021; (2) consensus-based panelist meetings using a modified Delphi process and surveys; and (3) a global survey of trial stakeholders.&lt;/p&gt;&lt;h3&gt;Findings&lt;/h3&gt;&lt;p&gt;The rapid review yielded 41 673 citations, of which 38 titles were relevant, including emerging guidance from regulatory and funding agencies for managing the effects of the COVID-19 pandemic on trials. However, no generalizable guidance for all circumstances in which trials and trial protocols might face unanticipated modifications were identified. The CONSERVE panel used these findings to develop a consensus reporting guidelines following 4 rounds of meetings and surveys. Responses were received from 198 professionals from 34 countries, of whom 90% (n = 178) indicated that they understood the concept definitions and 85.4% (n = 169) indicated that they understood and could use the implementation tool. Feedback from survey respondents was used to finalize the guideline and confirm that the guideline’s core concepts were applicable and had utility for the trial community. CONSERVE incorporates an implementation tool and checklists tailored to trial reports and trial protocols for which extenuating circumstances have resulted in important modifications to the intended study procedures. The checklists include 4 sections capturing extenuating circumstances, important modifications, responsible parties, and interim data analyses.&lt;/p&gt;&lt;h3&gt;Conclusions and Relevance&lt;/h3&gt;&lt;p&gt;CONSERVE offers an extension to CONSORT and SPIRIT that could improve the transparency, quality, and completeness of reporting important modifications to trials in extenuating circumstances such as COVID-19.&lt;/p&gt;" /><meta name="citation_journal_title" content="JAMA" /><meta name="citation_journal_abbrev" content="JAMA" /><meta name="citation_volume" content="326" /><meta name="citation_issue" content="3" /><meta name="citation_publication_date" content="2021/07/20" /><meta name="citation_issn" content="0098-7484" /><meta name="citation_publisher" content="American Medical Association" /><meta name="citation_reference" content="citation_title=Measuring the incidence, causes, and repercussions of protocol amendments.; citation_author=Getz  KA; citation_author=Zuckerman  R; citation_author=Cropp  AB;  citation_journal_title=Ther Innov Regul Sci;  citation_year=2011;  citation_volume=45;  citation_issue=3;  citation_pages=265-275; " /><meta name="citation_reference" content="citation_title=The scandal of poor medical research.; citation_author=Altman  DG;  citation_journal_title=BMJ;  citation_year=1994;  citation_volume=308;  citation_issue=6924;  citation_pages=283-284; " /><meta name="citation_reference" content="citation_title=Biomedical research: increasing value, reducing waste.; citation_author=Macleod  MR; citation_author=Michie  S; citation_author=Roberts  I;  citation_journal_title=Lancet;  citation_year=2014;  citation_volume=383;  citation_issue=9912;  citation_pages=101-104; " /><meta name="citation_reference" content="Carlisle BG. Clinical trials stopped by COVID-19. Updated January 29, 2021. Accessed May 31, 2021. https://covid19.bgcarlisle.com/ " /><meta name="citation_reference" content="US Food and Drug Administration. FDA guidance on conduct of clinical trials of medical products during the COVID-19 public health emergency. Published March 2020. Accessed February 5, 2021. https://www.fda.gov/regulatory-information/search-fda-guidance-documents/fda-guidance-conduct-clinical-trials-medical-products-during-covid-19-public-health-emergency " /><meta name="citation_reference" content="South African Health Products Regulatory Authority. SAHPRA policy on conduct of clinical trials of health products during the current COVID-19 pandemic. Published March 25, 2020. Accessed February 5, 2021. http://www.sahpra.org.za/wp-content/uploads/2020/03/SAHPRA-Communication_COVID_19-Final-25032020.pdf " /><meta name="citation_reference" content="Norwegian Medicines Agency. Management of clinical trials in relation to COVID-19. Updated May 20, 2020. Accessed February 5, 2021. https://legemiddelverket.no/english/clinical-trials/management-of-clinical-trials-in-relation-to-covid-19 " /><meta name="citation_reference" content="European Medicines Agency. Implications of coronavirus disease (COVID-19) on methodological aspects of ongoing clinical trials. Published June 29, 2020. Accessed February 5, 2021. https://www.ema.europa.eu/en/implications-coronavirus-disease-covid-19-methodological-aspects-ongoing-clinical-trials " /><meta name="citation_reference" content="citation_title=CONSORT 2010 statement.; citation_author=CONSORT Group; citation_author=Schulz  KF; citation_author=Altman  DG; citation_author=Moher  D;  citation_journal_title=PLoS Med;  citation_year=2010;  citation_volume=7;  citation_issue=3; " /><meta name="citation_reference" content="citation_title=SPIRIT 2013 statement.; citation_author=Chan  A-W; citation_author=Tetzlaff  JM; citation_author=Altman  DG;  citation_journal_title=Ann Intern Med;  citation_year=2013;  citation_volume=158;  citation_issue=3;  citation_pages=200-207; " /><meta name="citation_reference" content="citation_title=Guidance for developers of health research reporting guidelines.; citation_author=Moher  D; citation_author=Schulz  KF; citation_author=Simera  I; citation_author=Altman  DG;  citation_journal_title=PLoS Med;  citation_year=2010;  citation_volume=7;  citation_issue=2; " /><meta name="citation_reference" content="Orkin A,Gill P,Jüni P,. Development protocol: CONSORT and SPIRIT extension for RCTs revised in extenuating circumstances. Open Science Framework. Published 2020. Accessed February 7, 2021. https://osf.io/ms8bz " /><meta name="citation_reference" content="Canadian Institutes of Health Research;Natural Sciences and Engineering Research Council of Canada;Social Sciences and Humanities Research Council. Tri-council Policy Statement: Ethical Conduct for Research Involving Humans (TCPS2). Government of Canada; 2014. " /><meta name="citation_reference" content="citation_title=Evidence summaries: the evolution of a rapid review approach.; citation_author=Khangura  S; citation_author=Konnyu  K; citation_author=Cushman  R;  citation_journal_title=Syst Rev;  citation_year=2012;  citation_volume=1;  citation_issue=1;  citation_pages=10" /><meta name="citation_reference" content="Ayala A,Orkin A,Rombey T,. Managing and reporting major modifications to trial protocols and trial conduct due to extenuating circumstances: a rapid review protocol. Open Science Framework. Published 2020. Accessed February 7, 2021. https://osf.io/t49ev/ " /><meta name="citation_reference" content="citation_title=PRESS Peer Review of Electronic Search Strategies.; citation_author=McGowan  J; citation_author=Sampson  M; citation_author=Salzwedel  DM;  citation_journal_title=J Clin Epidemiol;  citation_year=2016;  citation_volume=75;  citation_pages=40-46; " /><meta name="citation_reference" content="citation_title=CONSORT 2010 explanation and elaboration.; citation_author=CONSORT; citation_author=Moher  D; citation_author=Hopewell  S; citation_author=Schulz  KF;  citation_journal_title=Int J Surg;  citation_year=2012;  citation_volume=10;  citation_issue=1;  citation_pages=28-55; " /><meta name="citation_reference" content="citation_title=SPIRIT 2013 explanation and elaboration.; citation_author=Chan  A-W; citation_author=Tetzlaff  JM; citation_author=Gøtzsche  PC;  citation_journal_title=BMJ;  citation_year=2013;  citation_volume=346; " /><meta name="citation_reference" content="citation_title=The impact of protocol amendments on clinical trial performance and cost.; citation_author=Getz  KA; citation_author=Stergiopoulos  S; citation_author=Short  M;  citation_journal_title=Ther Innov Regul Sci;  citation_year=2016;  citation_volume=50;  citation_issue=4;  citation_pages=436-441; " /><meta name="citation_reference" content="citation_title=Pragmatic strategy empowering paramedics to assess low-risk trauma patients with the Canadian C-Spine Rule and selectively transport them without immobilization.; citation_author=Vaillancourt  C; citation_author=Charette  M; citation_author=Taljaard  M;  citation_journal_title=JMIR Res Protoc;  citation_year=2020;  citation_volume=9;  citation_issue=6; " /><meta name="citation_reference" content="citation_title=Small-Volume Tubes to Reduce Anemia and Transfusion (STRATUS).; citation_author=Siegal  DM; citation_author=Belley-Cote  E; citation_author=Arnold  DM;  citation_journal_title=Blood;  citation_year=2019;  citation_volume=134;  citation_pages=3685" /><meta name="citation_reference" content="citation_title=Efficacy of a low-cost, heat-stable oral rotavirus vaccine in Niger.; citation_author=Isanaka  S; citation_author=Guindo  O; citation_author=Langendorf  C;  citation_journal_title=N Engl J Med;  citation_year=2017;  citation_volume=376;  citation_issue=12;  citation_pages=1121-1130; " /><meta name="citation_reference" content="citation_title=Celecoxib plus hormone therapy versus hormone therapy alone for hormone-sensitive prostate cancer.; citation_author=James  ND; citation_author=Sydes  MR; citation_author=Mason  MD;  citation_journal_title=Lancet Oncol;  citation_year=2012;  citation_volume=13;  citation_issue=5;  citation_pages=549-558; " /><meta name="citation_reference" content="citation_title=Prediction and prevention of the next pandemic zoonosis.; citation_author=Morse  SS; citation_author=Mazet  JA; citation_author=Woolhouse  M;  citation_journal_title=Lancet;  citation_year=2012;  citation_volume=380;  citation_issue=9857;  citation_pages=1956-1965; " /><meta name="citation_reference" content="citation_title=Design and analysis of pilot studies.; citation_author=Lancaster  GA; citation_author=Dodd  S; citation_author=Williamson  PR;  citation_journal_title=J Eval Clin Pract;  citation_year=2004;  citation_volume=10;  citation_issue=2;  citation_pages=307-312; " /><meta name="citation_reference" content="citation_title=Rational and design of the T-STORHM study.; citation_author=Martinaud  C; citation_author=Tiberghien  P; citation_author=Bégué  S;  citation_journal_title=Transfus Clin Biol;  citation_year=2019;  citation_volume=26;  citation_issue=4;  citation_pages=198-201; " /><meta name="citation_reference" content="citation_title=Multiplicity in randomised trials, II.; citation_author=Schulz  KF; citation_author=Grimes  DA;  citation_journal_title=Lancet;  citation_year=2005;  citation_volume=365;  citation_issue=9471;  citation_pages=1657-1661; " /><meta name="citation_reference" content="citation_title=Early stopping of randomized clinical trials for overt efficacy is problematic.; citation_author=Bassler  D; citation_author=Montori  VM; citation_author=Briel  M;  citation_journal_title=J Clin Epidemiol;  citation_year=2008;  citation_volume=61;  citation_issue=3;  citation_pages=241-246; " /><meta name="citation_reference" content="citation_title=Ethical issues in stopping randomized trials early because of apparent benefit.; citation_author=Mueller  PS; citation_author=Montori  VM; citation_author=Bassler  D;  citation_journal_title=Ann Intern Med;  citation_year=2007;  citation_volume=146;  citation_issue=12;  citation_pages=878-881; " /><meta name="citation_reference" content="citation_title=Randomized trials stopped early for benefit.; citation_author=Montori  VM; citation_author=Devereaux  PJ; citation_author=Adhikari  NKJ;  citation_journal_title=JAMA;  citation_year=2005;  citation_volume=294;  citation_issue=17;  citation_pages=2203-2209; " /><meta name="citation_reference" content="citation_title=The use of interim data and data monitoring committee recommendations in randomized controlled trial reports.; citation_author=Tharmanathan  P; citation_author=Calvert  M; citation_author=Hampton  J; citation_author=Freemantle  N;  citation_journal_title=BMC Med Res Methodol;  citation_year=2008;  citation_volume=8;  citation_issue=1;  citation_pages=12" /><meta name="citation_reference" content="citation_title=Changes to aspects of ongoing randomised controlled trials with fixed designs.; citation_author=Coskinas  X; citation_author=Simes  J; citation_author=Schou  M; citation_author=Martin  AJ;  citation_journal_title=Trials;  citation_year=2020;  citation_volume=21;  citation_issue=1;  citation_pages=457" /><meta name="citation_reference" content="citation_title=Ethics review of studies during public health emergencies—the experience of the WHO ethics review committee during the Ebola virus disease epidemic.; citation_author=Alirol  E; citation_author=Kuesel  AC; citation_author=Guraiib  MM;  citation_journal_title=BMC Med Ethics;  citation_year=2017;  citation_volume=18;  citation_issue=1;  citation_pages=43" /><meta name="citation_reference" content="citation_title=Failure to report protocol violations in clinical trials.; citation_author=Sweetman  EA; citation_author=Doig  GS;  citation_journal_title=Trials;  citation_year=2011;  citation_volume=12;  citation_pages=214" /><meta name="citation_reference" content="citation_title=Effect of conservative vs conventional oxygen therapy on mortality among patients in an intensive care unit.; citation_author=Girardis  M; citation_author=Busani  S; citation_author=Damiani  E;  citation_journal_title=JAMA;  citation_year=2016;  citation_volume=316;  citation_issue=15;  citation_pages=1583-1589; " /><meta name="citation_reference" content="citation_title=Effect of e-cigarettes plus counseling vs counseling alone on smoking cessation.; citation_author=Eisenberg  MJ; citation_author=Hébert-Losier  A; citation_author=Windle  SB;  citation_journal_title=JAMA;  citation_year=2020;  citation_volume=324;  citation_issue=18;  citation_pages=1844-1854; " /><meta name="citation_reference" content="citation_title=Effect of dexamethasone on days alive and ventilator-free in patients with moderate or severe acute respiratory distress syndrome and COVID-19.; citation_author=Tomazini  BM; citation_author=Maia  IS; citation_author=Cavalcanti  AB;  citation_journal_title=JAMA;  citation_year=2020;  citation_volume=324;  citation_issue=13;  citation_pages=1307-1316; " /><meta name="citation_reference" content="citation_title=Reproducible research: moving toward research the public can really trust.; citation_author=Laine  C; citation_author=Goodman  SN; citation_author=Griswold  ME; citation_author=Sox  HC;  citation_journal_title=Ann Intern Med;  citation_year=2007;  citation_volume=146;  citation_issue=6;  citation_pages=450-453; " /><meta name="citation_reference" content="Medicines and Healthcare Products Regulatory Agency. Managing clinical trials during coronavirus (COVID-19): how investigators and sponsors should manage clinical trials during COVID-19. Published 2020. Accessed March 2, 2021. https://www.gov.uk/guidance/managing-clinical-trials-during-coronavirus-covid-19 " /><meta name="citation_reference" content="US Food and Drug Administration. Statistical considerations for clinical trials during the COVID-19 public health emergency: guidance for industry. Published June 2020. Accessed May 3, 2021. https://www.fda.gov/regulatory-information/search-fda-guidance-documents/statistical-considerations-clinical-trials-during-covid-19-public-health-emergency-guidance-industry " /><meta name="citation_reference" content="citation_title=A four-step strategy for handling missing outcome data in randomised trials affected by a pandemic.; citation_author=Cro  S; citation_author=Morris  TP; citation_author=Kahan  BC;  citation_journal_title=BMC Med Res Methodol;  citation_year=2020;  citation_volume=20;  citation_issue=1;  citation_pages=208" /><meta name="citation_reference" content="citation_title=COVID-19 ethics and research.; citation_author=Meagher  KM; citation_author=Cummins  NW; citation_author=Bharucha  AE;  citation_journal_title=Mayo Clin Proc;  citation_year=2020;  citation_volume=95;  citation_issue=6;  citation_pages=1119-1123; " /><meta name="citation_reference" content="citation_title=The impact of the global COVID-19 pandemic on the conduct of clinical trials.; citation_author=Vissers  MFJM; citation_author=Cohen  AF; citation_author=Van Gerven  JMA; citation_author=Groeneveld  GJ;  citation_journal_title=Br J Clin Pharmacol;  citation_year=2021;  citation_volume=87;  citation_issue=3;  citation_pages=837-844; " /><meta name="citation_reference" content="citation_title=Challenges in tuberculosis clinical trials in the face of the COVID-19 pandemic.; citation_author=Rusen  ID;  citation_journal_title=Trop Med Infect Dis;  citation_year=2020;  citation_volume=5;  citation_issue=2; " /><meta name="citation_reference" content="citation_title=Challenges and opportunities for sponsors in conducting clinical trials during a pandemic.; citation_author=Davis  S; citation_author=Pai  S;  citation_journal_title=Perspect Clin Res;  citation_year=2020;  citation_volume=11;  citation_issue=3;  citation_pages=115-120; " /><meta name="citation_reference" content="citation_title=Conducting clinical trials in heart failure during (and after) the COVID-19 pandemic.; citation_author=Anker  SD; citation_author=Butler  J; citation_author=Khan  MS;  citation_journal_title=Eur Heart J;  citation_year=2020;  citation_volume=41;  citation_issue=22;  citation_pages=2109-2117; " /><meta name="citation_reference" content="citation_title=Recommendations from national regulatory agencies for ongoing cancer trials during the COVID-19 pandemic.; citation_author=de Paula  BHR; citation_author=Araújo  I; citation_author=Bandeira  L;  citation_journal_title=Lancet Oncol;  citation_year=2020;  citation_volume=21;  citation_issue=5;  citation_pages=624-627; " /><meta name="citation_reference" content="citation_title=Early impact of COVID-19 on the conduct of oncology clinical trials and long-term opportunities for transformation.; citation_author=Waterhouse  DM; citation_author=Harvey  RD; citation_author=Hurley  P;  citation_journal_title=JCO Oncol Pract;  citation_year=2020;  citation_volume=16;  citation_issue=7;  citation_pages=417-421; " /><meta name="citation_reference" content="citation_title=Implications for design and analyses of oncology clinical trials during the COVID-19 pandemic.; citation_author=Moskowitz  CS; citation_author=Panageas  KS;  citation_journal_title=JAMA Oncol;  citation_year=2020;  citation_volume=6;  citation_issue=9;  citation_pages=1326-1327; " /><meta name="citation_reference" content="citation_title=Clinical practice guidance for hepatology and liver transplant providers during the COVID-19 pandemic.; citation_author=APASL Covid-19 Task Force; citation_author=Lau  G; citation_author=Sharma  M;  citation_journal_title=Hepatol Int;  citation_year=2020;  citation_volume=14;  citation_issue=4;  citation_pages=415-428; " /><meta name="citation_reference" content="citation_title=Reporting clinical studies affected by the COVID-19 pandemic.; citation_author=Perlis  RH; citation_author=Haneuse  SJPA; citation_author=Rubenfeld  GD;  citation_journal_title=JAMA Netw Open;  citation_year=2021;  citation_volume=4;  citation_issue=1; " /><meta name="citation_reference" content="citation_title=Preserving clinical trial integrity during the coronavirus pandemic.; citation_author=McDermott  MM; citation_author=Newman  AB;  citation_journal_title=JAMA;  citation_year=2020;  citation_volume=323;  citation_issue=21;  citation_pages=2135-2136; " /><meta name="citation_reference" content="citation_title=“Serious adverse events” faced by clinical trials.; citation_author=Parikh  PM; citation_author=Mehta  P; citation_author=Mvt  KM;  citation_journal_title=Indian J Med Paediatr Oncol;  citation_year=2020;  citation_volume=41;  citation_issue=2;  citation_pages=127" /><meta name="citation_fulltext_world_readable" content="" /><meta name="citation_pdf_url" content="https://jamanetwork.com/journals/jama/articlepdf/2781397/jama_orkin_2021_sc_210001_1626283660.02954.pdf" />

    
        <title>Guidelines for Reporting Trial Protocols and Completed Trials Modified Due to the COVID-19 Pandemic and Other Extenuating Circumstances: The CONSERVE 2021 Statement | Medical Journals and Publishing | JAMA | JAMA Network</title>

    <meta name="description" content="This Special Communication describes CONSERVE, a guideline developed to improve the transparency, quality, and completeness of reporting of trials and">


    <link rel="canonical" href="https://jamanetwork.com/journals/jama/fullarticle/2781397" />









    
    <script src="//cdn.jamanetwork.com/UI/app/dist/head.min.js?v=638488852268208351"></script>
     
     <script src="https://r451.jamanetwork.com/script.js"></script>
        <div class="widget-WidgetLoader widget-instance-AMA_AdTag_HeaderScript">
        
    <meta class="SCM-SharedWidgets-AsyncHeaderAdLoader" data-url="/AMA/AdTag/AMA_AdTag_HeaderScript" data-params="{&quot;parameters&quot;:{&quot;siteName&quot;:&quot;jama&quot;,&quot;siteId&quot;:3,&quot;journalId&quot;:67,&quot;adDisplay&quot;:0,&quot;adSection&quot;:&quot;scholarly&quot;,&quot;adPosition&quot;:&quot;&quot;,&quot;fromGoogle&quot;:false},&quot;dynamicParameters&quot;:{&quot;localParams&quot;:&quot;[REPLACE_WITH_LOCAL]&quot;}}">
 
    </div>
</head>

<body data-sitename="jama" class="pg_article " data-thm="jama">
    
    <script>
        
        var App = App || {};
        App.suppressAds = App.suppressAds || !!document.getElementsByClassName('suppress-ads').length;
        App.suppressGtm = App.suppressGtm || !!document.getElementsByClassName('suppress-gtm').length;
    </script>

    

        <div id="ad-interstitial" class="ad-interstitial">
            <script>
      googletag.cmd.push(function() {
        if (App.suppressAds) { return; }
        App.Ads.slots[13] = googletag.defineOutOfPageSlot(App.Ads.adPath + '/scholarly', 'ad-interstitial')
          .setTargeting('pos', ['interstitial'])
          .addService(googletag.pubads());
        googletag.display('ad-interstitial');
        googletag.pubads().refresh([App.Ads.slots[13]], {changeCorrelator: false});
      });
            </script>
        </div>




    
    <a class="accessible js-skip-to-navigation" href="#skip-to-navigation">[Skip to Navigation]</a>

    <!-- Google Tag Manager --><noscript><iframe src="//www.googletagmanager.com/ns.html?id=GTM-WNKSNP" height="0" width="0" style="display:none;visibility:hidden"></iframe></noscript><script>(function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start': new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0], j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src='//www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f); })(window,document,'script','dataLayer','GTM-WNKSNP');</script><!-- End Google Tag Manager -->

    
    
    <span class="hide tagmanagervalue" data-attribute="productName" data-value="JAMA" data-type="string"></span>
    <form method="post" action="./2781397" id="webform" class="m0">
<input type="hidden" name="__VIEWSTATE" id="__VIEWSTATE" value="pE8iVUdRhog2qGxZ2q2jPBcpVH+lZNNxR7pX8L/i9oWhopxxzF+ueTs7keZGDuSWO8sCJbZb+mcGYZj2q+fHqwVYlpw=" />

<input type="hidden" name="__VIEWSTATEGENERATOR" id="__VIEWSTATEGENERATOR" value="2173C2F0" />
<input type="hidden" name="__EVENTVALIDATION" id="__EVENTVALIDATION" value="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" />
        
        <input id="hdnSiteID" type="hidden" value="3" />
        <input id="hdnDomain" type="hidden" value=".jamanetwork.com" />

        
        

        
        

    <section class="master-header">
        


<script type='text/javascript'>
    var App = App || {};
    App.LoginUserInfo = {
        isInstLoggedIn: [0],
        currentSessionId: 'ibgo5wh3s51i0lzbxyfqdc0c'
    };
</script>



<input name="ctl00$ctl00$BodyContent$Header$hfGlobalSearchSiteURL" type="hidden" id="hfGlobalSearchSiteURL" value="https://jamanetwork.com/" />

<input name="ctl00$ctl00$BodyContent$Header$hfAppIsPaidUser" type="hidden" id="hfAppIsPaidUser" value="false" />
<input name="ctl00$ctl00$BodyContent$Header$hfAppIsMember" type="hidden" id="hfAppIsMember" value="false" />
<input name="ctl00$ctl00$BodyContent$Header$hfAppSubscribedTo" type="hidden" id="hfAppSubscribedTo" />
<input name="ctl00$ctl00$BodyContent$Header$hfAppIsIndividual" type="hidden" id="hfAppIsIndividual" value="false" />
<input name="ctl00$ctl00$BodyContent$Header$hfAppHasAccess" type="hidden" id="hfAppHasAccess" value="false" />
<input name="ctl00$ctl00$BodyContent$Header$hfAppIsReferredFromGoogle" type="hidden" id="hfAppIsReferredFromGoogle" value="False" />
<input name="ctl00$ctl00$BodyContent$Header$hfSolrAutoSuggestMinimumCharactersLength" type="hidden" id="hfSolrAutoSuggestMinimumCharactersLength" value="2" />
<input name="ctl00$ctl00$BodyContent$Header$hfSolrJournalName" type="hidden" id="hfSolrJournalName" value="JAMA" />
<input name="ctl00$ctl00$BodyContent$Header$hfSolrJournalID" type="hidden" id="hfSolrJournalID" value="J67" />
<input name="ctl00$ctl00$BodyContent$Header$hfAppIsLucy" type="hidden" id="hfAppIsLucy" value="false" />


<div class="header-wrap">
    <header class="header">
            <div class="widget-GdprCookieBanner widget-instance-GdprCookieBanner">
        <div class="gdpr-cookie-wrapper js-gdpr-banner">
	<div class="gdpr-cookie-body">
Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our <a href="https://jamanetwork.com/pages/privacy-policy#cookies">Cookie Policy</a>&nbsp;<span class="pipe">|</span>&nbsp;<a href="javascript:;" class="js-gdpr-cookie-acceptLink at-acceptgdpr">Continue</a>	</div>
            <input id="hdnDomain" type="hidden" value=".jamanetwork.com" />

    <input id="hdnDomainGdpr" type="hidden" value=".jamanetwork.com" />
    <input id="hdnClientIdGdpr" type="hidden" value="3" />

</div> 
    </div>

        <div class="network-bar">
            <a class="jama-network" href="/" title="JAMA Network Home">
                <img alt="JAMA Network Home" class="title-image" width="443" height="52" src="//cdn.jamanetwork.com/UI/app/svg/Jama_Network_Logo.svg">
            </a>
            
        </div>

        <a class="nav-toggler" href="#nav">
            <div class="nav-toggler-indicator">
                <span class="indicator-stroke"></span>
                <span class="indicator-stroke"></span>
                <span class="indicator-stroke"></span>
                <span class="indicator-stroke"></span>
            </div>
            <div class="nav-toggler-site">
                <span id="BodyContent_Header_siteFullNamenav" class="nav-toggler-microsite"><span class='network'>JAMA</span></span>
            </div>
        </a>
        <nav id="nav" class="nav hide" >
            <div class="nav-journal-level sb-nav-journal-level">
                <a href="https://jamanetwork.com/journals/jama" id="BodyContent_Header_rptMicrositeHeaders_aItemResourceList_0" class="home">Home</a><a href="https://jamanetwork.com/journals/jama/newonline" id="BodyContent_Header_rptMicrositeHeaders_aItemResourceList_1" class="new-online">New Online</a><a href="https://jamanetwork.com/journals/jama/currentissue" id="BodyContent_Header_rptMicrositeHeaders_aItemResourceList_2" class="current-issue">Current Issue</a><a href="https://jamanetwork.com/journals/jama/pages/for-authors" id="BodyContent_Header_rptMicrositeHeaders_aItemResourceList_3" class="for-authors">For Authors</a>
            </div>
            <div class="nav-journals">
                    <div class="widget-SelfServeContent widget-instance-HamburgerPublicationMenu">
        


<div class="self-serve">
    <input type="hidden" class="SelfServeContentId" value="HamburgerPublicationMenu" />
    <input type="hidden" class="SelfServeVersionId" value="0" />

<style type="text/css">
    .nav-journals {margin-bottom: 1em;}
    .nav-heading {color: #B9B9B9;border-bottom: 1px solid #242424;border-top: 1px solid #242424;font-size: 1.15em;font-weight: 400;margin: 0;padding: .7em .75em;text-transform: uppercase;}
    a.no-bullet:before {content:none !important;}
    .nav-heading {font-size: 1.15em;margin-bottom:0;padding-left: 38px;}
    .nav-journals a.theme-jama {background-color: #242424;border-bottom: 1px solid #fff;border-top: 1px solid #fff;color: #fff;font-size: 1.15em;margin-bottom: 8px;padding: 11px 0 9px 37px;}
    .nav-journals a.theme-jama::before {background: unset;content: "\e91b";display: none;font-family: ama_icons !important;font-size: 1.25em;line-height: 1;}
    .nav-journals a.theme-jama-network-open {border-bottom:0;}
    .nav .widget-instance-HamburgerPublicationMenu a {padding-left: 36px;}
    .fake-ribbon {border-left: 8px solid #BE1E32;}
    .fake-ribbon a:before {content:none;}
    .nav .widget-instance-HamburgerPublicationMenu .fake-ribbon a {padding-left:30px;}
</style>
<h2 class="nav-heading">Journals</h2>
<a href="/journals/jama" class="theme-jama">JAMA</a>
<a href="/journals/jamanetworkopen" class="theme-jama-network-open">JAMA Network Open</a>
<a href="/journals/jamacardiology" class="theme-jama-cardiology">JAMA Cardiology</a>
<a href="/journals/jamadermatology" class="theme-jama-dermatology">JAMA Dermatology</a>
<a href="/journals/jama-health-forum" class="theme-jama-health-forum">JAMA Health Forum</a>
<a href="/journals/jamainternalmedicine" class="theme-jama-internal-medicine">JAMA Internal Medicine</a>
<a href="/journals/jamaneurology" class="theme-jama-neurology">JAMA Neurology</a>
<a href="/journals/jamaoncology" class="theme-jama-oncology">JAMA Oncology</a>
<a href="/journals/jamaophthalmology" class="theme-jama-ophthalmology">JAMA Ophthalmology </a>
<a href="/journals/jamaotolaryngology" class="theme-jama-otolaryngology-head-neck-surgery">JAMA Otolaryngology–Head &amp; Neck Surgery</a>
<a href="/journals/jamapediatrics" class="theme-jama-pediatrics">JAMA Pediatrics</a>
<a href="/journals/jamapsychiatry" class="theme-jama-psychiatry">JAMA Psychiatry</a>
<a href="/journals/jamasurgery" class="theme-jama-surgery">JAMA Surgery</a>
<a href="/journals/archneurpsyc" class="theme-archives-of-neurology-psychiatry-1919-1959-">Archives of Neurology &amp; Psychiatry (1919-1959)</a>
<h2 class="nav-heading">Podcasts</h2>
<a href="/journals/jama/pages/jama-clinical-reviews">Clinical Reviews</a>
<a href="/journals/jama/pages/jama-editors-summary">Editors' Summary</a>
<a href="/journals/jama/pages/jama-medical-news">Medical News</a>
<a href="/journals/jama/pages/jama-author-interviews">Author Interviews</a>
<a href="/pages/audio" class="no-bullet">More</a>


</div>

 
    </div>
    
            </div>
            <div class="nav-network-other">
                <a href="https://edhub.ama-assn.org/jn-learning" id="BodyContent_Header_rptOtherResources_aItemResourceList_0" class="is-b link-jn-learning-cme" target="_blank">JN Learning / CME</a><a href="https://store.jamanetwork.com/index.aspx?productcode=64" id="BodyContent_Header_rptOtherResources_aItemResourceList_1" class="is-b link-subscribe" target="_blank">Subscribe</a><a href="https://careers.jamanetwork.com/" id="BodyContent_Header_rptOtherResources_aItemResourceList_2" class="is-b link-jobs" target="_blank">Jobs</a><a href="https://jamanetwork.com/pages/resources-for-librarians" id="BodyContent_Header_rptOtherResources_aItemResourceList_3" class="is-b link-institutions-librarians">Institutions / Librarians</a><a href="https://jamanetwork.com/pages/reprints-and-permissions" id="BodyContent_Header_rptOtherResources_aItemResourceList_4" class="is-b link-reprints-permissions" rel="nofollow">Reprints &amp; Permissions</a>
            </div>
            <div class="white text-xxs">
                <div class="p05 ml4 mr3 mb1 mt10 flex hamburger-menu-legal">
                    <a href="/pages/conditions-of-use" class="p0" rel="nofollow">Terms of Use</a>
                    <span class="pl1 pr1">| </span>
                    <a href="/pages/privacy-policy" class="p0" rel="nofollow">Privacy Policy</a>
                    <span class="pl1 pr1">| </span>
                    <a href="/pages/accessibility-statement" class="p0" rel="nofollow">Accessibility Statement</a>
                </div>
                <div class="ta-c">
                    <span class="pb1">2024 American Medical Association. All Rights Reserved</span>
                </div>
            </div>
        </nav>

        

        
        <a class="toolbar-search-trigger is-b" data-mobile-tog-target=".site-search"></a>

        
        <div id="site-search" role="search" class="site-search">
            <div class="site-search-bar">
                
                <div role="search">
                    <select name="ctl00$ctl00$BodyContent$Header$ddlForSearch" id="BodyContent_Header_ddlForSearch" Name="dropDownList" class="cs-select cs-skin-border" title="Search Site Selector" role="options" aria-labelledby="searchLabel">
	<option value="J*">Search All</option>
	<option value="3">JAMA</option>
	<option value="214">JAMA Network Open</option>
	<option value="192">JAMA Cardiology</option>
	<option value="12">JAMA Dermatology</option>
	<option value="261">JAMA Forum Archive</option>
	<option value="193">JAMA Health Forum</option>
	<option value="15">JAMA Internal Medicine</option>
	<option value="16">JAMA Neurology</option>
	<option value="159">JAMA Oncology</option>
	<option value="17">JAMA Ophthalmology</option>
	<option value="18">JAMA Otolaryngology–Head &amp; Neck Surgery</option>
	<option value="19">JAMA Pediatrics</option>
	<option value="14">JAMA Psychiatry</option>
	<option value="20">JAMA Surgery</option>
	<option value="23">Archives of Neurology &amp; Psychiatry</option>

</select>
                </div>
                
                <div class="search-input-container">
                    <input type="search" name="textbox" autocomplete="off" role="textbox" id="search-term" aria-labelledby="searchLabel" class="search-term at-microsite-search-term" placeholder="Enter Search Term" maxlength="255" title="Enter Search Term">
                  
                    <ul id="umbrellaSiteAutoCompleteResults" class="term-list hidden"></ul>
                    
                    <label style="display:none" for="umbrellaSiteSearchInputHint" id="searchLabel">Input Search Term</label>
                      <input class="searchTerm search-input" name="textbox" role="textbox" type="text" id="umbrellaSiteSearchInputHint" aria-labelledby="searchLabel" title="Input Search Term" autocomplete="off">
                </div>
                <!-- /.search-input-container -->
                
                <a name="button" role="button" class="search-button is-b" alt="search button" href="javascript:;"></a>
            </div>
        </div>
        
        <div id="BodyContent_Header_GlobalSignIn_auth" class="auth">
            <a class="auth--trigger is-b is-a" href="javascript:;">
                <span id="BodyContent_Header_GlobalSignIn_spnUserFullName" class="user-full-name">Sign In</span>
            </a>

            <div class="auth--dropdown js-signIn-dropdown">
                
                <div class="auth--option auth--ind">
                    
                    <div id="BodyContent_Header_GlobalSignIn_divUserFullName" class="auth--ind-user"></div>                    
                    
                    <div id="BodyContent_Header_GlobalSignIn_divIndSignIn" class="auth--ind-auth">
                        <div class="auth--title">Individual Sign In</div>
                        <a href="https://jamanetwork.com/oauthsignin?return_url=https%3a%2f%2fjamanetwork.com%2fjournals%2fjama%2ffullarticle%2f2781397" id="BodyContent_Header_GlobalSignIn_oauthSignInLink" rel="nofollow" class="auth--ind-sign-in">Sign in</a><a href="https://jamanetwork.com/oauthsignin?return_url=https%3a%2f%2fjamanetwork.com%2fjournals%2fjama%2ffullarticle%2f2781397" id="BodyContent_Header_GlobalSignIn_oauthSignUpLink" rel="nofollow" class="auth--ind-create">Create an Account</a>
                    </div>
                </div>

                
                <div id="BodyContent_Header_GlobalSignIn_divInstSignIn" class="auth--option auth--inst">

                    
                    
                    <div class="auth--inst-auth">
                        <div class="auth--title">Access through your institution</div>
                        <a href="/signinshibboleth?returnUrl=https%3a%2f%2fjamanetwork.com%2fjournals%2fjama%2ffullarticle%2f2781397" id="BodyContent_Header_GlobalSignIn_institutionSignIn" rel="nofollow" class="auth--shib">Sign In</a>
                    </div>
                    </div>
 
                                               
                <div id="BodyContent_Header_GlobalSignIn_divPurchaseOptions" class="auth--option auth--purchase">
                    <div class="auth--title">Purchase Options:</div>
                    
                    <a id="BodyContent_Header_GlobalSignIn_lnkSubscribeJournal" class="auth--subscribe" rel="nofollow" href="https://store.jamanetwork.com/index.aspx?productcode=64">Subscribe to the JAMA journal</a>
                </div>

                
                

                
            </div>
        </div>




    </header>
</div>


<div class="editors-choice-header">
</div>

<div id="BodyContent_Header_divAds" class="header-ad-wrap sb-background-primary-dark">
        <div class="leader-ad desktop-only">
            
                <div class="widget-WidgetLoader widget-instance-AMA_AdTag_LeaderboardAd">
        
    <div class="SCM-SharedWidgets-AsyncAdLoader" data-url="/AMA/AdTag/AMA_AdTag_LeaderboardAd" data-params="{&quot;parameters&quot;:{&quot;siteName&quot;:&quot;jama&quot;,&quot;siteId&quot;:3,&quot;journalId&quot;:67,&quot;adDisplay&quot;:1,&quot;adSection&quot;:&quot;scholarly&quot;,&quot;adPosition&quot;:&quot;atf&quot;,&quot;fromGoogle&quot;:false},&quot;dynamicParameters&quot;:{&quot;localParams&quot;:&quot;[REPLACE_WITH_LOCAL]&quot;}}"></div>
 
    </div>

        </div>
    </div>

<!-- /.header-ad-wrap -->


    </section>


    <section class="master-main">
        
    <div class="social-share hide" data-share-journal="JAMA_current" data-share-title="CONSERVE Guidelines for Trials Modified Due to Extenuating Circumstances"></div>

        <div class="widget-UserContentAccessWrite widget-instance-AMA_LocalStorage_Article">
        <div class="SCM-SharedWidgets-LocalStorage-UserContentAccessWrite" data-values='{"id":"2781397","type":"Article","date":"5/5/2024 10:52:52 AM"}'></div>
 
    </div>
    <div class="widget-ArticleToggleView widget-instance-AMA_ArticleToggleView">
        
    <div class="widget-ArticleFullView widget-instance-AMA_ArticleFullView">
        
<script>
    (function () {
        var bodyElem = document.querySelector('body');
        var className = 'split-screen';

        if (bodyElem.classList) {
            bodyElem.classList.add(className);
        } else {
            el.className += ' ' + className;
        }
    })();
</script>


<div id="resources-panel" class="resources-panel">
                <span class="hide tagmanagervalue" data-attribute="template" data-value="splitscreen" data-type="string"></span>


    <div class="tab-nav">
        <a class="tab-nav-trigger tab-nav-full-text tablet-down" href="#full-text-tab">
            <i class="icon-full_text"><span class="sr-t">full text icon</span></i>
            <div class="tab-nav-tab-name">Full Text</div>
        </a>
        <a class="tab-nav-trigger tab-nav-contents target-tab-active" href="#contents-tab">
            <i class="icon-contents"><span class="sr-t">contents icon</span></i>
            <div class="tab-nav-tab-name">Contents</div>
        </a>
        <a class="tab-nav-trigger tab-nav-figure-table" href="#figure-table-tab">
            <i class="icon-figures"><span class="sr-t">figure icon</span></i>
            <div class="tab-nav-tab-name">Figures / <br> Tables</div>
        </a>
        <a class="tab-nav-trigger tab-nav-multimedia" href="#multimedia-tab">
            <i class="icon-multimedia"><span class="sr-t">multimedia icon</span></i>
            <div class="tab-nav-tab-name">Multimedia</div>
        </a>
        <a class="tab-nav-trigger tab-nav-supplemental" href="#supplemental-tab">
            <i class="icon-attach"><span class="sr-t">attach icon</span></i>
            <div class="tab-nav-tab-name">Supplemental <br> Content</div>
        </a>
        <a class="tab-nav-trigger tab-nav-references" href="#references-tab">
            <i class="icon-references"><span class="sr-t">references icon</span></i>
            <div class="tab-nav-tab-name">References</div>
        </a>
        <a class="tab-nav-trigger tab-nav-related" href="#related-tab">
            <i class="icon-related"><span class="sr-t">related icon</span></i>
            <div class="tab-nav-tab-name">Related</div>
        </a>
        <a class="tab-nav-trigger tab-nav-comments" href="#comments-tab">
            <i class="icon-user-comments"><span class="sr-t">comments icon</span></i>
            <div class="tab-nav-tab-name">Comments</div>
        </a>
    </div>



    <div class="resource-tabs">
        <div id="contents-tab" class="resource-tab js-resource-tab contents-tab tab-active">
            <div class="contents-tab-contents">
            <a id="pdf-link" class="toolbar-tool toolbar-pdf al-link pdfaccess" data-article-id="2781397" data-article-url="/journals/jama/articlepdf/2781397/jama_orkin_2021_sc_210001_1626283660.02954.pdf" data-ajax-url="/Content/CheckPdfAccess"><span class="toolbar-pdf-text"><span class="toolbar-link-text-extra">Download </span><span class="toolbar-link-text">PDF</span></span>
            </a>
                        <div class="content-comment-bubble">
                            <a class="content-comment-link">
                                <span class="content-comment-text">Comment</span>
                            </a>
                        </div>
    <div class="widget-ArticleJumpLinks widget-instance-AMA_ArticleJumpLinks_Widget">
            <a href="#top" class="section-jump-link contents-tab-jump-link top-of-article" data-tab-toggle=".tab-nav-full-text">Top of Article</a>
    <ul class="section-jump-links bullet ml2 pl1">
                <li><a class="section-jump-link contents-tab-jump-link scroll-to head-1" href="#247891022" data-tab-toggle=".tab-nav-full-text">Key Points</a></li>
                <li><a class="section-jump-link contents-tab-jump-link scroll-to head-1" href="#247891023" data-tab-toggle=".tab-nav-full-text">Abstract</a></li>
                <li><a class="section-jump-link contents-tab-jump-link scroll-to head-1" href="#247891028" data-tab-toggle=".tab-nav-full-text">Introduction</a></li>
                <li><a class="section-jump-link contents-tab-jump-link scroll-to head-1" href="#247891032" data-tab-toggle=".tab-nav-full-text">Methods</a></li>
                <li><a class="section-jump-link contents-tab-jump-link scroll-to head-1" href="#247891046" data-tab-toggle=".tab-nav-full-text">Results</a></li>
                <li><a class="section-jump-link contents-tab-jump-link scroll-to head-1" href="#247891071" data-tab-toggle=".tab-nav-full-text">Discussion</a></li>
                <li><a class="section-jump-link contents-tab-jump-link scroll-to head-1" href="#247891081" data-tab-toggle=".tab-nav-full-text">Article Information</a></li>
                <li><a class="section-jump-link contents-tab-jump-link scroll-to head-1" href="#247891082" data-tab-toggle=".tab-nav-full-text">References</a></li>
    </ul>
 
    </div>
    <div class="widget-SelfServeContent widget-instance-AMA_Contents_Tab_SelfServe">
        


<div class="self-serve">
    <input type="hidden" class="SelfServeContentId" value="v2_article_content_tab" />
    <input type="hidden" class="SelfServeVersionId" value="0" />

<div class="bc_right_rail_article_promo"><!-- Content Goes Here --></div>


</div>

 
    </div>

            </div>
            <div class="contents-tab-ad">
                <div id="split-screen-contab"></div>
            </div>
        </div>

        
        <div id="figure-table-tab" class="resource-tab js-resource-tab figure-table-tab need-jobs-ad">
    <div class="widget-ArticleFiguresAndTables widget-instance-AMA_Article_Figures_Tab">
        <div class="figure-table-wrapper thm-bd-top"><div class="figure-label">Figure.  CONSERVE Implementation Tool</div><a id="jsc210001f1" class="figure-table-anchor"> </a><div class="figure-table-links right"><a class="view-large figure-table-link is-b desktop-only" path-from-xml="jsc210001f1" href="https://cdn.jamanetwork.com/ama/content_public/journal/jama/938737/jsc210001f1_1626283660.46193.png?Expires=1717907442&amp;Signature=myDfjkdZcMDta-~i5Wc4qkdaNSCvcrekloHerq8-y-ZGeE20z4xOLKa2VlXQqxwXTevKDUsjmB4MMlDPWhv7TXSyRywPsAW4C8Dbsm9ZU28b4q1GmPqkI462wpvwCs5ro7DB5c~SGx2P8OK0W-lwxA58hFs-2iDX~GDlgqTWGGnn2yNIohm1QMeGu9w-~70lPmH7NgD09Q~kUirfkwxom4D1LkOluEOZ30ZxcgvZDLeEj2LB0ookNxLAkQwokYalCOJzO1M~XiOn1Oljbw9Rm5tALZBH1IYG6IS2~K4L6-NeqVpg3-u9Ni5lYy~Tsbmu2Wm8AW8UqPSKheg0yAUaHA__&amp;Key-Pair-Id=APKAIE5G5CRDK6RD3PGA" target="_blank" rel="nofollow"><span class="view-large-text">View Large</span></a><a class="download-ppt figure-table-link is-b stats-download-figure-table" path-from-xml="jsc210001f1" href="/downloadimage.aspx?image=https://cdn.jamanetwork.com/ama/content_public/journal/jama/938737/jsc210001f1_1626283660.46193.png?Expires=1717907442&Signature=myDfjkdZcMDta-~i5Wc4qkdaNSCvcrekloHerq8-y-ZGeE20z4xOLKa2VlXQqxwXTevKDUsjmB4MMlDPWhv7TXSyRywPsAW4C8Dbsm9ZU28b4q1GmPqkI462wpvwCs5ro7DB5c~SGx2P8OK0W-lwxA58hFs-2iDX~GDlgqTWGGnn2yNIohm1QMeGu9w-~70lPmH7NgD09Q~kUirfkwxom4D1LkOluEOZ30ZxcgvZDLeEj2LB0ookNxLAkQwokYalCOJzO1M~XiOn1Oljbw9Rm5tALZBH1IYG6IS2~K4L6-NeqVpg3-u9Ni5lYy~Tsbmu2Wm8AW8UqPSKheg0yAUaHA__&Key-Pair-Id=APKAIE5G5CRDK6RD3PGA&sec=247891049&ar=2781397&imagename=&siteId=3" rel="nofollow"><span class="download-ppt-text">Download</span></a><a class="figure-table-twitter figure-table-link figure-table-social addthis_button_twitter is-b" rel="nofollow"><span class="share-text"> </span></a><a class="figure-table-facebook figure-table-link figure-table-social addthis_button_facebook is-b" rel="nofollow"><span class="share-text"> </span></a></div><div class="figure-table cf cb"><div class="figure-table-image"><a href="https://cdn.jamanetwork.com/ama/content_public/journal/jama/938737/jsc210001f1_1626283660.46193.png?Expires=1717907442&amp;Signature=myDfjkdZcMDta-~i5Wc4qkdaNSCvcrekloHerq8-y-ZGeE20z4xOLKa2VlXQqxwXTevKDUsjmB4MMlDPWhv7TXSyRywPsAW4C8Dbsm9ZU28b4q1GmPqkI462wpvwCs5ro7DB5c~SGx2P8OK0W-lwxA58hFs-2iDX~GDlgqTWGGnn2yNIohm1QMeGu9w-~70lPmH7NgD09Q~kUirfkwxom4D1LkOluEOZ30ZxcgvZDLeEj2LB0ookNxLAkQwokYalCOJzO1M~XiOn1Oljbw9Rm5tALZBH1IYG6IS2~K4L6-NeqVpg3-u9Ni5lYy~Tsbmu2Wm8AW8UqPSKheg0yAUaHA__&amp;Key-Pair-Id=APKAIE5G5CRDK6RD3PGA" target="_blank" path-from-xml="jsc210001f1" rel="nofollow"><img data-original="https://cdn.jamanetwork.com/ama/content_public/journal/jama/938737/m_jsc210001f1_1626283660.46193.png?Expires=1717907442&amp;Signature=BDUpQeR2Uowgl~s6LlYMb1Pb4YgrRxc9baKlfaew2zBY-G3JcaXpg8~xy6X0KIPnYOQC8m2fF46VbH7XzMBlKwM4vavl2Yu582cqrix~DpBMifnQuT6lJxRF3yuUxXg6g6uYP~JDo0CNBISlsRJTIYYM335-pk6wcMUOpRqnLcUc43JvpzyVBWpqjYsguAM7lo1u1JBLw7DTB3pddFmGxRaHXfr5t2POLdCYH8hohkrrUAioU88VANXpB3V1jTfRbL5dOePNr98F97~YsrzWpCALab43FNX3BXGkv7mYSWrr2DAeXZ3psCzJB5ORhIZ58ze3jKW0Cbrre-3~J4IPAw__&amp;Key-Pair-Id=APKAIE5G5CRDK6RD3PGA" alt="CONSERVE Implementation Tool" class="content-img lazy" path-from-xml="jsc210001f1" /></a></div></div><div class="figure-caption clip-last-child"><p class="para">The CONSERVE implementation tool is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International license.</p></div></div> 
    </div>
    <div class="widget-ArticleFiguresAndTables widget-instance-AMA_Article_Tables_Tab">
        <div class="figure-table-wrapper thm-bd-top"><div class="table-label">Table.  Examples of Trials Undergoing Important Modifications in Extenuating Circumstances</div><a class="figure-table-anchor" id="jsc210001t1"> </a><div class="figure-table-links right"><a class="view-large figure-table-link is-b desktop-only" path-from-xml="jsc210001t1" href="https://cdn.jamanetwork.com/ama/content_public/journal/jama/938737/jsc210001t1_1626283660.49195.png?Expires=1717907442&amp;Signature=cl3P9G6pQuS0F1~PiUyqPlM3Ho8CWA6F4zcsjHBf1Ubaj7ClrQVRceW731piKE2~oV2sCPb8JHCtcK-dPQfrJMIJP-4q2xpNinu8z~~eqXonfvQYqwn3rE3NNrTe6k-tgvVV~NndUDRti~ZqX7FOidW~dioiukxG2jPS9bJn-Ccil9WrUSh52Nm0~COUFrA88iQCVmggHQU14D7~fOmxdYzzL2RTfoLKy1ibGpWS3fR8Or6kgClvF2Q6hEjs3EaiimRveJ1vL8FvhdmUoJkMaWrvwVinNWppQNX1EEugw~HW~blA-8wI5630qxXtBBS-uQVKi42Ae5TyOJMioGDuFg__&amp;Key-Pair-Id=APKAIE5G5CRDK6RD3PGA" target="_blank" rel="nofollow"><span class="view-large-text">View Large</span></a><a class="download-ppt figure-table-link is-b stats-download-figure-table" path-from-xml="jsc210001t1" href="/downloadimage.aspx?image=https://cdn.jamanetwork.com/ama/content_public/journal/jama/938737/jsc210001t1_1626283660.49195.png?Expires=1717907442&Signature=cl3P9G6pQuS0F1~PiUyqPlM3Ho8CWA6F4zcsjHBf1Ubaj7ClrQVRceW731piKE2~oV2sCPb8JHCtcK-dPQfrJMIJP-4q2xpNinu8z~~eqXonfvQYqwn3rE3NNrTe6k-tgvVV~NndUDRti~ZqX7FOidW~dioiukxG2jPS9bJn-Ccil9WrUSh52Nm0~COUFrA88iQCVmggHQU14D7~fOmxdYzzL2RTfoLKy1ibGpWS3fR8Or6kgClvF2Q6hEjs3EaiimRveJ1vL8FvhdmUoJkMaWrvwVinNWppQNX1EEugw~HW~blA-8wI5630qxXtBBS-uQVKi42Ae5TyOJMioGDuFg__&Key-Pair-Id=APKAIE5G5CRDK6RD3PGA&sec=247891054&ar=2781397&imagename=&siteId=3" rel="nofollow"><span class="download-ppt-text">Download</span></a><a class="figure-table-twitter figure-table-link figure-table-social addthis_button_twitter is-b" rel="nofollow"><span class="share-text"> </span></a><a class="figure-table-facebook figure-table-link figure-table-social addthis_button_facebook is-b" rel="nofollow"><span class="share-text"> </span></a></div><div class="figure-table cf cb"><div class="figure-table-image"><a href="https://cdn.jamanetwork.com/ama/content_public/journal/jama/938737/jsc210001t1_1626283660.49195.png?Expires=1717907442&amp;Signature=cl3P9G6pQuS0F1~PiUyqPlM3Ho8CWA6F4zcsjHBf1Ubaj7ClrQVRceW731piKE2~oV2sCPb8JHCtcK-dPQfrJMIJP-4q2xpNinu8z~~eqXonfvQYqwn3rE3NNrTe6k-tgvVV~NndUDRti~ZqX7FOidW~dioiukxG2jPS9bJn-Ccil9WrUSh52Nm0~COUFrA88iQCVmggHQU14D7~fOmxdYzzL2RTfoLKy1ibGpWS3fR8Or6kgClvF2Q6hEjs3EaiimRveJ1vL8FvhdmUoJkMaWrvwVinNWppQNX1EEugw~HW~blA-8wI5630qxXtBBS-uQVKi42Ae5TyOJMioGDuFg__&amp;Key-Pair-Id=APKAIE5G5CRDK6RD3PGA" target="_blank" path-from-xml="jsc210001t1" rel="nofollow"><img data-original="https://cdn.jamanetwork.com/ama/content_public/journal/jama/938737/m_jsc210001t1_1626283660.49195.png?Expires=1717907442&amp;Signature=J9WUKCM3fgjLRkPMNU1C4GE48wYY5smQfRU-f4sW5Si9Sn8T4Nltdl9taxNesjb8ZsiwsSpZlq8qoWuL8Ppfbxqh07LkdaWk9Tb5i0Hq4OoMvhjcXZBB6CX13v9lGgYKXIw4z6FW70pYQFkccdvCLx0OB9zfNY8DtEqvzUi0~Sq47OqW3so7vWe5j2xJI8CDTDmFSVxgYdga73XvzB6qxsGKubAXnWM4RgWw~Wa3NIMjp2yepi2sAa5mZtxoY9lW~n~I-wuc~-H9CMbT2lGoHBTvY8sMnu2fGjpDa7tZqDP1sKmb7sx3w8cNZgo0VQTmu6wWBDRNBDcb9UYtmnYCDw__&amp;Key-Pair-Id=APKAIE5G5CRDK6RD3PGA" alt="Examples of Trials Undergoing Important Modifications in Extenuating Circumstances" class="content-img lazy" path-from-xml="jsc210001t1" /></a></div></div><div class="table-caption"></div></div> 
    </div>

        </div>

        
        <div id="multimedia-tab" class="resource-tab js-resource-tab multimedia-tab need-jobs-ad">

        </div>

        
        <div id="supplemental-tab" class="resource-tab js-resource-tab supplemental-tab need-jobs-ad">
    <div class="widget-ArticleDataSupplements widget-instance-AMA_Data_Supplements_Tab">
            <div class="supplement">
        <a id="note-JSC210001-1" href="https://cdn.jamanetwork.com/ama/content_public/journal/jama/938737/jsc210001supp1_prod_1626283660.03453.pdf?Expires=1717907748&amp;Signature=x7aOyRRZA9d3DG7TE-zLsAWFwLB5KTCUSl-QyfSC5cFMtU63mFtLMzZtXbtAP6TejiHQXlQfQ6s1YKFBN6It9l59HZjVGiglaNeftrMqTI-kPjxKlfcCCJO-WAVd7e5REnm4Yssgj8VVkypmcYp2fTMxdiyydVHs2C8VF-hP7MlIMmuFbwxwzRpG89GjVxp4gfgkgPao~HbZrUiF47B2~R1jYWo-c9PNmSz1NUY~4QcJAeu58uk2r1Y15vJUZbo~c2CkNC0frlzwzlQEYeojzlCNpEDUcCu21MNsjGy49nUwkAycg4LdZxU0wWhkuiRGFAJ2~mKYfsuwIgBeArlzvA__&amp;Key-Pair-Id=APKAIE5G5CRDK6RD3PGA" class="supplement-link supplement-download stats-supplement-download" rel=&quot;nofollow&quot;>
            <div class="pdf supplement-type"></div>
                <div class="supplement-title"><span class="title-label">Supplement 1.</span><p class="para"><strong>eAppendix 1.</strong> Summary of Survey of Trial Professionals</p><p class="para"><strong>eAppendix 2.</strong> Summary Rapid Review Findings</p><p class="para"><strong>eAppendix 3.</strong> Search Strategies</p></div>
        </a>        
    </div>
    <div class="supplement">
        <a id="note-JSC210001-1" href="https://cdn.jamanetwork.com/ama/content_public/journal/jama/938737/jsc210001supp2_prod_1626283660.03951.pdf?Expires=1717907748&amp;Signature=sfh7jg20h5wlGaW5vLD4~M7UlZvfAT8BKCvibg--269F3qy5J4cqiA12Tg25OzS1AUBwjPDMQKwCQD50cnPUvYgZIfavDuRP6qfIIAirtRNOs-7LDA8B7i49seqoDB9PR59zct5Wvj~O13HZyli8lGxwDvCs2miQxlkTNjv2XDq5GglWgw0D3XBFut2pOH3QPbH5k1yAnWsYzex7yYSZe2CnEpvxGPqGpZYr9vifRweEmTkQfkApNBUrG5TL5w3TUdSLB58k8iP6Uv9tlg0DnhTn-xV8JPaNyUE26gOfD7C7PE2jdVVhL~Ws0emaCgN6hV5r5W1pApch54Nud1lk5A__&amp;Key-Pair-Id=APKAIE5G5CRDK6RD3PGA" class="supplement-link supplement-download stats-supplement-download" rel=&quot;nofollow&quot;>
            <div class="pdf supplement-type"></div>
                <div class="supplement-title"><span class="title-label">Supplement 2.</span><p class="para"><strong>CONSERVE Checklists</strong></p></div>
        </a>        
    </div>
    <div class="supplement">
        <a id="note-JSC210001-1" href="https://cdn.jamanetwork.com/ama/content_public/journal/jama/938737/jsc210001supp3_prod_1626283660.04451.pdf?Expires=1717907748&amp;Signature=By9DJDjj85igRqQfUkZ1r47UtX9fKX--e2OueQI7cW0K5p-g6cSAM15Yhh5u6NqnOkGnfOmt2FEZV8L1zvhzig9xtdBdjtFRVGfthQX3PsR3bjCXCw4V4ZSKqNqFwFXjCX~E04PT03vYinxZ2m7Kc0xQ5VwNERp~c5K6FSWQegk0srx1y2Pe4hPV8ahdufMYHRPdRu0rqO0lpSLgyJ8h8L2J6ggt-cDfPumMogTmECer-hImD9DHekQKh8HSnmS8zv4zmRDiCw61Gmn~0ZIcD9zIKKf9XlqIElrCEh55Ovr5fdg64KpxDkZJnyV00bJMwwseDKnOWM5vBB07QhuZZA__&amp;Key-Pair-Id=APKAIE5G5CRDK6RD3PGA" class="supplement-link supplement-download stats-supplement-download" rel=&quot;nofollow&quot;>
            <div class="pdf supplement-type"></div>
                <div class="supplement-title"><span class="title-label">Supplement 3.</span><p class="para"><strong>Collaborators.</strong> CONSERVE Group</p></div>
        </a>        
    </div>

 
    </div>

        </div>

        
        <div id="references-tab" class="resource-tab js-resource-tab references-tab need-jobs-ad">
            <div class="references-wrap">
    <div class="widget-SectionDisplay widget-instance-AMA_References_Tab">
        
<div class="references"><div class="reference"><a class="reference-number" id="jsc210001r1">1.</a><div class="reference-content">Getz
         KA﻿, Zuckerman
         R﻿, Cropp
         AB﻿, 
     et al.  Measuring the incidence, causes, and repercussions of protocol amendments. ﻿ <i xmlns:helper="urn:XsltStringHelper"> Ther Innov Regul Sci</i>. 2011;45(3):265-275. doi:<a href="http://dx.doi.org/10.1177/009286151104500307">10.1177/009286151104500307</a><a class="google-scholar-ref-link" href="https://scholar.google.com/scholar_lookup?title=Measuring%20the%20incidence%2C%20causes%2C%20and%20repercussions%20of%20protocol%20amendments.&amp;author=KA%20Getz&amp;author=R%20Zuckerman&amp;author=AB%20Cropp&amp;publication_year=2011&amp;journal=Ther%20Innov%20Regul%20Sci&amp;volume=45&amp;pages=265-275" target="_blank" xmlns:helper="urn:XsltStringHelper">Google Scholar</a></div></div><div class="reference"><a class="reference-number" id="jsc210001r2">2.</a><div class="reference-content">Altman
         DG﻿.  The scandal of poor medical research. ﻿ <i xmlns:helper="urn:XsltStringHelper"> BMJ</i>. 1994;308(6924):283-284. doi:<a href="http://dx.doi.org/10.1136/bmj.308.6924.283">10.1136/bmj.308.6924.283</a><a class="pubmed-link" href="https://www.ncbi.nlm.nih.gov/pubmed/8124111" target="_blank" xmlns:helper="urn:XsltStringHelper">PubMed</a><a class="google-scholar-ref-link" href="https://scholar.google.com/scholar_lookup?title=The%20scandal%20of%20poor%20medical%20research.&amp;author=DG%20Altman&amp;publication_year=1994&amp;journal=BMJ&amp;volume=308&amp;pages=283-284" target="_blank" xmlns:helper="urn:XsltStringHelper">Google Scholar</a><a href="https://doi.org/10.1136/bmj.308.6924.283" class="crossref-doi" target="_blank" xmlns:helper="urn:XsltStringHelper">Crossref</a><span class="inst-open-url-holders" data-targetId="10.1136/bmj.308.6924.283" xmlns:helper="urn:XsltStringHelper"> </span></div></div><div class="reference"><a class="reference-number" id="jsc210001r3">3.</a><div class="reference-content">Macleod
         MR﻿, Michie
         S﻿, Roberts
         I﻿, 
     et al.  Biomedical research: increasing value, reducing waste. ﻿ <i xmlns:helper="urn:XsltStringHelper"> Lancet</i>. 2014;383(9912):101-104. doi:<a href="http://dx.doi.org/10.1016/S0140-6736(13)62329-6">10.1016/S0140-6736(13)62329-6</a><a class="pubmed-link" href="https://www.ncbi.nlm.nih.gov/pubmed/24411643" target="_blank" xmlns:helper="urn:XsltStringHelper">PubMed</a><a class="google-scholar-ref-link" href="https://scholar.google.com/scholar_lookup?title=Biomedical%20research%3A%20increasing%20value%2C%20reducing%20waste.&amp;author=MR%20Macleod&amp;author=S%20Michie&amp;author=I%20Roberts&amp;publication_year=2014&amp;journal=Lancet&amp;volume=383&amp;pages=101-104" target="_blank" xmlns:helper="urn:XsltStringHelper">Google Scholar</a><a href="https://doi.org/10.1016/S0140-6736(13)62329-6" class="crossref-doi" target="_blank" xmlns:helper="urn:XsltStringHelper">Crossref</a><span class="inst-open-url-holders" data-targetId="10.1016/S0140-6736(13)62329-6" xmlns:helper="urn:XsltStringHelper"> </span></div></div><div class="reference"><a class="reference-number" id="jsc210001r4">4.</a><div class="reference-content">Carlisle
         BG﻿. Clinical trials stopped by COVID-19. Updated January 29, 2021. Accessed May 31, 2021. <a href="https://covid19.bgcarlisle.com/">https://covid19.bgcarlisle.com/</a></div></div><div class="reference"><a class="reference-number" id="jsc210001r5">5.</a><div class="reference-content">US Food and Drug Administration. FDA guidance on conduct of clinical trials of medical products during the COVID-19 public health emergency. Published March 2020. Accessed February 5, 2021. <a href="https://www.fda.gov/regulatory-information/search-fda-guidance-documents/fda-guidance-conduct-clinical-trials-medical-products-during-covid-19-public-health-emergency">https://www.fda.gov/regulatory-information/search-fda-guidance-documents/fda-guidance-conduct-clinical-trials-medical-products-during-covid-19-public-health-emergency</a></div></div><div class="reference"><a class="reference-number" id="jsc210001r6">6.</a><div class="reference-content">South African Health Products Regulatory Authority. SAHPRA policy on conduct of clinical trials of health products during the current COVID-19 pandemic. Published March 25, 2020. Accessed February 5, 2021. <a href="http://www.sahpra.org.za/wp-content/uploads/2020/03/SAHPRA-Communication_COVID_19-Final-25032020.pdf">http://www.sahpra.org.za/wp-content/uploads/2020/03/SAHPRA-Communication_COVID_19-Final-25032020.pdf</a></div></div><div class="reference"><a class="reference-number" id="jsc210001r7">7.</a><div class="reference-content">Norwegian Medicines Agency. Management of clinical trials in relation to COVID-19. Updated May 20, 2020. Accessed February 5, 2021. <a href="https://legemiddelverket.no/english/clinical-trials/management-of-clinical-trials-in-relation-to-covid-19">https://legemiddelverket.no/english/clinical-trials/management-of-clinical-trials-in-relation-to-covid-19</a></div></div><div class="reference"><a class="reference-number" id="jsc210001r8">8.</a><div class="reference-content">European Medicines Agency. Implications of coronavirus disease (COVID-19) on methodological aspects of ongoing clinical trials. Published June 29, 2020. Accessed February 5, 2021. <a href="https://www.ema.europa.eu/en/implications-coronavirus-disease-covid-19-methodological-aspects-ongoing-clinical-trials">https://www.ema.europa.eu/en/implications-coronavirus-disease-covid-19-methodological-aspects-ongoing-clinical-trials</a></div></div><div class="reference"><a class="reference-number" id="jsc210001r9">9.</a><div class="reference-content">Schulz
         KF﻿, Altman
         DG﻿, Moher
         D﻿; CONSORT Group.  CONSORT 2010 statement. ﻿ <i xmlns:helper="urn:XsltStringHelper"> PLoS Med</i>. 2010;7(3):e1000251. doi:<a href="http://dx.doi.org/10.1371/journal.pmed.1000251">10.1371/journal.pmed.1000251</a><a class="pubmed-link" href="https://www.ncbi.nlm.nih.gov/pubmed/20352064" target="_blank" xmlns:helper="urn:XsltStringHelper">PubMed</a><a class="google-scholar-ref-link" href="https://scholar.google.com/scholar_lookup?title=CONSORT%202010%20statement.&amp;author=KF%20Schulz&amp;author=DG%20Altman&amp;author=D%20Moher&amp;publication_year=2010&amp;journal=PLoS%20Med&amp;volume=7&amp;pages=" target="_blank" xmlns:helper="urn:XsltStringHelper">Google Scholar</a></div></div><div class="reference"><a class="reference-number" id="jsc210001r10">10.</a><div class="reference-content">Chan
         A-W﻿, Tetzlaff
         JM﻿, Altman
         DG﻿, 
     et al.  SPIRIT 2013 statement. ﻿ <i xmlns:helper="urn:XsltStringHelper"> Ann Intern Med</i>. 2013;158(3):200-207. doi:<a href="http://dx.doi.org/10.7326/0003-4819-158-3-201302050-00583">10.7326/0003-4819-158-3-201302050-00583</a><a class="pubmed-link" href="https://www.ncbi.nlm.nih.gov/pubmed/23295957" target="_blank" xmlns:helper="urn:XsltStringHelper">PubMed</a><a class="google-scholar-ref-link" href="https://scholar.google.com/scholar_lookup?title=SPIRIT%202013%20statement.&amp;author=A-W%20Chan&amp;author=JM%20Tetzlaff&amp;author=DG%20Altman&amp;publication_year=2013&amp;journal=Ann%20Intern%20Med&amp;volume=158&amp;pages=200-207" target="_blank" xmlns:helper="urn:XsltStringHelper">Google Scholar</a><a href="https://doi.org/10.7326/0003-4819-158-3-201302050-00583" class="crossref-doi" target="_blank" xmlns:helper="urn:XsltStringHelper">Crossref</a><span class="inst-open-url-holders" data-targetId="10.7326/0003-4819-158-3-201302050-00583" xmlns:helper="urn:XsltStringHelper"> </span></div></div><div class="reference"><a class="reference-number" id="jsc210001r11">11.</a><div class="reference-content">Moher
         D﻿, Schulz
         KF﻿, Simera
         I﻿, Altman
         DG﻿.  Guidance for developers of health research reporting guidelines. ﻿ <i xmlns:helper="urn:XsltStringHelper"> PLoS Med</i>. 2010;7(2):e1000217. doi:<a href="http://dx.doi.org/10.1371/journal.pmed.1000217">10.1371/journal.pmed.1000217</a><a class="pubmed-link" href="https://www.ncbi.nlm.nih.gov/pubmed/20169112" target="_blank" xmlns:helper="urn:XsltStringHelper">PubMed</a><a class="google-scholar-ref-link" href="https://scholar.google.com/scholar_lookup?title=Guidance%20for%20developers%20of%20health%20research%20reporting%20guidelines.&amp;author=D%20Moher&amp;author=KF%20Schulz&amp;author=I%20Simera&amp;author=DG%20Altman&amp;publication_year=2010&amp;journal=PLoS%20Med&amp;volume=7&amp;pages=" target="_blank" xmlns:helper="urn:XsltStringHelper">Google Scholar</a></div></div><div class="reference"><a class="reference-number" id="jsc210001r12">12.</a><div class="reference-content">Orkin
         A﻿, Gill
         P﻿, Jüni
         P﻿, 
     et al. Development protocol: CONSORT and SPIRIT extension for RCTs revised in extenuating circumstances. Open Science Framework. Published 2020. Accessed February 7, 2021. <a href="https://osf.io/ms8bz">https://osf.io/ms8bz</a></div></div><div class="reference"><a class="reference-number" id="jsc210001r13">13.</a><div class="reference-content">Canadian Institutes of Health Research; Natural Sciences and Engineering Research Council of Canada; Social Sciences and Humanities Research Council. <i>Tri-council Policy Statement: Ethical Conduct for Research Involving Humans (TCPS2)</i>. Government of Canada; 2014.</div></div><div class="reference"><a class="reference-number" id="jsc210001r14">14.</a><div class="reference-content">Khangura
         S﻿, Konnyu
         K﻿, Cushman
         R﻿, 
     et al.  Evidence summaries: the evolution of a rapid review approach. ﻿ <i xmlns:helper="urn:XsltStringHelper"> Syst Rev</i>. 2012;1(1):10. doi:<a href="http://dx.doi.org/10.1186/2046-4053-1-10">10.1186/2046-4053-1-10</a><a class="pubmed-link" href="https://www.ncbi.nlm.nih.gov/pubmed/22587960" target="_blank" xmlns:helper="urn:XsltStringHelper">PubMed</a><a class="google-scholar-ref-link" href="https://scholar.google.com/scholar_lookup?title=Evidence%20summaries%3A%20the%20evolution%20of%20a%20rapid%20review%20approach.&amp;author=S%20Khangura&amp;author=K%20Konnyu&amp;author=R%20Cushman&amp;publication_year=2012&amp;journal=Syst%20Rev&amp;volume=1&amp;pages=10" target="_blank" xmlns:helper="urn:XsltStringHelper">Google Scholar</a><a href="https://doi.org/10.1186/2046-4053-1-10" class="crossref-doi" target="_blank" xmlns:helper="urn:XsltStringHelper">Crossref</a><span class="inst-open-url-holders" data-targetId="10.1186/2046-4053-1-10" xmlns:helper="urn:XsltStringHelper"> </span></div></div><div class="reference"><a class="reference-number" id="jsc210001r15">15.</a><div class="reference-content">Ayala
         A﻿, Orkin
         A﻿, Rombey
         T﻿, 
     et al. Managing and reporting major modifications to trial protocols and trial conduct due to extenuating circumstances: a rapid review protocol. Open Science Framework. Published 2020. Accessed February 7, 2021. <a href="https://osf.io/t49ev/">https://osf.io/t49ev/</a></div></div><div class="reference"><a class="reference-number" id="jsc210001r16">16.</a><div class="reference-content">McGowan
         J﻿, Sampson
         M﻿, Salzwedel
         DM﻿, 
     et al.  PRESS Peer Review of Electronic Search Strategies. ﻿ <i xmlns:helper="urn:XsltStringHelper"> J Clin Epidemiol</i>. 2016;75:40-46. doi:<a href="http://dx.doi.org/10.1016/j.jclinepi.2016.01.021">10.1016/j.jclinepi.2016.01.021</a><a class="pubmed-link" href="https://www.ncbi.nlm.nih.gov/pubmed/27005575" target="_blank" xmlns:helper="urn:XsltStringHelper">PubMed</a><a class="google-scholar-ref-link" href="https://scholar.google.com/scholar_lookup?title=PRESS%20Peer%20Review%20of%20Electronic%20Search%20Strategies.&amp;author=J%20McGowan&amp;author=M%20Sampson&amp;author=DM%20Salzwedel&amp;publication_year=2016&amp;journal=J%20Clin%20Epidemiol&amp;volume=75&amp;pages=40-46" target="_blank" xmlns:helper="urn:XsltStringHelper">Google Scholar</a><a href="https://doi.org/10.1016/j.jclinepi.2016.01.021" class="crossref-doi" target="_blank" xmlns:helper="urn:XsltStringHelper">Crossref</a><span class="inst-open-url-holders" data-targetId="10.1016/j.jclinepi.2016.01.021" xmlns:helper="urn:XsltStringHelper"> </span></div></div><div class="reference"><a class="reference-number" id="jsc210001r17">17.</a><div class="reference-content">Moher
         D﻿, Hopewell
         S﻿, Schulz
         KF﻿, 
     et al; CONSORT.  CONSORT 2010 explanation and elaboration. ﻿ <i xmlns:helper="urn:XsltStringHelper"> Int J Surg</i>. 2012;10(1):28-55. doi:<a href="http://dx.doi.org/10.1016/j.ijsu.2011.10.001">10.1016/j.ijsu.2011.10.001</a><a class="pubmed-link" href="https://www.ncbi.nlm.nih.gov/pubmed/22036893" target="_blank" xmlns:helper="urn:XsltStringHelper">PubMed</a><a class="google-scholar-ref-link" href="https://scholar.google.com/scholar_lookup?title=CONSORT%202010%20explanation%20and%20elaboration.&amp;author=D%20Moher&amp;author=S%20Hopewell&amp;author=KF%20Schulz&amp;publication_year=2012&amp;journal=Int%20J%20Surg&amp;volume=10&amp;pages=28-55" target="_blank" xmlns:helper="urn:XsltStringHelper">Google Scholar</a><a href="https://doi.org/10.1016/j.ijsu.2011.10.001" class="crossref-doi" target="_blank" xmlns:helper="urn:XsltStringHelper">Crossref</a><span class="inst-open-url-holders" data-targetId="10.1016/j.ijsu.2011.10.001" xmlns:helper="urn:XsltStringHelper"> </span></div></div><div class="reference"><a class="reference-number" id="jsc210001r18">18.</a><div class="reference-content">Chan
         A-W﻿, Tetzlaff
         JM﻿, Gøtzsche
         PC﻿, 
     et al.  SPIRIT 2013 explanation and elaboration. ﻿ <i xmlns:helper="urn:XsltStringHelper"> BMJ</i>. 2013;346:e7586. doi:<a href="http://dx.doi.org/10.1136/bmj.e7586">10.1136/bmj.e7586</a><a class="pubmed-link" href="https://www.ncbi.nlm.nih.gov/pubmed/23303884" target="_blank" xmlns:helper="urn:XsltStringHelper">PubMed</a><a class="google-scholar-ref-link" href="https://scholar.google.com/scholar_lookup?title=SPIRIT%202013%20explanation%20and%20elaboration.&amp;author=A-W%20Chan&amp;author=JM%20Tetzlaff&amp;author=PC%20Gøtzsche&amp;publication_year=2013&amp;journal=BMJ&amp;volume=346&amp;pages=" target="_blank" xmlns:helper="urn:XsltStringHelper">Google Scholar</a></div></div><div class="reference"><a class="reference-number" id="jsc210001r19">19.</a><div class="reference-content">Getz
         KA﻿, Stergiopoulos
         S﻿, Short
         M﻿, 
     et al.  The impact of protocol amendments on clinical trial performance and cost. ﻿ <i xmlns:helper="urn:XsltStringHelper"> Ther Innov Regul Sci</i>. 2016;50(4):436-441. doi:<a href="http://dx.doi.org/10.1177/2168479016632271">10.1177/2168479016632271</a><a class="pubmed-link" href="https://www.ncbi.nlm.nih.gov/pubmed/30227022" target="_blank" xmlns:helper="urn:XsltStringHelper">PubMed</a><a class="google-scholar-ref-link" href="https://scholar.google.com/scholar_lookup?title=The%20impact%20of%20protocol%20amendments%20on%20clinical%20trial%20performance%20and%20cost.&amp;author=KA%20Getz&amp;author=S%20Stergiopoulos&amp;author=M%20Short&amp;publication_year=2016&amp;journal=Ther%20Innov%20Regul%20Sci&amp;volume=50&amp;pages=436-441" target="_blank" xmlns:helper="urn:XsltStringHelper">Google Scholar</a><a href="https://doi.org/10.1177/2168479016632271" class="crossref-doi" target="_blank" xmlns:helper="urn:XsltStringHelper">Crossref</a><span class="inst-open-url-holders" data-targetId="10.1177/2168479016632271" xmlns:helper="urn:XsltStringHelper"> </span></div></div><div class="reference"><a class="reference-number" id="jsc210001r20">20.</a><div class="reference-content">Vaillancourt
         C﻿, Charette
         M﻿, Taljaard
         M﻿, 
     et al.  Pragmatic strategy empowering paramedics to assess low-risk trauma patients with the Canadian C-Spine Rule and selectively transport them without immobilization. ﻿ <i xmlns:helper="urn:XsltStringHelper"> JMIR Res Protoc</i>. 2020;9(6):e16966. doi:<a href="http://dx.doi.org/10.2196/16966">10.2196/16966</a><a class="pubmed-link" href="https://www.ncbi.nlm.nih.gov/pubmed/32348267" target="_blank" xmlns:helper="urn:XsltStringHelper">PubMed</a><a class="google-scholar-ref-link" href="https://scholar.google.com/scholar_lookup?title=Pragmatic%20strategy%20empowering%20paramedics%20to%20assess%20low-risk%20trauma%20patients%20with%20the%20Canadian%20C-Spine%20Rule%20and%20selectively%20transport%20them%20without%20immobilization.&amp;author=C%20Vaillancourt&amp;author=M%20Charette&amp;author=M%20Taljaard&amp;publication_year=2020&amp;journal=JMIR%20Res%20Protoc&amp;volume=9&amp;pages=" target="_blank" xmlns:helper="urn:XsltStringHelper">Google Scholar</a></div></div><div class="reference"><a class="reference-number" id="jsc210001r21">21.</a><div class="reference-content">Siegal
         DM﻿, Belley-Cote
         E﻿, Arnold
         DM﻿, 
     et al.  Small-Volume Tubes to Reduce Anemia and Transfusion (STRATUS). ﻿ <i xmlns:helper="urn:XsltStringHelper"> Blood</i>. 2019;134(suppl 1):3685. doi:<a href="http://dx.doi.org/10.1182/blood-2019-130257">10.1182/blood-2019-130257</a><a class="google-scholar-ref-link" href="https://scholar.google.com/scholar_lookup?title=Small-Volume%20Tubes%20to%20Reduce%20Anemia%20and%20Transfusion%20%28STRATUS%29.&amp;author=DM%20Siegal&amp;author=E%20Belley-Cote&amp;author=DM%20Arnold&amp;publication_year=2019&amp;journal=Blood&amp;volume=134&amp;pages=3685" target="_blank" xmlns:helper="urn:XsltStringHelper">Google Scholar</a><a href="https://doi.org/10.1182/blood-2019-130257" class="crossref-doi" target="_blank" xmlns:helper="urn:XsltStringHelper">Crossref</a><span class="inst-open-url-holders" data-targetId="10.1182/blood-2019-130257" xmlns:helper="urn:XsltStringHelper"> </span></div></div><div class="reference"><a class="reference-number" id="jsc210001r22">22.</a><div class="reference-content">Isanaka
         S﻿, Guindo
         O﻿, Langendorf
         C﻿, 
     et al.  Efficacy of a low-cost, heat-stable oral rotavirus vaccine in Niger. ﻿ <i xmlns:helper="urn:XsltStringHelper"> N Engl J Med</i>. 2017;376(12):1121-1130. doi:<a href="http://dx.doi.org/10.1056/NEJMoa1609462">10.1056/NEJMoa1609462</a><a class="pubmed-link" href="https://www.ncbi.nlm.nih.gov/pubmed/28328346" target="_blank" xmlns:helper="urn:XsltStringHelper">PubMed</a><a class="google-scholar-ref-link" href="https://scholar.google.com/scholar_lookup?title=Efficacy%20of%20a%20low-cost%2C%20heat-stable%20oral%20rotavirus%20vaccine%20in%20Niger.&amp;author=S%20Isanaka&amp;author=O%20Guindo&amp;author=C%20Langendorf&amp;publication_year=2017&amp;journal=N%20Engl%20J%20Med&amp;volume=376&amp;pages=1121-1130" target="_blank" xmlns:helper="urn:XsltStringHelper">Google Scholar</a><a href="https://doi.org/10.1056/NEJMoa1609462" class="crossref-doi" target="_blank" xmlns:helper="urn:XsltStringHelper">Crossref</a><span class="inst-open-url-holders" data-targetId="10.1056/NEJMoa1609462" xmlns:helper="urn:XsltStringHelper"> </span></div></div><div class="reference"><a class="reference-number" id="jsc210001r23">23.</a><div class="reference-content">James
         ND﻿, Sydes
         MR﻿, Mason
         MD﻿, 
     et al.  Celecoxib plus hormone therapy versus hormone therapy alone for hormone-sensitive prostate cancer. ﻿ <i xmlns:helper="urn:XsltStringHelper"> Lancet Oncol</i>. 2012;13(5):549-558. doi:<a href="http://dx.doi.org/10.1016/S1470-2045(12)70088-8">10.1016/S1470-2045(12)70088-8</a><a class="pubmed-link" href="https://www.ncbi.nlm.nih.gov/pubmed/22452894" target="_blank" xmlns:helper="urn:XsltStringHelper">PubMed</a><a class="google-scholar-ref-link" href="https://scholar.google.com/scholar_lookup?title=Celecoxib%20plus%20hormone%20therapy%20versus%20hormone%20therapy%20alone%20for%20hormone-sensitive%20prostate%20cancer.&amp;author=ND%20James&amp;author=MR%20Sydes&amp;author=MD%20Mason&amp;publication_year=2012&amp;journal=Lancet%20Oncol&amp;volume=13&amp;pages=549-558" target="_blank" xmlns:helper="urn:XsltStringHelper">Google Scholar</a><a href="https://doi.org/10.1016/S1470-2045(12)70088-8" class="crossref-doi" target="_blank" xmlns:helper="urn:XsltStringHelper">Crossref</a><span class="inst-open-url-holders" data-targetId="10.1016/S1470-2045(12)70088-8" xmlns:helper="urn:XsltStringHelper"> </span></div></div><div class="reference"><a class="reference-number" id="jsc210001r24">24.</a><div class="reference-content">Morse
         SS﻿, Mazet
         JA﻿, Woolhouse
         M﻿, 
     et al.  Prediction and prevention of the next pandemic zoonosis. ﻿ <i xmlns:helper="urn:XsltStringHelper"> Lancet</i>. 2012;380(9857):1956-1965. doi:<a href="http://dx.doi.org/10.1016/S0140-6736(12)61684-5">10.1016/S0140-6736(12)61684-5</a><a class="pubmed-link" href="https://www.ncbi.nlm.nih.gov/pubmed/23200504" target="_blank" xmlns:helper="urn:XsltStringHelper">PubMed</a><a class="google-scholar-ref-link" href="https://scholar.google.com/scholar_lookup?title=Prediction%20and%20prevention%20of%20the%20next%20pandemic%20zoonosis.&amp;author=SS%20Morse&amp;author=JA%20Mazet&amp;author=M%20Woolhouse&amp;publication_year=2012&amp;journal=Lancet&amp;volume=380&amp;pages=1956-1965" target="_blank" xmlns:helper="urn:XsltStringHelper">Google Scholar</a><a href="https://doi.org/10.1016/S0140-6736(12)61684-5" class="crossref-doi" target="_blank" xmlns:helper="urn:XsltStringHelper">Crossref</a><span class="inst-open-url-holders" data-targetId="10.1016/S0140-6736(12)61684-5" xmlns:helper="urn:XsltStringHelper"> </span></div></div><div class="reference"><a class="reference-number" id="jsc210001r25">25.</a><div class="reference-content">Lancaster
         GA﻿, Dodd
         S﻿, Williamson
         PR﻿.  Design and analysis of pilot studies. ﻿ <i xmlns:helper="urn:XsltStringHelper"> J Eval Clin Pract</i>. 2004;10(2):307-312. doi:<a href="http://dx.doi.org/10.1111/j..2002.384.doc.x">10.1111/j..2002.384.doc.x</a><a class="pubmed-link" href="https://www.ncbi.nlm.nih.gov/pubmed/15189396" target="_blank" xmlns:helper="urn:XsltStringHelper">PubMed</a><a class="google-scholar-ref-link" href="https://scholar.google.com/scholar_lookup?title=Design%20and%20analysis%20of%20pilot%20studies.&amp;author=GA%20Lancaster&amp;author=S%20Dodd&amp;author=PR%20Williamson&amp;publication_year=2004&amp;journal=J%20Eval%20Clin%20Pract&amp;volume=10&amp;pages=307-312" target="_blank" xmlns:helper="urn:XsltStringHelper">Google Scholar</a><a href="https://doi.org/10.1111/jep.2004.10.issue-2" class="crossref-doi" target="_blank" xmlns:helper="urn:XsltStringHelper">Crossref</a><span class="inst-open-url-holders" data-targetId="10.1111/jep.2004.10.issue-2" xmlns:helper="urn:XsltStringHelper"> </span></div></div><div class="reference"><a class="reference-number" id="jsc210001r26">26.</a><div class="reference-content">Martinaud
         C﻿, Tiberghien
         P﻿, Bégué
         S﻿, 
     et al.  Rational and design of the T-STORHM study. ﻿ <i xmlns:helper="urn:XsltStringHelper"> Transfus Clin Biol</i>. 2019;26(4):198-201. doi:<a href="http://dx.doi.org/10.1016/j.tracli.2019.09.004">10.1016/j.tracli.2019.09.004</a><a class="pubmed-link" href="https://www.ncbi.nlm.nih.gov/pubmed/31645305" target="_blank" xmlns:helper="urn:XsltStringHelper">PubMed</a><a class="google-scholar-ref-link" href="https://scholar.google.com/scholar_lookup?title=Rational%20and%20design%20of%20the%20T-STORHM%20study.&amp;author=C%20Martinaud&amp;author=P%20Tiberghien&amp;author=S%20Bégué&amp;publication_year=2019&amp;journal=Transfus%20Clin%20Biol&amp;volume=26&amp;pages=198-201" target="_blank" xmlns:helper="urn:XsltStringHelper">Google Scholar</a><a href="https://doi.org/10.1016/j.tracli.2019.09.004" class="crossref-doi" target="_blank" xmlns:helper="urn:XsltStringHelper">Crossref</a><span class="inst-open-url-holders" data-targetId="10.1016/j.tracli.2019.09.004" xmlns:helper="urn:XsltStringHelper"> </span></div></div><div class="reference"><a class="reference-number" id="jsc210001r27">27.</a><div class="reference-content">Schulz
         KF﻿, Grimes
         DA﻿.  Multiplicity in randomised trials, II. ﻿ <i xmlns:helper="urn:XsltStringHelper"> Lancet</i>. 2005;365(9471):1657-1661. doi:<a href="http://dx.doi.org/10.1016/S0140-6736(05)66516-6">10.1016/S0140-6736(05)66516-6</a><a class="pubmed-link" href="https://www.ncbi.nlm.nih.gov/pubmed/15885299" target="_blank" xmlns:helper="urn:XsltStringHelper">PubMed</a><a class="google-scholar-ref-link" href="https://scholar.google.com/scholar_lookup?title=Multiplicity%20in%20randomised%20trials%2C%20II.&amp;author=KF%20Schulz&amp;author=DA%20Grimes&amp;publication_year=2005&amp;journal=Lancet&amp;volume=365&amp;pages=1657-1661" target="_blank" xmlns:helper="urn:XsltStringHelper">Google Scholar</a><a href="https://doi.org/10.1016/S0140-6736(05)66516-6" class="crossref-doi" target="_blank" xmlns:helper="urn:XsltStringHelper">Crossref</a><span class="inst-open-url-holders" data-targetId="10.1016/S0140-6736(05)66516-6" xmlns:helper="urn:XsltStringHelper"> </span></div></div><div class="reference"><a class="reference-number" id="jsc210001r28">28.</a><div class="reference-content">Bassler
         D﻿, Montori
         VM﻿, Briel
         M﻿, 
     et al.  Early stopping of randomized clinical trials for overt efficacy is problematic. ﻿ <i xmlns:helper="urn:XsltStringHelper"> J Clin Epidemiol</i>. 2008;61(3):241-246. doi:<a href="http://dx.doi.org/10.1016/j.jclinepi.2007.07.016">10.1016/j.jclinepi.2007.07.016</a><a class="pubmed-link" href="https://www.ncbi.nlm.nih.gov/pubmed/18226746" target="_blank" xmlns:helper="urn:XsltStringHelper">PubMed</a><a class="google-scholar-ref-link" href="https://scholar.google.com/scholar_lookup?title=Early%20stopping%20of%20randomized%20clinical%20trials%20for%20overt%20efficacy%20is%20problematic.&amp;author=D%20Bassler&amp;author=VM%20Montori&amp;author=M%20Briel&amp;publication_year=2008&amp;journal=J%20Clin%20Epidemiol&amp;volume=61&amp;pages=241-246" target="_blank" xmlns:helper="urn:XsltStringHelper">Google Scholar</a><a href="https://doi.org/10.1016/j.jclinepi.2007.07.016" class="crossref-doi" target="_blank" xmlns:helper="urn:XsltStringHelper">Crossref</a><span class="inst-open-url-holders" data-targetId="10.1016/j.jclinepi.2007.07.016" xmlns:helper="urn:XsltStringHelper"> </span></div></div><div class="reference"><a class="reference-number" id="jsc210001r29">29.</a><div class="reference-content">Mueller
         PS﻿, Montori
         VM﻿, Bassler
         D﻿, 
     et al.  Ethical issues in stopping randomized trials early because of apparent benefit. ﻿ <i xmlns:helper="urn:XsltStringHelper"> Ann Intern Med</i>. 2007;146(12):878-881. doi:<a href="http://dx.doi.org/10.7326/0003-4819-146-12-200706190-00009">10.7326/0003-4819-146-12-200706190-00009</a><a class="pubmed-link" href="https://www.ncbi.nlm.nih.gov/pubmed/17577007" target="_blank" xmlns:helper="urn:XsltStringHelper">PubMed</a><a class="google-scholar-ref-link" href="https://scholar.google.com/scholar_lookup?title=Ethical%20issues%20in%20stopping%20randomized%20trials%20early%20because%20of%20apparent%20benefit.&amp;author=PS%20Mueller&amp;author=VM%20Montori&amp;author=D%20Bassler&amp;publication_year=2007&amp;journal=Ann%20Intern%20Med&amp;volume=146&amp;pages=878-881" target="_blank" xmlns:helper="urn:XsltStringHelper">Google Scholar</a><a href="https://doi.org/10.7326/0003-4819-146-12-200706190-00009" class="crossref-doi" target="_blank" xmlns:helper="urn:XsltStringHelper">Crossref</a><span class="inst-open-url-holders" data-targetId="10.7326/0003-4819-146-12-200706190-00009" xmlns:helper="urn:XsltStringHelper"> </span></div></div><div class="reference"><a class="reference-number" id="jsc210001r30">30.</a><div class="reference-content">Montori
         VM﻿, Devereaux
         PJ﻿, Adhikari
         NKJ﻿, 
     et al.  Randomized trials stopped early for benefit. ﻿ <i xmlns:helper="urn:XsltStringHelper"> JAMA</i>. 2005;294(17):2203-2209. doi:<a href="http://jamanetwork.com/article.aspx?doi=10.1001/jama.294.17.2203">10.1001/jama.294.17.2203</a><a class="pubmed-link" href="https://www.ncbi.nlm.nih.gov/pubmed/16264162" target="_blank" xmlns:helper="urn:XsltStringHelper">PubMed</a><a class="google-scholar-ref-link" href="https://scholar.google.com/scholar_lookup?title=Randomized%20trials%20stopped%20early%20for%20benefit.&amp;author=VM%20Montori&amp;author=PJ%20Devereaux&amp;author=NKJ%20Adhikari&amp;publication_year=2005&amp;journal=JAMA&amp;volume=294&amp;pages=2203-2209" target="_blank" xmlns:helper="urn:XsltStringHelper">Google Scholar</a><a href="https://doi.org/10.1001/jama.294.17.2203" class="crossref-doi" target="_blank" xmlns:helper="urn:XsltStringHelper">Crossref</a><span class="inst-open-url-holders" data-targetId="10.1001/jama.294.17.2203" xmlns:helper="urn:XsltStringHelper"> </span></div></div><div class="reference"><a class="reference-number" id="jsc210001r31">31.</a><div class="reference-content">Tharmanathan
         P﻿, Calvert
         M﻿, Hampton
         J﻿, Freemantle
         N﻿.  The use of interim data and data monitoring committee recommendations in randomized controlled trial reports. ﻿ <i xmlns:helper="urn:XsltStringHelper"> BMC Med Res Methodol</i>. 2008;8(1):12. doi:<a href="http://dx.doi.org/10.1186/1471-2288-8-12">10.1186/1471-2288-8-12</a><a class="pubmed-link" href="https://www.ncbi.nlm.nih.gov/pubmed/18366697" target="_blank" xmlns:helper="urn:XsltStringHelper">PubMed</a><a class="google-scholar-ref-link" href="https://scholar.google.com/scholar_lookup?title=The%20use%20of%20interim%20data%20and%20data%20monitoring%20committee%20recommendations%20in%20randomized%20controlled%20trial%20reports.&amp;author=P%20Tharmanathan&amp;author=M%20Calvert&amp;author=J%20Hampton&amp;author=N%20Freemantle&amp;publication_year=2008&amp;journal=BMC%20Med%20Res%20Methodol&amp;volume=8&amp;pages=12" target="_blank" xmlns:helper="urn:XsltStringHelper">Google Scholar</a><a href="https://doi.org/10.1186/1471-2288-8-12" class="crossref-doi" target="_blank" xmlns:helper="urn:XsltStringHelper">Crossref</a><span class="inst-open-url-holders" data-targetId="10.1186/1471-2288-8-12" xmlns:helper="urn:XsltStringHelper"> </span></div></div><div class="reference"><a class="reference-number" id="jsc210001r32">32.</a><div class="reference-content">Coskinas
         X﻿, Simes
         J﻿, Schou
         M﻿, Martin
         AJ﻿.  Changes to aspects of ongoing randomised controlled trials with fixed designs. ﻿ <i xmlns:helper="urn:XsltStringHelper"> Trials</i>. 2020;21(1):457. doi:<a href="http://dx.doi.org/10.1186/s13063-020-04374-3">10.1186/s13063-020-04374-3</a><a class="pubmed-link" href="https://www.ncbi.nlm.nih.gov/pubmed/32493444" target="_blank" xmlns:helper="urn:XsltStringHelper">PubMed</a><a class="google-scholar-ref-link" href="https://scholar.google.com/scholar_lookup?title=Changes%20to%20aspects%20of%20ongoing%20randomised%20controlled%20trials%20with%20fixed%20designs.&amp;author=X%20Coskinas&amp;author=J%20Simes&amp;author=M%20Schou&amp;author=AJ%20Martin&amp;publication_year=2020&amp;journal=Trials&amp;volume=21&amp;pages=457" target="_blank" xmlns:helper="urn:XsltStringHelper">Google Scholar</a><a href="https://doi.org/10.1186/s13063-020-04374-3" class="crossref-doi" target="_blank" xmlns:helper="urn:XsltStringHelper">Crossref</a><span class="inst-open-url-holders" data-targetId="10.1186/s13063-020-04374-3" xmlns:helper="urn:XsltStringHelper"> </span></div></div><div class="reference"><a class="reference-number" id="jsc210001r33">33.</a><div class="reference-content">Alirol
         E﻿, Kuesel
         AC﻿, Guraiib
         MM﻿, 
     et al.  Ethics review of studies during public health emergencies—the experience of the WHO ethics review committee during the Ebola virus disease epidemic. ﻿ <i xmlns:helper="urn:XsltStringHelper"> BMC Med Ethics</i>. 2017;18(1):43. doi:<a href="http://dx.doi.org/10.1186/s12910-017-0201-1">10.1186/s12910-017-0201-1</a><a class="pubmed-link" href="https://www.ncbi.nlm.nih.gov/pubmed/28651650" target="_blank" xmlns:helper="urn:XsltStringHelper">PubMed</a><a class="google-scholar-ref-link" href="https://scholar.google.com/scholar_lookup?title=Ethics%20review%20of%20studies%20during%20public%20health%20emergencies%E2%80%94the%20experience%20of%20the%20WHO%20ethics%20review%20committee%20during%20the%20Ebola%20virus%20disease%20epidemic.&amp;author=E%20Alirol&amp;author=AC%20Kuesel&amp;author=MM%20Guraiib&amp;publication_year=2017&amp;journal=BMC%20Med%20Ethics&amp;volume=18&amp;pages=43" target="_blank" xmlns:helper="urn:XsltStringHelper">Google Scholar</a><a href="https://doi.org/10.1186/s12910-017-0201-1" class="crossref-doi" target="_blank" xmlns:helper="urn:XsltStringHelper">Crossref</a><span class="inst-open-url-holders" data-targetId="10.1186/s12910-017-0201-1" xmlns:helper="urn:XsltStringHelper"> </span></div></div><div class="reference"><a class="reference-number" id="jsc210001r34">34.</a><div class="reference-content">Sweetman
         EA﻿, Doig
         GS﻿.  Failure to report protocol violations in clinical trials. ﻿ <i xmlns:helper="urn:XsltStringHelper"> Trials</i>. 2011;12:214. doi:<a href="http://dx.doi.org/10.1186/1745-6215-12-214">10.1186/1745-6215-12-214</a><a class="pubmed-link" href="https://www.ncbi.nlm.nih.gov/pubmed/21955551" target="_blank" xmlns:helper="urn:XsltStringHelper">PubMed</a><a class="google-scholar-ref-link" href="https://scholar.google.com/scholar_lookup?title=Failure%20to%20report%20protocol%20violations%20in%20clinical%20trials.&amp;author=EA%20Sweetman&amp;author=GS%20Doig&amp;publication_year=2011&amp;journal=Trials&amp;volume=12&amp;pages=214" target="_blank" xmlns:helper="urn:XsltStringHelper">Google Scholar</a><a href="https://doi.org/10.1186/1745-6215-12-214" class="crossref-doi" target="_blank" xmlns:helper="urn:XsltStringHelper">Crossref</a><span class="inst-open-url-holders" data-targetId="10.1186/1745-6215-12-214" xmlns:helper="urn:XsltStringHelper"> </span></div></div><div class="reference"><a class="reference-number" id="jsc210001r35">35.</a><div class="reference-content">Girardis
         M﻿, Busani
         S﻿, Damiani
         E﻿, 
     et al.  Effect of conservative vs conventional oxygen therapy on mortality among patients in an intensive care unit. ﻿ <i xmlns:helper="urn:XsltStringHelper"> JAMA</i>. 2016;316(15):1583-1589. doi:<a href="http://jamanetwork.com/article.aspx?doi=10.1001/jama.2016.11993">10.1001/jama.2016.11993</a><a class="pubmed-link" href="https://www.ncbi.nlm.nih.gov/pubmed/27706466" target="_blank" xmlns:helper="urn:XsltStringHelper">PubMed</a><a class="google-scholar-ref-link" href="https://scholar.google.com/scholar_lookup?title=Effect%20of%20conservative%20vs%20conventional%20oxygen%20therapy%20on%20mortality%20among%20patients%20in%20an%20intensive%20care%20unit.&amp;author=M%20Girardis&amp;author=S%20Busani&amp;author=E%20Damiani&amp;publication_year=2016&amp;journal=JAMA&amp;volume=316&amp;pages=1583-1589" target="_blank" xmlns:helper="urn:XsltStringHelper">Google Scholar</a><a href="https://doi.org/10.1001/jama.2016.11993" class="crossref-doi" target="_blank" xmlns:helper="urn:XsltStringHelper">Crossref</a><span class="inst-open-url-holders" data-targetId="10.1001/jama.2016.11993" xmlns:helper="urn:XsltStringHelper"> </span></div></div><div class="reference"><a class="reference-number" id="jsc210001r36">36.</a><div class="reference-content">Eisenberg
         MJ﻿, Hébert-Losier
         A﻿, Windle
         SB﻿, 
     et al.  Effect of e-cigarettes plus counseling vs counseling alone on smoking cessation. ﻿ <i xmlns:helper="urn:XsltStringHelper"> JAMA</i>. 2020;324(18):1844-1854. doi:<a href="http://jamanetwork.com/article.aspx?doi=10.1001/jama.2020.18889">10.1001/jama.2020.18889</a><a class="pubmed-link" href="https://www.ncbi.nlm.nih.gov/pubmed/33170240" target="_blank" xmlns:helper="urn:XsltStringHelper">PubMed</a><a class="google-scholar-ref-link" href="https://scholar.google.com/scholar_lookup?title=Effect%20of%20e-cigarettes%20plus%20counseling%20vs%20counseling%20alone%20on%20smoking%20cessation.&amp;author=MJ%20Eisenberg&amp;author=A%20Hébert-Losier&amp;author=SB%20Windle&amp;publication_year=2020&amp;journal=JAMA&amp;volume=324&amp;pages=1844-1854" target="_blank" xmlns:helper="urn:XsltStringHelper">Google Scholar</a><a href="https://doi.org/10.1001/jama.2020.18889" class="crossref-doi" target="_blank" xmlns:helper="urn:XsltStringHelper">Crossref</a><span class="inst-open-url-holders" data-targetId="10.1001/jama.2020.18889" xmlns:helper="urn:XsltStringHelper"> </span></div></div><div class="reference"><a class="reference-number" id="jsc210001r37">37.</a><div class="reference-content">Tomazini
         BM﻿, Maia
         IS﻿, Cavalcanti
         AB﻿, 
     et al.  Effect of dexamethasone on days alive and ventilator-free in patients with moderate or severe acute respiratory distress syndrome and COVID-19. ﻿ <i xmlns:helper="urn:XsltStringHelper"> JAMA</i>. 2020;324(13):1307-1316. doi:<a href="http://jamanetwork.com/article.aspx?doi=10.1001/jama.2020.17021">10.1001/jama.2020.17021</a><a class="pubmed-link" href="https://www.ncbi.nlm.nih.gov/pubmed/32876695" target="_blank" xmlns:helper="urn:XsltStringHelper">PubMed</a><a class="google-scholar-ref-link" href="https://scholar.google.com/scholar_lookup?title=Effect%20of%20dexamethasone%20on%20days%20alive%20and%20ventilator-free%20in%20patients%20with%20moderate%20or%20severe%20acute%20respiratory%20distress%20syndrome%20and%20COVID-19.&amp;author=BM%20Tomazini&amp;author=IS%20Maia&amp;author=AB%20Cavalcanti&amp;publication_year=2020&amp;journal=JAMA&amp;volume=324&amp;pages=1307-1316" target="_blank" xmlns:helper="urn:XsltStringHelper">Google Scholar</a><a href="https://doi.org/10.1001/jama.2020.17021" class="crossref-doi" target="_blank" xmlns:helper="urn:XsltStringHelper">Crossref</a><span class="inst-open-url-holders" data-targetId="10.1001/jama.2020.17021" xmlns:helper="urn:XsltStringHelper"> </span></div></div><div class="reference"><a class="reference-number" id="jsc210001r38">38.</a><div class="reference-content">Laine
         C﻿, Goodman
         SN﻿, Griswold
         ME﻿, Sox
         HC﻿.  Reproducible research: moving toward research the public can really trust. ﻿ <i xmlns:helper="urn:XsltStringHelper"> Ann Intern Med</i>. 2007;146(6):450-453. doi:<a href="http://dx.doi.org/10.7326/0003-4819-146-6-200703200-00154">10.7326/0003-4819-146-6-200703200-00154</a><a class="pubmed-link" href="https://www.ncbi.nlm.nih.gov/pubmed/17339612" target="_blank" xmlns:helper="urn:XsltStringHelper">PubMed</a><a class="google-scholar-ref-link" href="https://scholar.google.com/scholar_lookup?title=Reproducible%20research%3A%20moving%20toward%20research%20the%20public%20can%20really%20trust.&amp;author=C%20Laine&amp;author=SN%20Goodman&amp;author=ME%20Griswold&amp;author=HC%20Sox&amp;publication_year=2007&amp;journal=Ann%20Intern%20Med&amp;volume=146&amp;pages=450-453" target="_blank" xmlns:helper="urn:XsltStringHelper">Google Scholar</a><a href="https://doi.org/10.7326/0003-4819-146-6-200703200-00154" class="crossref-doi" target="_blank" xmlns:helper="urn:XsltStringHelper">Crossref</a><span class="inst-open-url-holders" data-targetId="10.7326/0003-4819-146-6-200703200-00154" xmlns:helper="urn:XsltStringHelper"> </span></div></div><div class="reference"><a class="reference-number" id="jsc210001r39">39.</a><div class="reference-content">Medicines and Healthcare Products Regulatory Agency. Managing clinical trials during coronavirus (COVID-19): how investigators and sponsors should manage clinical trials during COVID-19. Published 2020. Accessed March 2, 2021. <a href="https://www.gov.uk/guidance/managing-clinical-trials-during-coronavirus-covid-19">https://www.gov.uk/guidance/managing-clinical-trials-during-coronavirus-covid-19</a></div></div><div class="reference"><a class="reference-number" id="jsc210001r40">40.</a><div class="reference-content">US Food and Drug Administration. Statistical considerations for clinical trials during the COVID-19 public health emergency: guidance for industry. Published June 2020. Accessed May 3, 2021. <a href="https://www.fda.gov/regulatory-information/search-fda-guidance-documents/statistical-considerations-clinical-trials-during-covid-19-public-health-emergency-guidance-industry">https://www.fda.gov/regulatory-information/search-fda-guidance-documents/statistical-considerations-clinical-trials-during-covid-19-public-health-emergency-guidance-industry</a></div></div><div class="reference"><a class="reference-number" id="jsc210001r41">41.</a><div class="reference-content">Cro
         S﻿, Morris
         TP﻿, Kahan
         BC﻿, 
     et al.  A four-step strategy for handling missing outcome data in randomised trials affected by a pandemic. ﻿ <i xmlns:helper="urn:XsltStringHelper"> BMC Med Res Methodol</i>. 2020;20(1):208. doi:<a href="http://dx.doi.org/10.1186/s12874-020-01089-6">10.1186/s12874-020-01089-6</a><a class="pubmed-link" href="https://www.ncbi.nlm.nih.gov/pubmed/32787782" target="_blank" xmlns:helper="urn:XsltStringHelper">PubMed</a><a class="google-scholar-ref-link" href="https://scholar.google.com/scholar_lookup?title=A%20four-step%20strategy%20for%20handling%20missing%20outcome%20data%20in%20randomised%20trials%20affected%20by%20a%20pandemic.&amp;author=S%20Cro&amp;author=TP%20Morris&amp;author=BC%20Kahan&amp;publication_year=2020&amp;journal=BMC%20Med%20Res%20Methodol&amp;volume=20&amp;pages=208" target="_blank" xmlns:helper="urn:XsltStringHelper">Google Scholar</a><a href="https://doi.org/10.1186/s12874-020-01089-6" class="crossref-doi" target="_blank" xmlns:helper="urn:XsltStringHelper">Crossref</a><span class="inst-open-url-holders" data-targetId="10.1186/s12874-020-01089-6" xmlns:helper="urn:XsltStringHelper"> </span></div></div><div class="reference"><a class="reference-number" id="jsc210001r42">42.</a><div class="reference-content">Meagher
         KM﻿, Cummins
         NW﻿, Bharucha
         AE﻿, 
     et al.  COVID-19 ethics and research. ﻿ <i xmlns:helper="urn:XsltStringHelper"> Mayo Clin Proc</i>. 2020;95(6):1119-1123. doi:<a href="http://dx.doi.org/10.1016/j.mayocp.2020.04.019">10.1016/j.mayocp.2020.04.019</a><a class="pubmed-link" href="https://www.ncbi.nlm.nih.gov/pubmed/32402511" target="_blank" xmlns:helper="urn:XsltStringHelper">PubMed</a><a class="google-scholar-ref-link" href="https://scholar.google.com/scholar_lookup?title=COVID-19%20ethics%20and%20research.&amp;author=KM%20Meagher&amp;author=NW%20Cummins&amp;author=AE%20Bharucha&amp;publication_year=2020&amp;journal=Mayo%20Clin%20Proc&amp;volume=95&amp;pages=1119-1123" target="_blank" xmlns:helper="urn:XsltStringHelper">Google Scholar</a><a href="https://doi.org/10.1016/j.mayocp.2020.04.019" class="crossref-doi" target="_blank" xmlns:helper="urn:XsltStringHelper">Crossref</a><span class="inst-open-url-holders" data-targetId="10.1016/j.mayocp.2020.04.019" xmlns:helper="urn:XsltStringHelper"> </span></div></div><div class="reference"><a class="reference-number" id="jsc210001r43">43.</a><div class="reference-content">Vissers
         MFJM﻿, Cohen
         AF﻿, Van Gerven
         JMA﻿, Groeneveld
         GJ﻿.  The impact of the global COVID-19 pandemic on the conduct of clinical trials. ﻿ <i xmlns:helper="urn:XsltStringHelper"> Br J Clin Pharmacol</i>. 2021;87(3):837-844. doi:<a href="http://dx.doi.org/10.1111/bcp.14480">10.1111/bcp.14480</a><a class="pubmed-link" href="https://www.ncbi.nlm.nih.gov/pubmed/32668047" target="_blank" xmlns:helper="urn:XsltStringHelper">PubMed</a><a class="google-scholar-ref-link" href="https://scholar.google.com/scholar_lookup?title=The%20impact%20of%20the%20global%20COVID-19%20pandemic%20on%20the%20conduct%20of%20clinical%20trials.&amp;author=MFJM%20Vissers&amp;author=AF%20Cohen&amp;author=JMA%20Van Gerven&amp;author=GJ%20Groeneveld&amp;publication_year=2021&amp;journal=Br%20J%20Clin%20Pharmacol&amp;volume=87&amp;pages=837-844" target="_blank" xmlns:helper="urn:XsltStringHelper">Google Scholar</a><a href="https://doi.org/10.1111/bcp.v87.3" class="crossref-doi" target="_blank" xmlns:helper="urn:XsltStringHelper">Crossref</a><span class="inst-open-url-holders" data-targetId="10.1111/bcp.v87.3" xmlns:helper="urn:XsltStringHelper"> </span></div></div><div class="reference"><a class="reference-number" id="jsc210001r44">44.</a><div class="reference-content">Rusen
         ID﻿.  Challenges in tuberculosis clinical trials in the face of the COVID-19 pandemic. ﻿ <i xmlns:helper="urn:XsltStringHelper"> Trop Med Infect Dis</i>. 2020;5(2):E86. doi:<a href="http://dx.doi.org/10.3390/tropicalmed5020086">10.3390/tropicalmed5020086</a><a class="pubmed-link" href="https://www.ncbi.nlm.nih.gov/pubmed/32471274" target="_blank" xmlns:helper="urn:XsltStringHelper">PubMed</a><a class="google-scholar-ref-link" href="https://scholar.google.com/scholar_lookup?title=Challenges%20in%20tuberculosis%20clinical%20trials%20in%20the%20face%20of%20the%20COVID-19%20pandemic.&amp;author=ID%20Rusen&amp;publication_year=2020&amp;journal=Trop%20Med%20Infect%20Dis&amp;volume=5&amp;pages=" target="_blank" xmlns:helper="urn:XsltStringHelper">Google Scholar</a></div></div><div class="reference"><a class="reference-number" id="jsc210001r45">45.</a><div class="reference-content">Davis
         S﻿, Pai
         S﻿.  Challenges and opportunities for sponsors in conducting clinical trials during a pandemic. ﻿ <i xmlns:helper="urn:XsltStringHelper"> Perspect Clin Res</i>. 2020;11(3):115-120. doi:<a href="http://dx.doi.org/10.4103/picr.PICR_177_20">10.4103/picr.PICR_177_20</a><a class="pubmed-link" href="https://www.ncbi.nlm.nih.gov/pubmed/33033700" target="_blank" xmlns:helper="urn:XsltStringHelper">PubMed</a><a class="google-scholar-ref-link" href="https://scholar.google.com/scholar_lookup?title=Challenges%20and%20opportunities%20for%20sponsors%20in%20conducting%20clinical%20trials%20during%20a%20pandemic.&amp;author=S%20Davis&amp;author=S%20Pai&amp;publication_year=2020&amp;journal=Perspect%20Clin%20Res&amp;volume=11&amp;pages=115-120" target="_blank" xmlns:helper="urn:XsltStringHelper">Google Scholar</a><a href="https://doi.org/10.4103/picr.PICR_177_20" class="crossref-doi" target="_blank" xmlns:helper="urn:XsltStringHelper">Crossref</a><span class="inst-open-url-holders" data-targetId="10.4103/picr.PICR_177_20" xmlns:helper="urn:XsltStringHelper"> </span></div></div><div class="reference"><a class="reference-number" id="jsc210001r46">46.</a><div class="reference-content">Anker
         SD﻿, Butler
         J﻿, Khan
         MS﻿, 
     et al.  Conducting clinical trials in heart failure during (and after) the COVID-19 pandemic. ﻿ <i xmlns:helper="urn:XsltStringHelper"> Eur Heart J</i>. 2020;41(22):2109-2117. doi:<a href="http://dx.doi.org/10.1093/eurheartj/ehaa461">10.1093/eurheartj/ehaa461</a><a class="pubmed-link" href="https://www.ncbi.nlm.nih.gov/pubmed/32498081" target="_blank" xmlns:helper="urn:XsltStringHelper">PubMed</a><a class="google-scholar-ref-link" href="https://scholar.google.com/scholar_lookup?title=Conducting%20clinical%20trials%20in%20heart%20failure%20during%20%28and%20after%29%20the%20COVID-19%20pandemic.&amp;author=SD%20Anker&amp;author=J%20Butler&amp;author=MS%20Khan&amp;publication_year=2020&amp;journal=Eur%20Heart%20J&amp;volume=41&amp;pages=2109-2117" target="_blank" xmlns:helper="urn:XsltStringHelper">Google Scholar</a><a href="https://doi.org/10.1093/eurheartj/ehaa461" class="crossref-doi" target="_blank" xmlns:helper="urn:XsltStringHelper">Crossref</a><span class="inst-open-url-holders" data-targetId="10.1093/eurheartj/ehaa461" xmlns:helper="urn:XsltStringHelper"> </span></div></div><div class="reference"><a class="reference-number" id="jsc210001r47">47.</a><div class="reference-content">de Paula
         BHR﻿, Araújo
         I﻿, Bandeira
         L﻿, 
     et al.  Recommendations from national regulatory agencies for ongoing cancer trials during the COVID-19 pandemic. ﻿ <i xmlns:helper="urn:XsltStringHelper"> Lancet Oncol</i>. 2020;21(5):624-627. doi:<a href="http://dx.doi.org/10.1016/S1470-2045(20)30226-6">10.1016/S1470-2045(20)30226-6</a><a class="pubmed-link" href="https://www.ncbi.nlm.nih.gov/pubmed/32277907" target="_blank" xmlns:helper="urn:XsltStringHelper">PubMed</a><a class="google-scholar-ref-link" href="https://scholar.google.com/scholar_lookup?title=Recommendations%20from%20national%20regulatory%20agencies%20for%20ongoing%20cancer%20trials%20during%20the%20COVID-19%20pandemic.&amp;author=BHR%20de Paula&amp;author=I%20Araújo&amp;author=L%20Bandeira&amp;publication_year=2020&amp;journal=Lancet%20Oncol&amp;volume=21&amp;pages=624-627" target="_blank" xmlns:helper="urn:XsltStringHelper">Google Scholar</a><a href="https://doi.org/10.1016/S1470-2045(20)30226-6" class="crossref-doi" target="_blank" xmlns:helper="urn:XsltStringHelper">Crossref</a><span class="inst-open-url-holders" data-targetId="10.1016/S1470-2045(20)30226-6" xmlns:helper="urn:XsltStringHelper"> </span></div></div><div class="reference"><a class="reference-number" id="jsc210001r48">48.</a><div class="reference-content">Waterhouse
         DM﻿, Harvey
         RD﻿, Hurley
         P﻿, 
     et al.  Early impact of COVID-19 on the conduct of oncology clinical trials and long-term opportunities for transformation. ﻿ <i xmlns:helper="urn:XsltStringHelper"> JCO Oncol Pract</i>. 2020;16(7):417-421. doi:<a href="http://dx.doi.org/10.1200/OP.20.00275">10.1200/OP.20.00275</a><a class="pubmed-link" href="https://www.ncbi.nlm.nih.gov/pubmed/32396491" target="_blank" xmlns:helper="urn:XsltStringHelper">PubMed</a><a class="google-scholar-ref-link" href="https://scholar.google.com/scholar_lookup?title=Early%20impact%20of%20COVID-19%20on%20the%20conduct%20of%20oncology%20clinical%20trials%20and%20long-term%20opportunities%20for%20transformation.&amp;author=DM%20Waterhouse&amp;author=RD%20Harvey&amp;author=P%20Hurley&amp;publication_year=2020&amp;journal=JCO%20Oncol%20Pract&amp;volume=16&amp;pages=417-421" target="_blank" xmlns:helper="urn:XsltStringHelper">Google Scholar</a><a href="https://doi.org/10.1200/OP.20.00275" class="crossref-doi" target="_blank" xmlns:helper="urn:XsltStringHelper">Crossref</a><span class="inst-open-url-holders" data-targetId="10.1200/OP.20.00275" xmlns:helper="urn:XsltStringHelper"> </span></div></div><div class="reference"><a class="reference-number" id="jsc210001r49">49.</a><div class="reference-content">Moskowitz
         CS﻿, Panageas
         KS﻿.  Implications for design and analyses of oncology clinical trials during the COVID-19 pandemic. ﻿ <i xmlns:helper="urn:XsltStringHelper"> JAMA Oncol</i>. 2020;6(9):1326-1327. doi:<a href="http://jamanetwork.com/article.aspx?doi=10.1001/jamaoncol.2020.2370">10.1001/jamaoncol.2020.2370</a><a class="pubmed-link" href="https://www.ncbi.nlm.nih.gov/pubmed/32556067" target="_blank" xmlns:helper="urn:XsltStringHelper">PubMed</a><a class="google-scholar-ref-link" href="https://scholar.google.com/scholar_lookup?title=Implications%20for%20design%20and%20analyses%20of%20oncology%20clinical%20trials%20during%20the%20COVID-19%20pandemic.&amp;author=CS%20Moskowitz&amp;author=KS%20Panageas&amp;publication_year=2020&amp;journal=JAMA%20Oncol&amp;volume=6&amp;pages=1326-1327" target="_blank" xmlns:helper="urn:XsltStringHelper">Google Scholar</a><a href="https://doi.org/10.1001/jamaoncol.2020.2370" class="crossref-doi" target="_blank" xmlns:helper="urn:XsltStringHelper">Crossref</a><span class="inst-open-url-holders" data-targetId="10.1001/jamaoncol.2020.2370" xmlns:helper="urn:XsltStringHelper"> </span></div></div><div class="reference"><a class="reference-number" id="jsc210001r50">50.</a><div class="reference-content">Lau
         G﻿, Sharma
         M﻿; APASL Covid-19 Task Force.  Clinical practice guidance for hepatology and liver transplant providers during the COVID-19 pandemic. ﻿ <i xmlns:helper="urn:XsltStringHelper"> Hepatol Int</i>. 2020;14(4):415-428. doi:<a href="http://dx.doi.org/10.1007/s12072-020-10054-w">10.1007/s12072-020-10054-w</a><a class="pubmed-link" href="https://www.ncbi.nlm.nih.gov/pubmed/32447721" target="_blank" xmlns:helper="urn:XsltStringHelper">PubMed</a><a class="google-scholar-ref-link" href="https://scholar.google.com/scholar_lookup?title=Clinical%20practice%20guidance%20for%20hepatology%20and%20liver%20transplant%20providers%20during%20the%20COVID-19%20pandemic.&amp;author=G%20Lau&amp;author=M%20Sharma&amp;publication_year=2020&amp;journal=Hepatol%20Int&amp;volume=14&amp;pages=415-428" target="_blank" xmlns:helper="urn:XsltStringHelper">Google Scholar</a><a href="https://doi.org/10.1007/s12072-020-10054-w" class="crossref-doi" target="_blank" xmlns:helper="urn:XsltStringHelper">Crossref</a><span class="inst-open-url-holders" data-targetId="10.1007/s12072-020-10054-w" xmlns:helper="urn:XsltStringHelper"> </span></div></div><div class="reference"><a class="reference-number" id="jsc210001r51">51.</a><div class="reference-content">Perlis
         RH﻿, Haneuse
         SJPA﻿, Rubenfeld
         GD﻿, 
     et al.  Reporting clinical studies affected by the COVID-19 pandemic. ﻿ <i xmlns:helper="urn:XsltStringHelper"> JAMA Netw Open</i>. 2021;4(1):e2036155. doi:<a href="http://jamanetwork.com/article.aspx?doi=10.1001/jamanetworkopen.2020.36155">10.1001/jamanetworkopen.2020.36155</a><a class="pubmed-link" href="https://www.ncbi.nlm.nih.gov/pubmed/33443576" target="_blank" xmlns:helper="urn:XsltStringHelper">PubMed</a><a class="google-scholar-ref-link" href="https://scholar.google.com/scholar_lookup?title=Reporting%20clinical%20studies%20affected%20by%20the%20COVID-19%20pandemic.&amp;author=RH%20Perlis&amp;author=SJPA%20Haneuse&amp;author=GD%20Rubenfeld&amp;publication_year=2021&amp;journal=JAMA%20Netw%20Open&amp;volume=4&amp;pages=" target="_blank" xmlns:helper="urn:XsltStringHelper">Google Scholar</a></div></div><div class="reference"><a class="reference-number" id="jsc210001r52">52.</a><div class="reference-content">McDermott
         MM﻿, Newman
         AB﻿.  Preserving clinical trial integrity during the coronavirus pandemic. ﻿ <i xmlns:helper="urn:XsltStringHelper"> JAMA</i>. 2020;323(21):2135-2136. doi:<a href="http://jamanetwork.com/article.aspx?doi=10.1001/jama.2020.4689">10.1001/jama.2020.4689</a><a class="pubmed-link" href="https://www.ncbi.nlm.nih.gov/pubmed/32211830" target="_blank" xmlns:helper="urn:XsltStringHelper">PubMed</a><a class="google-scholar-ref-link" href="https://scholar.google.com/scholar_lookup?title=Preserving%20clinical%20trial%20integrity%20during%20the%20coronavirus%20pandemic.&amp;author=MM%20McDermott&amp;author=AB%20Newman&amp;publication_year=2020&amp;journal=JAMA&amp;volume=323&amp;pages=2135-2136" target="_blank" xmlns:helper="urn:XsltStringHelper">Google Scholar</a><a href="https://doi.org/10.1001/jama.2020.4689" class="crossref-doi" target="_blank" xmlns:helper="urn:XsltStringHelper">Crossref</a><span class="inst-open-url-holders" data-targetId="10.1001/jama.2020.4689" xmlns:helper="urn:XsltStringHelper"> </span></div></div><div class="reference"><a class="reference-number" id="jsc210001r53">53.</a><div class="reference-content">Parikh
         PM﻿, Mehta
         P﻿, Mvt
         KM﻿, 
     et al.  “Serious adverse events” faced by clinical trials. ﻿ <i xmlns:helper="urn:XsltStringHelper"> Indian J Med Paediatr Oncol</i>. 2020;41(2):127. doi:<a href="http://dx.doi.org/10.4103/ijmpo.ijmpo_114_20">10.4103/ijmpo.ijmpo_114_20</a><a class="google-scholar-ref-link" href="https://scholar.google.com/scholar_lookup?title=%E2%80%9CSerious%20adverse%20events%E2%80%9D%20faced%20by%20clinical%20trials.&amp;author=PM%20Parikh&amp;author=P%20Mehta&amp;author=KM%20Mvt&amp;publication_year=2020&amp;journal=Indian%20J%20Med%20Paediatr%20Oncol&amp;volume=41&amp;pages=127" target="_blank" xmlns:helper="urn:XsltStringHelper">Google Scholar</a></div></div></div> 
    </div>

            </div>
        </div>

        
        <div id="related-tab" class="resource-tab js-resource-tab related-tab need-jobs-ad">
    <div class="widget-ArticleLinks widget-instance-AMA_See_Also_Related_Content">
        
    <ul class="article-links related-content">

            <li class="article-link related-article odd">
                <a href="https://jamanetwork.com/journals/jama/fullarticle/1487502" class="td-n">
                        <div class="related-article-title">Reporting of Noninferiority and Equivalence Randomized Trials<span class="subtitle"><span class="colon-for-citation-subtitle">: </span>Extension of the CONSORT 2010 Statement</span></div>
                                            <div class="related-journal-name">JAMA</div>
                    <div class="related-article-type">Special Communication</div>
                    <div class="related-article-date">December 26, 2012</div>
                    <div class="related-article-excerpt">To improve reporting and interpretation of noninferiority and equivalence trials, Piaggio and coauthors present and discuss an updated extension of the CONSORT checklist based on the 2010 version of the CONSORT Statement and the 2008 CONSORT Statement for the reporting of abstracts.</div>
                    <div class="related-article-authors">Gilda Piaggio, PhD; Diana R. Elbourne, PhD; Stuart J. Pocock, PhD; Stephen J. W. Evans, MSc; Douglas G. Altman, DSc; for the CONSORT Group</div>
                </a>
            </li>
            <li class="article-link related-article even">
                <a href="https://jamanetwork.com/journals/jama/fullarticle/1656259" class="td-n">
                        <div class="related-article-title">Reporting of Patient-Reported Outcomes in Randomized Trials<span class="subtitle"><span class="colon-for-citation-subtitle">: </span>The CONSORT PRO Extension</span></div>
                                            <div class="related-journal-name">JAMA</div>
                    <div class="related-article-type">Special Communication</div>
                    <div class="related-article-date">February 27, 2013</div>
                    <div class="related-article-excerpt">Calvert and colleagues expand the Consolidated Standards of Reporting Trials (CONSORT) to include 5 guidelines essential for adequately reporting patientreported outcomes as primary or major secondary end points in research articles in its CONSORT PRO guidelines.</div>
                    <div class="related-article-authors">Melanie Calvert, PhD; Jane Blazeby, MD; Douglas G. Altman, DSc; Dennis A. Revicki, PhD; David Moher, PhD; Michael D. Brundage, MD; for the CONSORT PRO Group</div>
                </a>
            </li>
            <li class="article-link related-article odd">
                <a href="https://jamanetwork.com/journals/jama/fullarticle/2731183" class="td-n">
                        <div class="related-article-title">CONSORT Extension for Reporting Multi-Arm Parallel Group Randomized Trials</div>
                                            <div class="related-journal-name">JAMA</div>
                    <div class="related-article-type">Special Communication</div>
                    <div class="related-article-date">April 23, 2019</div>
                    <div class="related-article-excerpt">This extension of the CONSORT 2010 Statement, a guideline and checklist for reporting parallel group randomized trials, provides updates for the reporting of multi-arm trials to assist evaluations of rigor and reproducibility and enhance understanding of the methodology of trials with more than 2 comparison arms.</div>
                    <div class="related-article-authors">Edmund Juszczak, MSc; Douglas G. Altman, DSc; Sally Hopewell, DPhil; Kenneth Schulz, PhD</div>
                </a>
            </li>
            <li class="article-link related-article even">
                <a href="https://jamanetwork.com/journals/jama/fullarticle/2789561" class="td-n">
                        <div class="related-article-title">CONSERVE Guideline for Modified Trials</div>
                                            <div class="related-journal-name">JAMA</div>
                    <div class="related-article-type">JAMA Guide to Statistics and Methods</div>
                    <div class="related-article-date">March 1, 2022</div>
                    <div class="related-article-excerpt">This JAMA Guide to Statistics and Methods discusses the CONSERVE guidelines, which address how to report extenuating circumstances that lead to a modification in trial design, conduct, or analysis.</div>
                    <div class="related-article-authors">Maria Mori Brooks, PhD; Stephen R. Wisniewski, PhD</div>
                </a>
            </li>
            <li class="article-link related-article odd">
                <a href="https://jamanetwork.com/journals/jama/fullarticle/2799401" class="td-n">
                        <div class="related-article-title">Guidelines for Reporting Outcomes in Trial Reports</div>
                                            <div class="related-journal-name">JAMA</div>
                    <div class="related-article-type">Special Communication</div>
                    <div class="related-article-date">December 13, 2022</div>
                    <div class="related-article-excerpt">This report, the Consolidated Standards of Reporting Trials (CONSORT)–Outcomes 2022 extension, is a consensus statement on the standards for reporting outcomes in clinical trial reports and contains recommendations to be integrated with the CONSORT 2010 statement.</div>
                    <div class="related-article-authors">Nancy J. Butcher, PhD; Andrea Monsour, MPH; Emma J. Mew, MPH, MPhil; An-Wen Chan, MD, DPhil; David Moher, PhD; Evan Mayo-Wilson, DPhil; Caroline B. Terwee, PhD; Alyssandra Chee-A-Tow, MPH; Ami Baba, MRes; Frank Gavin, MA; Jeremy M. Grimshaw, MBCHB, PhD; Lauren E. Kelly, PhD; Leena Saeed, BSc, BEd; Lehana Thabane, PhD; Lisa Askie, PhD; Maureen Smith, MEd; Mufiza Farid-Kapadia, MD, PhD; Paula R. Williamson, PhD; Peter Szatmari, MD; Peter Tugwell, MD; Robert M. Golub, MD; Suneeta Monga, MD; Sunita Vohra, MD; Susan Marlin, MSc; Wendy J. Ungar, MSc, PhD; Martin Offringa, MD, PhD</div>
                </a>
            </li>
    </ul>
 
    </div>
    <div class="widget-EditorsChoice widget-instance-AMA_EditorsChoice_Links">
        
 
    </div>
    <div class="widget-RelatedTopics widget-instance-AMA_Related_Topics">
        
        <div class="related-topics-block">
            <h4 class="related-topics-heading topic-suggestions-heading sb-sc">
See More About            </h4>
            <div class="related-topics topic-suggestions">
    <a href="https://jamanetwork.com/collections/5713/medical-journals-and-publishing" id="item_Link" class="related-topic topic-suggestion no-wrap sb-anchor-light">Medical Journals and Publishing</a>    <a href="https://jamanetwork.com/collections/5916/research-methods-statistics" id="item_Link_1" class="related-topic topic-suggestion no-wrap sb-anchor-light">Research, Methods, Statistics</a>    <a href="https://jamanetwork.com/collections/5672/guidelines" id="item_Link_2" class="related-topic topic-suggestion no-wrap sb-anchor-light">Guidelines</a>            </div>
        </div>
 
    </div>
                <div class="ymal--footer">
    <div class="widget-WidgetLoader widget-instance-AMA_PersonalizedContent_SplitScreenView_Footer">
        <div class="SCM-SharedWidgets-AsyncWidgetLoader" data-url="/Personalization/PersonalizedContent/AMA_PersonalizedContent_SplitScreenView_Footer" data-params="{&quot;parameters&quot;:{&quot;resourceIdToExclude&quot;:2781397,&quot;resourceTypeToExclude&quot;:3},&quot;dynamicParameters&quot;:{&quot;localParams&quot;:&quot;[REPLACE_WITH_LOCAL]&quot;}}"></div>
 
    </div>

                </div>
                <hr />
                <div class="manage-interest">
                    <h4><a href="#" class="manage-interests-link-no-access thm-col-sec">Select Your Interests</a></h4>
    <div class="widget-ManageCollectionInterests widget-instance-ManageCollectionInterests_SplitScreen">
        <div class="manage-interests-modal reveal-modal small modal" data-reveal>
<div class="manage-interests--header">
    <div class="widget-SelfServeContent widget-instance-AMA_ManageInterests_Header">
        


<div class="self-serve">
    <input type="hidden" class="SelfServeContentId" value="AllSitesManageInterestsHeader" />
    <input type="hidden" class="SelfServeVersionId" value="0" />

<style>
    h4 {
    font-size: 20px !important;
    }
</style>
<h4>Select Your Interests</h4>
<p>Customize your JAMA Network experience by selecting one or more topics from the list below.</p>


</div>

 
    </div>

</div><div class="manage-interests--categories">
    <ul class="category-list">
            <li><span class="category-list-item " data-categoryid="46425">Academic Medicine</span></li>
            <li><span class="category-list-item " data-categoryid="5489">Acid Base, Electrolytes, Fluids</span></li>
            <li><span class="category-list-item " data-categoryid="5504">Allergy and Clinical Immunology</span></li>
            <li><span class="category-list-item " data-categoryid="46447">American Indian or Alaska Natives</span></li>
            <li><span class="category-list-item " data-categoryid="5510">Anesthesiology</span></li>
            <li><span class="category-list-item " data-categoryid="42143">Anticoagulation</span></li>
            <li><span class="category-list-item " data-categoryid="6261">Art and Images in Psychiatry</span></li>
            <li><span class="category-list-item " data-categoryid="44024">Artificial Intelligence</span></li>
            <li><span class="category-list-item " data-categoryid="42097">Assisted Reproduction</span></li>
            <li><span class="category-list-item " data-categoryid="42099">Bleeding and Transfusion</span></li>
            <li><span class="category-list-item " data-categoryid="5548">Cardiology</span></li>
            <li><span class="category-list-item " data-categoryid="44036">Caring for the Critically Ill Patient</span></li>
            <li><span class="category-list-item " data-categoryid="6255">Challenges in Clinical Electrocardiography</span></li>
            <li><span class="category-list-item " data-categoryid="46435">Climate and Health</span></li>
            <li><span class="category-list-item " data-categoryid="46448">Climate Change</span></li>
            <li><span class="category-list-item " data-categoryid="44038">Clinical Challenge</span></li>
            <li><span class="category-list-item " data-categoryid="5589">Clinical Decision Support</span></li>
            <li><span class="category-list-item " data-categoryid="44039">Clinical Implications of Basic Neuroscience</span></li>
            <li><span class="category-list-item " data-categoryid="5614">Clinical Pharmacy and Pharmacology</span></li>
            <li><span class="category-list-item " data-categoryid="5575">Complementary and Alternative Medicine</span></li>
            <li><span class="category-list-item " data-categoryid="44040">Consensus Statements</span></li>
            <li><span class="category-list-item " data-categoryid="46099">Coronavirus (COVID-19)</span></li>
            <li><span class="category-list-item " data-categoryid="5584">Critical Care Medicine</span></li>
            <li><span class="category-list-item " data-categoryid="46325">Cultural Competency</span></li>
            <li><span class="category-list-item " data-categoryid="44019">Dental Medicine</span></li>
            <li><span class="category-list-item " data-categoryid="5598">Dermatology</span></li>
            <li><span class="category-list-item " data-categoryid="44011">Diabetes and Endocrinology</span></li>
            <li><span class="category-list-item " data-categoryid="46320">Diagnostic Test Interpretation</span></li>
            <li><span class="category-list-item " data-categoryid="42054">Drug Development</span></li>
            <li><span class="category-list-item " data-categoryid="5620">Electronic Health Records</span></li>
            <li><span class="category-list-item " data-categoryid="5621">Emergency Medicine</span></li>
            <li><span class="category-list-item " data-categoryid="5819">End of Life, Hospice, Palliative Care</span></li>
            <li><span class="category-list-item " data-categoryid="42107">Environmental Health</span></li>
            <li><span class="category-list-item " data-categoryid="46387">Equity, Diversity, and Inclusion</span></li>
            <li><span class="category-list-item " data-categoryid="42108">Ethics</span></li>
            <li><span class="category-list-item " data-categoryid="5644">Facial Plastic Surgery</span></li>
            <li><span class="category-list-item " data-categoryid="44012">Gastroenterology and Hepatology</span></li>
            <li><span class="category-list-item " data-categoryid="5664">Genetics and Genomics</span></li>
            <li><span class="category-list-item " data-categoryid="44041">Genomics and Precision Health</span></li>
            <li><span class="category-list-item " data-categoryid="5668">Geriatrics</span></li>
            <li><span class="category-list-item " data-categoryid="5670">Global Health</span></li>
            <li><span class="category-list-item " data-categoryid="46427">Guide to Statistics and Methods</span></li>
            <li><span class="category-list-item " data-categoryid="5672">Guidelines</span></li>
            <li><span class="category-list-item " data-categoryid="5674">Hair Disorders</span></li>
            <li><span class="category-list-item " data-categoryid="42113">Health Care Delivery Models</span></li>
            <li><span class="category-list-item " data-categoryid="42114">Health Care Economics, Insurance, Payment</span></li>
            <li><span class="category-list-item " data-categoryid="42116">Health Care Quality</span></li>
            <li><span class="category-list-item " data-categoryid="5680">Health Care Reform</span></li>
            <li><span class="category-list-item " data-categoryid="5830">Health Care Safety</span></li>
            <li><span class="category-list-item " data-categoryid="5682">Health Care Workforce</span></li>
            <li><span class="category-list-item " data-categoryid="5679">Health Disparities</span></li>
            <li><span class="category-list-item " data-categoryid="46328">Health Inequities</span></li>
            <li><span class="category-list-item " data-categoryid="44020">Health Policy</span></li>
            <li><span class="category-list-item " data-categoryid="46451">Health Systems Science</span></li>
            <li><span class="category-list-item " data-categoryid="5688">Hematology</span></li>
            <li><span class="category-list-item " data-categoryid="5692">History of Medicine</span></li>
            <li><span class="category-list-item " data-categoryid="5514">Humanities</span></li>
            <li><span class="category-list-item " data-categoryid="5697">Hypertension</span></li>
            <li><span class="category-list-item " data-categoryid="44043">Images in Neurology</span></li>
            <li><span class="category-list-item " data-categoryid="45887">Implementation Science</span></li>
            <li><span class="category-list-item " data-categoryid="5702">Infectious Diseases</span></li>
            <li><span class="category-list-item " data-categoryid="44044">Innovations in Health Care Delivery</span></li>
            <li><span class="category-list-item " data-categoryid="44070">JAMA Infographic</span></li>
            <li><span class="category-list-item " data-categoryid="5716">Law and Medicine</span></li>
            <li><span class="category-list-item " data-categoryid="45308">Leading Change</span></li>
            <li><span class="category-list-item " data-categoryid="44045">Less is More</span></li>
            <li><span class="category-list-item " data-categoryid="46327">LGBTQIA Medicine</span></li>
            <li><span class="category-list-item " data-categoryid="5720">Lifestyle Behaviors</span></li>
            <li><span class="category-list-item " data-categoryid="45311">Medical Coding</span></li>
            <li><span class="category-list-item " data-categoryid="5738">Medical Devices and Equipment</span></li>
            <li><span class="category-list-item " data-categoryid="44023">Medical Education</span></li>
            <li><span class="category-list-item " data-categoryid="5739">Medical Education and Training</span></li>
            <li><span class="category-list-item " data-categoryid="5713">Medical Journals and Publishing</span></li>
            <li><span class="category-list-item " data-categoryid="5746">Melanoma</span></li>
            <li><span class="category-list-item " data-categoryid="44025">Mobile Health and Telemedicine</span></li>
            <li><span class="category-list-item " data-categoryid="5766">Narrative Medicine</span></li>
            <li><span class="category-list-item " data-categoryid="5769">Nephrology</span></li>
            <li><span class="category-list-item " data-categoryid="5777">Neurology</span></li>
            <li><span class="category-list-item " data-categoryid="44052">Neuroscience and Psychiatry</span></li>
            <li><span class="category-list-item " data-categoryid="44053">Notable Notes</span></li>
            <li><span class="category-list-item " data-categoryid="5787">Nursing</span></li>
            <li><span class="category-list-item " data-categoryid="5788">Nutrition</span></li>
            <li><span class="category-list-item " data-categoryid="44027">Nutrition, Obesity, Exercise</span></li>
            <li><span class="category-list-item " data-categoryid="5791">Obesity</span></li>
            <li><span class="category-list-item " data-categoryid="44013">Obstetrics and Gynecology</span></li>
            <li><span class="category-list-item " data-categoryid="5796">Occupational Health</span></li>
            <li><span class="category-list-item " data-categoryid="5801">Oncology</span></li>
            <li><span class="category-list-item " data-categoryid="5804">Ophthalmology</span></li>
            <li><span class="category-list-item " data-categoryid="5808">Orthopedics</span></li>
            <li><span class="category-list-item " data-categoryid="5811">Otolaryngology</span></li>
            <li><span class="category-list-item " data-categoryid="44028">Pain Medicine</span></li>
            <li><span class="category-list-item " data-categoryid="46446">Palliative Care</span></li>
            <li><span class="category-list-item " data-categoryid="44029">Pathology and Laboratory Medicine</span></li>
            <li><span class="category-list-item " data-categoryid="45306">Patient Care</span></li>
            <li><span class="category-list-item " data-categoryid="6258">Patient Information</span></li>
            <li><span class="category-list-item " data-categoryid="5843">Pediatrics</span></li>
            <li><span class="category-list-item " data-categoryid="44060">Performance Improvement</span></li>
            <li><span class="category-list-item " data-categoryid="45315">Performance Measures</span></li>
            <li><span class="category-list-item " data-categoryid="42050">Perioperative Care and Consultation</span></li>
            <li><span class="category-list-item " data-categoryid="42125">Pharmacoeconomics</span></li>
            <li><span class="category-list-item " data-categoryid="42126">Pharmacoepidemiology</span></li>
            <li><span class="category-list-item " data-categoryid="5851">Pharmacogenetics</span></li>
            <li><span class="category-list-item " data-categoryid="44030">Pharmacy and Clinical Pharmacology</span></li>
            <li><span class="category-list-item " data-categoryid="5856">Physical Medicine and Rehabilitation</span></li>
            <li><span class="category-list-item " data-categoryid="42059">Physical Therapy</span></li>
            <li><span class="category-list-item " data-categoryid="45313">Physician Leadership</span></li>
            <li><span class="category-list-item " data-categoryid="44061">Poetry</span></li>
            <li><span class="category-list-item " data-categoryid="45316">Population Health</span></li>
            <li><span class="category-list-item " data-categoryid="46445">Primary Care</span></li>
            <li><span class="category-list-item " data-categoryid="45309">Professional Well-being</span></li>
            <li><span class="category-list-item " data-categoryid="44064">Professionalism</span></li>
            <li><span class="category-list-item " data-categoryid="5871">Psychiatry and Behavioral Health</span></li>
            <li><span class="category-list-item " data-categoryid="42128">Public Health</span></li>
            <li><span class="category-list-item " data-categoryid="5877">Pulmonary Medicine</span></li>
            <li><span class="category-list-item " data-categoryid="42129">Radiology</span></li>
            <li><span class="category-list-item " data-categoryid="42058">Regulatory Agencies</span></li>
            <li><span class="category-list-item " data-categoryid="46443">Reproductive Health</span></li>
            <li><span class="category-list-item " data-categoryid="5916">Research, Methods, Statistics</span></li>
            <li><span class="category-list-item " data-categoryid="42142">Resuscitation</span></li>
            <li><span class="category-list-item " data-categoryid="5896">Rheumatology</span></li>
            <li><span class="category-list-item " data-categoryid="46326">Risk Management</span></li>
            <li><span class="category-list-item " data-categoryid="38802">Scientific Discovery and the Future of Medicine</span></li>
            <li><span class="category-list-item " data-categoryid="5833">Shared Decision Making and Communication</span></li>
            <li><span class="category-list-item " data-categoryid="5912">Sleep Medicine</span></li>
            <li><span class="category-list-item " data-categoryid="5915">Sports Medicine</span></li>
            <li><span class="category-list-item " data-categoryid="5533">Stem Cell Transplantation</span></li>
            <li><span class="category-list-item " data-categoryid="5921">Substance Use and Addiction Medicine</span></li>
            <li><span class="category-list-item " data-categoryid="5923">Surgery</span></li>
            <li><span class="category-list-item " data-categoryid="44065">Surgical Innovation</span></li>
            <li><span class="category-list-item " data-categoryid="44066">Surgical Pearls</span></li>
            <li><span class="category-list-item " data-categoryid="44067">Teachable Moment</span></li>
            <li><span class="category-list-item " data-categoryid="45310">Technology and Finance</span></li>
            <li><span class="category-list-item " data-categoryid="44034">The Art of JAMA</span></li>
            <li><span class="category-list-item " data-categoryid="44037">The Arts and Medicine</span></li>
            <li><span class="category-list-item " data-categoryid="6257">The Rational Clinical Examination</span></li>
            <li><span class="category-list-item " data-categoryid="5936">Tobacco and e-Cigarettes</span></li>
            <li><span class="category-list-item " data-categoryid="5938">Toxicology</span></li>
            <li><span class="category-list-item " data-categoryid="46433">Translational Medicine</span></li>
            <li><span class="category-list-item " data-categoryid="42136">Trauma and Injury</span></li>
            <li><span class="category-list-item " data-categoryid="5942">Treatment Adherence</span></li>
            <li><span class="category-list-item " data-categoryid="46323">Ultrasonography</span></li>
            <li><span class="category-list-item " data-categoryid="5947">Urology</span></li>
            <li><span class="category-list-item " data-categoryid="44069">Users&#39; Guide to the Medical Literature</span></li>
            <li><span class="category-list-item " data-categoryid="5950">Vaccination</span></li>
            <li><span class="category-list-item " data-categoryid="5955">Venous Thromboembolism</span></li>
            <li><span class="category-list-item " data-categoryid="45312">Veterans Health</span></li>
            <li><span class="category-list-item " data-categoryid="5957">Violence</span></li>
            <li><span class="category-list-item " data-categoryid="42139">Women&#39;s Health</span></li>
            <li><span class="category-list-item " data-categoryid="45307">Workflow and Process</span></li>
            <li><span class="category-list-item " data-categoryid="42140">Wound Care, Infection, Healing</span></li>
    </ul>
</div>

    
<div class="manage-interests--save-preferences">
    <div class="save-preferences-btn thm-bg ">
        <span class="save-preferences-btn-text fw-b">Save Preferences</span>
    </div>
</div>
<div class="manage-interests--privacy-terms"> <a class="manage-interests--privacy-terms-color" href="/pages/privacy-policy">Privacy Policy</a> | <a class="manage-interests--privacy-terms-color" href="/pages/terms-of-use">Terms of Use</a></div>

    
    <a class="close-reveal-modal icon-close"></a>
</div> 
    </div>

                </div>
                <h4 class="thm-col-sec" align="center">
                    Others Also Liked
                </h4>
                <div id="trendmd-suggestions"></div>

        </div>


        
        <div id="comments-tab" class="resource-tab js-resource-tab comments-tab js-comments-tab single-comment-view">
    <div class="widget-UserComment widget-instance-AMA_SplitScreen_UserComment">
        
    <div id="comment-wrapper">
            <div class="comment-btn">
        <a id="modal-opener" class="btn d-b mb1 sb-background-sc js-modal-opener" href="javascript:;">Comment</a>
    </div>

    </div>
 
    </div>
    <div class="widget-UserCommentBody widget-instance-AMA_UserCommentBody_SplitScreen">
        


    <div class="user-comments">
        <div class="comment-header clearfix">
            <div class="comment-count left text-small"><span class="user-comments-secondary-text">1 Comment for this article</span></div>
            
                <a href="#" class="comment-expand-all fw-b right text-small sb-sc">EXPAND ALL</a>
        </div>

    <div class="comment-item">
        <div class="comment-item--date-submitted">July 23, 2021</div>
        <div class="comment-item--title thm-col fw-b sb-pc">Anti-Industry Bias in CONSERVE 2021 Authorship?</div>
        <div class="comment-item--author">
            <span class="author-name fw-b">Kenneth Gorelick, MD</span>
                 | Zymo Consulting Group LLC        </div>
        <div class="comment-item--text">
            <span class="comment-item--text-limited ellipsis">Among the author affiliations in this article, well-represented are academic institutions, regulatory bodies, medical journals, and government agencies, all of which are important stakeholders in this conversation. Conspicuously absent however is a single individual identified with the biotechnology, pharmaceutical, or medical device industries. <br />
<br />
A look at clinicaltrials.gov (1) shows that in a total database of 384,288 trials, 120,896 (31%) were funded by industry, 34137 (9%) were funded by NIH, and 7,379 (2%) were funded by other US federal agencies. This becomes even more striking when examining currently recruiting Phase 3 interventional trials (n=4323) for which 1874 (43%) were</span>
            <span class="comment-item--text-remaining"> funded by industry, 277 (6%) by NIH, and 48 (1%) by other US federal agencies.<br />
<br />
As the single largest stakeholder in the medical publication universe, I am dismayed to see the exclusion of the medical industry from the development of these important guidelines.<br />
<br />
While I am certain to hear protests about "industry bias", it is in fact rare to see retractions of industry-sponsored research because the vetting process for industry studies, in anticipation of regulatory submissions, is in fact far more rigorous than academic peer review. Thousands of physicians with impeccable integrity work in the biotech, pharma, and medical device industries. It is time for them to be recognized and incorporated into the process of clinical research guideline development.<br /><br />
Reference<br /><br />
1. https://clinicaltrials.gov/ct2/results?Search=Apply&recrs=a&age_v=&gndr=&type=&rslt= accessed 23 July 2021<br /><br /></span>
                
        </div>
        <div class="comment-item--separator-collapse thm-col"></div>
        <div class="comment-item--disclosure-collapse">
            <strong>CONFLICT OF INTEREST:</strong>
            <span>I consult for the pharmaceutical industry. Clients have included Wyeth, Pfizer, Shire Takeda, GSK, Infinity, and others</span>
        </div>
       <a href="#" class="comment-item--read-more-link right user-comments-secondary-text">READ MORE</a>
    </div>
    </div>


 
    </div>



        </div>
    </div>
</div>

<a id="skip-to-navigation" href="#" tabindex="-1"></a>
<div id="content-panel" class="content-panel">
    <a id="top"></a>

    <div id="full-text-tab" class="resource-tab js-resource-tab full-text-tab">
    <div class="widget-ArticleLinks widget-instance-AMA_ErrataArticleLinks_FullText">
         
    </div>
    <div class="widget-ArticleLinks widget-instance-AMA_ArticleLinks_ToErrata_FullText">
        
 
    </div>
    <div class="widget-ArticleNavLinks widget-instance-AMA_ArticleNavLinks">
                <a class="toc-link btn" href="https://jamanetwork.com/journals/jama/issue/326/3">This Issue</a>
 
    </div>



            <div class="article-metrics-wrapper" id="divArticleLevelMetrics">
    <div class="widget-ArticleLevelMetrics widget-instance-AMA_ArticleMetrics">
        

    <div class="artmet-condensed-wrap clearfix">
        <div class="artmet-condensed-stats clearfix">
                <div class="artmet-item artmet-views">
                    <span class="artmet-text sb-sc">Views</span>
                    <span class="artmet-number sb-sc">113,581</span>
                </div>
                                <div class="artmet-item artmet-citations">
                            <a class="artmet-citations-link" href="https://www.webofscience.com/api/gateway?GWVersion=2&amp;SrcApp=silverchair&amp;SrcAuth=WosAPI&amp;KeyUT=WOS:000666399000001&amp;DestLinkType=FullRecord&amp;DestApp=WOS_CPL" target="_blank">
                                <span class="artmet-text">Citations</span>
                                <span class="artmet-number">155</span>
                            </a>
                    </div>
                                <div class="artmet-item artmet-altmetric">
    <div class="widget-AltmetricLink widget-instance-AMAv2_ArticleLevelMetrics_AltmetricLinkSummary">
            <!-- Altmetrics -->
    <div id="altmetricEmbedId" class='altmetric-embed' data-link-target="_blank" data-badge-type="text" data-hide-no-mentions="false" data-doi="10.1001/jama.2021.9941"
     
        
        ></div>
 
    </div>

                    </div>

<div class="artmet-item artmet-comments">
                        <a class="artmet-comments-link" href="#comment-wrapper">
                            <span class="artmet-text sb-sc">Comments</span>
                            <span class="artmet-number sb-sc">1</span>
                        </a>
                    </div>
        </div>

        <div class="artmet-modal-trigger-wrap">
            <a rel="nofollow" class="artmet-modal-trigger" data-article-id="2781397"><i class="icon-metrics"></i><span>View Metrics</span></a>
        </div>
    </div>

 
    </div>

            </div>
        <ul class="toolbar">
            <li class="toolbar-pdf-wrap toolbar-tool-wrap">
            <a id="pdf-link" class="toolbar-tool toolbar-pdf al-link pdfaccess" data-article-id="2781397" data-article-url="/journals/jama/articlepdf/2781397/jama_orkin_2021_sc_210001_1626283660.02954.pdf" data-ajax-url="/Content/CheckPdfAccess"><span class="toolbar-pdf-text"><span class="toolbar-link-text-extra">Download </span><span class="toolbar-link-text">PDF</span></span>
            </a>

            </li>
            <li class="toolbar-share-wrap toolbar-tool-wrap">
                <div class="toolbar-tool">
                    <a class="st-custom-button addthis_button_twitter is-b toolbar-twitter toolbar-share"
                       data-network="twitter"
                       data-title=""
                       data-url=""
                       data-email-subject=""
                       rel="nofollow"
                       href="javascript:;">
                        <span class="share-text">X</span>
                    </a>
                    <a class="st-custom-button addthis_button_facebook is-b toolbar-facebook toolbar-share"
                       data-network="facebook"
                       data-title=""
                       data-url=""
                       data-email-subject=""
                       rel="nofollow"
                       href="javascript:;">
                        <span class="share-text">Facebook</span>
                    </a>
                    <a class="toolbar-share-more-link is-a" rel="nofollow"><span class="icon icon-carrot_down social-arrow"></span><span class="more-text-wrap">More</span></a>
                    <div class="toolbar-share-more">
                        <a class="st-custom-button addthis_button_linkedin is-b toolbar-linkedin toolbar-share"
                           data-network="linkedin"
                           data-title=""
                           data-url=""
                           data-email-subject=""
                           rel="nofollow"
                           href="javascript:;">
                            <span class="share-text">LinkedIn</span>
                        </a>
                    </div>
                </div>
            </li>

            <li class="toolbar-citation-wrap toolbar-tool-wrap">
    <div class="widget-ToolboxGetCitation widget-instance-AMA_Get_Citation">
        
        <a class="toolbar-tool toolbar-citation is-b stats-citation" rel="nofollow" data-reveal-id="get-citation" data-reveal>
            <span class="toolbar-link-text">Cite</span>
            <span class="toolbar-link-text-extra">This</span>
        </a>
    <div id="get-citation" class="reveal-modal get-citation" data-reveal>
        <h3 class="get-citation-title">Citation</h3>
        <p class="get-citation-citation">Orkin AM<span class='al-author-delim'>, </span>Gill PJ<span class='al-author-delim'>, </span>Ghersi D, et al. Guidelines for Reporting Trial Protocols and Completed Trials Modified Due to the COVID-19 Pandemic and Other Extenuating Circumstances<span class="subtitle"><span class="colon-for-citation-subtitle">: </span>The CONSERVE 2021 Statement</span>. <em>JAMA.</em> 2021;326(3):257–265. doi:10.1001/jama.2021.9941</p>
        <h4 class="get-citation-download-heading">Manage citations:</h4>
        <div class="get-citation-types">
            <a class="get-citation-format" rel="nofollow" href="/Citation/Download?resourceId=2781397&amp;resourceType=3&amp;citationFormat=0">Ris (Zotero)</a>
            <a class="get-citation-format" rel="nofollow" href="/Citation/Download?resourceId=2781397&amp;resourceType=3&amp;citationFormat=1">EndNote</a>
            <a class="get-citation-format" rel="nofollow" href="/Citation/Download?resourceId=2781397&amp;resourceType=3&amp;citationFormat=2">BibTex</a>
            <a class="get-citation-format" rel="nofollow" href="/Citation/Download?resourceId=2781397&amp;resourceType=3&amp;citationFormat=3">Medlars</a>
            <a class="get-citation-format" rel="nofollow" href="/Citation/Download?resourceId=2781397&amp;resourceType=3&amp;citationFormat=0">ProCite</a>
            <a class="get-citation-format" rel="nofollow" href="/Citation/Download?resourceId=2781397&amp;resourceType=3&amp;citationFormat=3">RefWorks</a>
            <a class="get-citation-format" rel="nofollow" href="/Citation/Download?resourceId=2781397&amp;resourceType=3&amp;citationFormat=0">Reference Manager</a>
            <a class="get-citation-format" rel="nofollow" href="/Citation/Download?resourceId=2781397&amp;resourceType=3&amp;citationFormat=0">Mendeley</a>
        </div>

        <p class="get-citation-copyright">&#169; 2024 </p>
        <a class="close-reveal-modal icon-close" rel="nofollow"></a>
    </div>


 
    </div>

            </li>
            <li class="toolbar-permissions-wrap toolbar-tool-wrap">
    <div class="widget-ToolboxPermissions widget-instance-AMA_Get_Permissions">
            <a href="http://s100.copyright.com/AppDispatchServlet?publisherName=AMA&amp;publication=0098-7484&amp;title=Guidelines+for+Reporting+Trial+Protocols+and+Completed+Trials+Modified+Due+to+the+COVID-19+Pandemic+and+Other+Extenuating+Circumstances%3a+The+CONSERVE+2021+Statement&amp;publicationDate=2021-07-20&amp;volumeNum=326&amp;issueNum=3&amp;author=Orkin%2c+Aaron+M.%3b+Gill%2c+Peter+J.&amp;startPage=257&amp;endPage=265&amp;contentId=10.1001%2fjama.2021.9941&amp;oa=&amp;orderBeanReset=True" rel="nofollow" id="PermissionsLink" class="toolbar-tool toolbar-permissions is-b" target="_blank"><span class="toolbar-link-text">Permissions</span></a>
 
    </div>

            </li>
        </ul>

    <div class="widget-ArticleTopInfo widget-instance-AMA_ArticleTop_Info_Widget">
        

    <div class="meta-access-type free-access is-b"></div>


            <span class="hide tagmanagervalue" data-attribute="articleId" data-value="2781397" data-type="string"></span>
            <span class="hide tagmanagervalue" data-attribute="arrArticleAuthor" data-value="Aaron%20M.%C2%A0Orkin%2C%C2%A0MD%2C%20MSc%2C%20MPH,Peter%20J.%C2%A0Gill%2C%C2%A0MD%2C%20DPhil,Davina%C2%A0Ghersi%2C%C2%A0MD%2C%20PhD,Lisa%C2%A0Campbell%2C%C2%A0MD%2C%20MBBCh%2C%20BSc,Jeremy%C2%A0Sugarman%2C%C2%A0MD%2C%20MPH%2C%20MA,Richard%C2%A0Emsley%2C%C2%A0PhD,Philippe%20Gabriel%C2%A0Steg%2C%C2%A0MD,Charles%C2%A0Weijer%2C%C2%A0MD%2C%20PhD,John%C2%A0Simes%2C%C2%A0MBBS%2C%20MD,Tanja%C2%A0Rombey%2C%C2%A0MPH,Hywel%20C.%C2%A0Williams%2C%C2%A0DSc,Janet%C2%A0Wittes%2C%C2%A0PhD,David%C2%A0Moher%2C%C2%A0PhD,Dawn%20P.%C2%A0Richards%2C%C2%A0PhD,Yvette%C2%A0Kasamon%2C%C2%A0MD,Kenneth%C2%A0Getz%2C%C2%A0MBA,Sally%C2%A0Hopewell%2C%C2%A0MSc%2C%20DPhil,Kay%C2%A0Dickersin%2C%C2%A0MA%2C%20PhD,Taixiang%C2%A0Wu%2C%C2%A0MPH,Ana%20Patricia%C2%A0Ayala%2C%C2%A0MISt,Kenneth%20F.%C2%A0Schulz%2C%C2%A0PhD,Sabine%C2%A0Calleja%2C%C2%A0MI,Isabelle%C2%A0Boutron%2C%C2%A0MD%2C%20PhD,Joseph%20S.%C2%A0Ross%2C%C2%A0MD%2C%20MHS,Robert%20M.%C2%A0Golub%2C%C2%A0MD,Karim%20M.%C2%A0Khan%2C%C2%A0MD%2C%20PhD,Cindy%C2%A0Mulrow%2C%C2%A0MD%2C%20MSc,Nandi%C2%A0Siegfried%2C%C2%A0PhD%2C%20MPH,Joerg%C2%A0Heber%2C%C2%A0PhD,Naomi%C2%A0Lee%2C%C2%A0MD,Pamela%20Reed%C2%A0Kearney%2C%C2%A0MD,Rhoda%20K.%C2%A0Wanyenze%2C%C2%A0MBChB%2C%20MPH%2C%20PhD,Asbj%C3%B8rn%C2%A0Hr%C3%B3bjartsson%2C%C2%A0MD%2C%20PhD%2C%20MPhil,Rebecca%C2%A0Williams%2C%C2%A0PharmD%2C%20MPH,Nita%C2%A0Bhandari%2C%C2%A0PhD,Peter%C2%A0J%C3%BCni%2C%C2%A0MD,An-Wen%C2%A0Chan%2C%C2%A0MD%2C%20DPhil,CONSERVE%20Group" data-type="array"></span>
            <span class="hide tagmanagervalue" data-attribute="articleDOI" data-value="10.1001/jama.2021.9941" data-type="string"></span>
            <span class="hide tagmanagervalue" data-attribute="articleTitle" data-value="Guidelines for Reporting Trial Protocols and Completed Trials Modified Due to the COVID-19 Pandemic and Other Extenuating Circumstances&lt;span class=&quot;subtitle&quot;&gt;&lt;span class=&quot;colon-for-citation-subtitle&quot;&gt;: &lt;/span&gt;The CONSERVE 2021 Statement&lt;/span&gt;" data-type="string"></span>
            <span class="hide tagmanagervalue" data-attribute="type" data-value="Special Communication" data-type="string"></span>
            <span class="hide tagmanagervalue" data-attribute="issueVolume" data-value="326" data-type="string"></span>
            <span class="hide tagmanagervalue" data-attribute="issueNo" data-value="3" data-type="string"></span>
            <span class="hide tagmanagervalue" data-attribute="publishDate" data-value="July 20, 2021" data-type="string"></span>
            <span class="hide tagmanagervalue" data-attribute="topics" data-value="Medical Journals and Publishing, Research, Methods, Statistics, Guidelines" data-type="array"></span>
            <span class="hide tagmanagervalue" data-attribute="topicCode" data-value="5713, 5916, 5672" data-type="array"></span>
            <span class="hide tagmanagervalue" data-attribute="category" data-value="Review" data-type="string"></span>
            <span class="hide tagmanagervalue" data-attribute="journalClub" data-value="No" data-type="string"></span>
            <span class="hide tagmanagervalue" data-attribute="contentStatus" data-value="Free" data-type="string"></span>
            <span class="hide tagmanagervalue" data-attribute="articlePubState" data-value="Final" data-type="string"></span>
            <span class="hide tagmanagervalue" data-attribute="contentMedium" data-value="Article" data-type="string"></span>


        <div class="meta-article-type-wrap">
            <div class="meta-article-type thm-col">Special Communication </div>
        </div>
        <div class="meta-date">June 21, 2021</div>
        <div class="meta-article-title-wrap">
            
            <h1 class="meta-article-title ">Guidelines for Reporting Trial Protocols and Completed Trials Modified Due to the COVID-19 Pandemic and Other Extenuating Circumstances<span class="subtitle"><span class="colon-for-citation-subtitle">: </span>The CONSERVE 2021 Statement</span></h1>

            
        </div>
            <div class="meta-authors">
                <span class="meta-authors--limited"><span class="wi-fullname brand-fg"><a href="/searchresults?author=Aaron+M.+Orkin&q=Aaron+M.+Orkin" rel=nofollow target="_blank">Aaron M. Orkin, MD, MSc, MPH<sup>1,2</sup></a></span><span class='al-author-delim'>; </span><span class="wi-fullname brand-fg"><a href="/searchresults?author=Peter+J.+Gill&q=Peter+J.+Gill" rel=nofollow target="_blank">Peter J. Gill, MD, DPhil<sup>3</sup></a></span><span class='al-author-delim'>; </span><span class="wi-fullname brand-fg"><a href="/searchresults?author=Davina+Ghersi&q=Davina+Ghersi" rel=nofollow target="_blank">Davina Ghersi, MD, PhD<sup>4</sup></a></span>; <a class="meta-authors--etal td-u stats-meta-authors--etal">et al</a></span>
                <span class="meta-authors--remaining"><span class="wi-fullname brand-fg"><a href="/searchresults?author=Lisa+Campbell&q=Lisa+Campbell" rel=nofollow target="_blank">Lisa Campbell, MD, MBBCh, BSc<sup>5</sup></a></span><span class='al-author-delim'>; </span><span class="wi-fullname brand-fg"><a href="/searchresults?author=Jeremy+Sugarman&q=Jeremy+Sugarman" rel=nofollow target="_blank">Jeremy Sugarman, MD, MPH, MA<sup>6</sup></a></span><span class='al-author-delim'>; </span><span class="wi-fullname brand-fg"><a href="/searchresults?author=Richard+Emsley&q=Richard+Emsley" rel=nofollow target="_blank">Richard Emsley, PhD<sup>7</sup></a></span><span class='al-author-delim'>; </span><span class="wi-fullname brand-fg"><a href="/searchresults?author=Philippe+Gabriel+Steg&q=Philippe+Gabriel+Steg" rel=nofollow target="_blank">Philippe Gabriel Steg, MD<sup>8</sup></a></span><span class='al-author-delim'>; </span><span class="wi-fullname brand-fg"><a href="/searchresults?author=Charles+Weijer&q=Charles+Weijer" rel=nofollow target="_blank">Charles Weijer, MD, PhD<sup>9</sup></a></span><span class='al-author-delim'>; </span><span class="wi-fullname brand-fg"><a href="/searchresults?author=John+Simes&q=John+Simes" rel=nofollow target="_blank">John Simes, MBBS, MD<sup>10</sup></a></span><span class='al-author-delim'>; </span><span class="wi-fullname brand-fg"><a href="/searchresults?author=Tanja+Rombey&q=Tanja+Rombey" rel=nofollow target="_blank">Tanja Rombey, MPH<sup>11</sup></a></span><span class='al-author-delim'>; </span><span class="wi-fullname brand-fg"><a href="/searchresults?author=Hywel+C.+Williams&q=Hywel+C.+Williams" rel=nofollow target="_blank">Hywel C. Williams, DSc<sup>12,13</sup></a></span><span class='al-author-delim'>; </span><span class="wi-fullname brand-fg"><a href="/searchresults?author=Janet+Wittes&q=Janet+Wittes" rel=nofollow target="_blank">Janet Wittes, PhD<sup>14</sup></a></span><span class='al-author-delim'>; </span><span class="wi-fullname brand-fg"><a href="/searchresults?author=David+Moher&q=David+Moher" rel=nofollow target="_blank">David Moher, PhD<sup>15</sup></a></span><span class='al-author-delim'>; </span><span class="wi-fullname brand-fg"><a href="/searchresults?author=Dawn+P.+Richards&q=Dawn+P.+Richards" rel=nofollow target="_blank">Dawn P. Richards, PhD<sup>16</sup></a></span><span class='al-author-delim'>; </span><span class="wi-fullname brand-fg"><a href="/searchresults?author=Yvette+Kasamon&q=Yvette+Kasamon" rel=nofollow target="_blank">Yvette Kasamon, MD<sup>17</sup></a></span><span class='al-author-delim'>; </span><span class="wi-fullname brand-fg"><a href="/searchresults?author=Kenneth+Getz&q=Kenneth+Getz" rel=nofollow target="_blank">Kenneth Getz, MBA<sup>18</sup></a></span><span class='al-author-delim'>; </span><span class="wi-fullname brand-fg"><a href="/searchresults?author=Sally+Hopewell&q=Sally+Hopewell" rel=nofollow target="_blank">Sally Hopewell, MSc, DPhil<sup>19</sup></a></span><span class='al-author-delim'>; </span><span class="wi-fullname brand-fg"><a href="/searchresults?author=Kay+Dickersin&q=Kay+Dickersin" rel=nofollow target="_blank">Kay Dickersin, MA, PhD<sup>20</sup></a></span><span class='al-author-delim'>; </span><span class="wi-fullname brand-fg"><a href="/searchresults?author=Taixiang+Wu&q=Taixiang+Wu" rel=nofollow target="_blank">Taixiang Wu, MPH<sup>21</sup></a></span><span class='al-author-delim'>; </span><span class="wi-fullname brand-fg"><a href="/searchresults?author=Ana+Patricia+Ayala&q=Ana+Patricia+Ayala" rel=nofollow target="_blank">Ana Patricia Ayala, MISt<sup>22</sup></a></span><span class='al-author-delim'>; </span><span class="wi-fullname brand-fg"><a href="/searchresults?author=Kenneth+F.+Schulz&q=Kenneth+F.+Schulz" rel=nofollow target="_blank">Kenneth F. Schulz, PhD<sup>23,24</sup></a></span><span class='al-author-delim'>; </span><span class="wi-fullname brand-fg"><a href="/searchresults?author=Sabine+Calleja&q=Sabine+Calleja" rel=nofollow target="_blank">Sabine Calleja, MI<sup>25</sup></a></span><span class='al-author-delim'>; </span><span class="wi-fullname brand-fg"><a href="/searchresults?author=Isabelle+Boutron&q=Isabelle+Boutron" rel=nofollow target="_blank">Isabelle Boutron, MD, PhD<sup>26</sup></a></span><span class='al-author-delim'>; </span><span class="wi-fullname brand-fg"><a href="/searchresults?author=Joseph+S.+Ross&q=Joseph+S.+Ross" rel=nofollow target="_blank">Joseph S. Ross, MD, MHS<sup>27,28</sup></a></span><span class='al-author-delim'>; </span><span class="wi-fullname brand-fg"><a href="/searchresults?author=Robert+M.+Golub&q=Robert+M.+Golub" rel=nofollow target="_blank">Robert M. Golub, MD<sup>29,30</sup></a></span><span class='al-author-delim'>; </span><span class="wi-fullname brand-fg"><a href="/searchresults?author=Karim+M.+Khan&q=Karim+M.+Khan" rel=nofollow target="_blank">Karim M. Khan, MD, PhD<sup>31</sup></a></span><span class='al-author-delim'>; </span><span class="wi-fullname brand-fg"><a href="/searchresults?author=Cindy+Mulrow&q=Cindy+Mulrow" rel=nofollow target="_blank">Cindy Mulrow, MD, MSc<sup>32</sup></a></span><span class='al-author-delim'>; </span><span class="wi-fullname brand-fg"><a href="/searchresults?author=Nandi+Siegfried&q=Nandi+Siegfried" rel=nofollow target="_blank">Nandi Siegfried, PhD, MPH<sup>33</sup></a></span><span class='al-author-delim'>; </span><span class="wi-fullname brand-fg"><a href="/searchresults?author=Joerg+Heber&q=Joerg+Heber" rel=nofollow target="_blank">Joerg Heber, PhD<sup>34</sup></a></span><span class='al-author-delim'>; </span><span class="wi-fullname brand-fg"><a href="/searchresults?author=Naomi+Lee&q=Naomi+Lee" rel=nofollow target="_blank">Naomi Lee, MD<sup>35</sup></a></span><span class='al-author-delim'>; </span><span class="wi-fullname brand-fg"><a href="/searchresults?author=Pamela+Reed+Kearney&q=Pamela+Reed+Kearney" rel=nofollow target="_blank">Pamela Reed Kearney, MD<sup>36</sup></a></span><span class='al-author-delim'>; </span><span class="wi-fullname brand-fg"><a href="/searchresults?author=Rhoda+K.+Wanyenze&q=Rhoda+K.+Wanyenze" rel=nofollow target="_blank">Rhoda K. Wanyenze, MBChB, MPH, PhD<sup>37</sup></a></span><span class='al-author-delim'>; </span><span class="wi-fullname brand-fg"><a href="/searchresults?author=Asbj%c3%b8rn+Hr%c3%b3bjartsson&q=Asbj%c3%b8rn+Hr%c3%b3bjartsson" rel=nofollow target="_blank">Asbjørn Hróbjartsson, MD, PhD, MPhil<sup>38</sup></a></span><span class='al-author-delim'>; </span><span class="wi-fullname brand-fg"><a href="/searchresults?author=Rebecca+Williams&q=Rebecca+Williams" rel=nofollow target="_blank">Rebecca Williams, PharmD, MPH<sup>39</sup></a></span><span class='al-author-delim'>; </span><span class="wi-fullname brand-fg"><a href="/searchresults?author=Nita+Bhandari&q=Nita+Bhandari" rel=nofollow target="_blank">Nita Bhandari, PhD<sup>40</sup></a></span><span class='al-author-delim'>; </span><span class="wi-fullname brand-fg"><a href="/searchresults?author=Peter+J%c3%bcni&q=Peter+J%c3%bcni" rel=nofollow target="_blank">Peter Jüni, MD<sup>41</sup></a></span><span class='al-author-delim'>; </span><span class="wi-fullname brand-fg"><a href="/searchresults?author=An-Wen+Chan&q=An-Wen+Chan" rel=nofollow target="_blank">An-Wen Chan, MD, DPhil<sup>42</sup></a></span><span class='al-author-delim'>; </span>for the CONSERVE Group<sup></sup></span>
            </div>
            <div class="meta-author">
                <a class="meta-author-title is-b stats-meta-author-toggle" data-tog-target=".meta-author-content">Author Affiliations</a>
                    <a class="meta-articleinfo-jumplink section-jump-link scroll-to stats-scroll-to-articleinfo" data-tab-toggle=".tab-nav-full-text" href="#247891081">Article Information</a>


                <div class="meta-author-content">
                        <ul class="meta-author-affiliations">
                                <li class="meta-author-affiliation">
                                        <div class="meta-author-name"><sup>1</sup>Division of Emergency Medicine, Department of Family and Community Medicine, University of Toronto, Toronto, Ontario, Canada</div>
                                </li>
                                <li class="meta-author-affiliation">
                                        <div class="meta-author-name"><sup>2</sup>Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada</div>
                                </li>
                                <li class="meta-author-affiliation">
                                        <div class="meta-author-name"><sup>3</sup>Hospital for Sick Children, Department of Paediatrics, University of Toronto, Toronto, Ontario, Canada</div>
                                </li>
                                <li class="meta-author-affiliation">
                                        <div class="meta-author-name"><sup>4</sup>National Health and Medical Research Council, Canberra, Australia</div>
                                </li>
                                <li class="meta-author-affiliation">
                                        <div class="meta-author-name"><sup>5</sup>Clinical Trials Unit, Medicines and Healthcare Products Regulatory Agency, London, England</div>
                                </li>
                                <li class="meta-author-affiliation">
                                        <div class="meta-author-name"><sup>6</sup>Berman Institute of Bioethics, Johns Hopkins University, Baltimore, Maryland</div>
                                </li>
                                <li class="meta-author-affiliation">
                                        <div class="meta-author-name"><sup>7</sup>Department of Biostatistics and Health Informatics, Institute of Psychiatry, Psychology, and Neuroscience, King’s College London, London, England</div>
                                </li>
                                <li class="meta-author-affiliation">
                                        <div class="meta-author-name"><sup>8</sup>Université de Paris, AP-HP, Paris, France</div>
                                </li>
                                <li class="meta-author-affiliation">
                                        <div class="meta-author-name"><sup>9</sup>Departments of Medicine, Epidemiology and Biostatistics, and Philosophy, Western University, London, Ontario, Canada</div>
                                </li>
                                <li class="meta-author-affiliation">
                                        <div class="meta-author-name"><sup>10</sup>National Health and Medical Research Council Clinical Trials Centre, University of Sydney, Sydney, Australia</div>
                                </li>
                                <li class="meta-author-affiliation">
                                        <div class="meta-author-name"><sup>11</sup>Department of Health Care Management, Technische Universität Berlin, Berlin, Germany</div>
                                </li>
                                <li class="meta-author-affiliation">
                                        <div class="meta-author-name"><sup>12</sup>University of Nottingham, Nottingham, England</div>
                                </li>
                                <li class="meta-author-affiliation">
                                        <div class="meta-author-name"><sup>13</sup>National Institute for Health Research, Nottingham, England</div>
                                </li>
                                <li class="meta-author-affiliation">
                                        <div class="meta-author-name"><sup>14</sup>WCG Statistics Collaborative, Washington, DC</div>
                                </li>
                                <li class="meta-author-affiliation">
                                        <div class="meta-author-name"><sup>15</sup>Centre for Journalology, Clinical Epidemiology Program, Ottawa Hospital Research Institute, School of Epidemiology and Public Health, University of Ottawa, Ottawa, Ontario, Canada</div>
                                </li>
                                <li class="meta-author-affiliation">
                                        <div class="meta-author-name"><sup>16</sup>Clinical Trials Ontario, Toronto, Ontario, Canada</div>
                                </li>
                                <li class="meta-author-affiliation">
                                        <div class="meta-author-name"><sup>17</sup>Office of Oncologic Diseases, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland</div>
                                </li>
                                <li class="meta-author-affiliation">
                                        <div class="meta-author-name"><sup>18</sup>Tufts Center for the Study of Drug Development, Boston, Massachusetts</div>
                                </li>
                                <li class="meta-author-affiliation">
                                        <div class="meta-author-name"><sup>19</sup>Oxford Clinical Trials Research Unit, Centre for Statistics in Medicine, University of Oxford, Oxford, England</div>
                                </li>
                                <li class="meta-author-affiliation">
                                        <div class="meta-author-name"><sup>20</sup>Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland</div>
                                </li>
                                <li class="meta-author-affiliation">
                                        <div class="meta-author-name"><sup>21</sup>Chinese Clinical Trial Registry, Sichuan University, Chengdu, China</div>
                                </li>
                                <li class="meta-author-affiliation">
                                        <div class="meta-author-name"><sup>22</sup>Gerstein Science Information Centre, University of Toronto, Toronto, Ontario, Canada</div>
                                </li>
                                <li class="meta-author-affiliation">
                                        <div class="meta-author-name"><sup>23</sup>FHI 360, Durham, North Carolina</div>
                                </li>
                                <li class="meta-author-affiliation">
                                        <div class="meta-author-name"><sup>24</sup>School of Medicine, University of North Carolina at Chapel Hill</div>
                                </li>
                                <li class="meta-author-affiliation">
                                        <div class="meta-author-name"><sup>25</sup>Gerstein Science Information Centre, University of Toronto, Toronto, Ontario, Canada</div>
                                </li>
                                <li class="meta-author-affiliation">
                                        <div class="meta-author-name"><sup>26</sup>Centre of Research in Epidemiology and Statistics, Université de Paris, Inserm, Paris, France</div>
                                </li>
                                <li class="meta-author-affiliation">
                                        <div class="meta-author-name"><sup>27</sup>Department of Internal Medicine, Yale School of Medicine, New Haven, Connecticut</div>
                                </li>
                                <li class="meta-author-affiliation">
                                        <div class="meta-author-name"><sup>28</sup><i>The BMJ</i>, London, England</div>
                                </li>
                                <li class="meta-author-affiliation">
                                        <div class="meta-author-name"><sup>29</sup>Deputy Editor, <i>JAMA</i></div>
                                </li>
                                <li class="meta-author-affiliation">
                                        <div class="meta-author-name"><sup>30</sup>Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois</div>
                                </li>
                                <li class="meta-author-affiliation">
                                        <div class="meta-author-name"><sup>31</sup>Canadian Institutes of Health Research Institute of Musculoskeletal Health and Arthritis, Ottawa, Ontario, Canada</div>
                                </li>
                                <li class="meta-author-affiliation">
                                        <div class="meta-author-name"><sup>32</sup>University of Texas Health Science Center, San Antonio</div>
                                </li>
                                <li class="meta-author-affiliation">
                                        <div class="meta-author-name"><sup>33</sup>Alcohol, Tobacco, and Other Drugs Research Unit, South African Medical Research Council, Cape Town, South Africa</div>
                                </li>
                                <li class="meta-author-affiliation">
                                        <div class="meta-author-name"><sup>34</sup>Lawrence Berkeley National Laboratory, Berkeley, California</div>
                                </li>
                                <li class="meta-author-affiliation">
                                        <div class="meta-author-name"><sup>35</sup><i>The Lancet</i>, London, England</div>
                                </li>
                                <li class="meta-author-affiliation">
                                        <div class="meta-author-name"><sup>36</sup>Office of Extramural Research, Division of Human Subjects Research, National Institutes of Health, Bethesda, Maryland</div>
                                </li>
                                <li class="meta-author-affiliation">
                                        <div class="meta-author-name"><sup>37</sup>Department of Disease Control and Environmental Health, School of Public Health, Makerere University, Kampala, Uganda</div>
                                </li>
                                <li class="meta-author-affiliation">
                                        <div class="meta-author-name"><sup>38</sup>Centre for Evidence-Based Medicine Odense (CEBMO) and Cochrane Denmark, University of Southern Denmark, Odense, Denmark</div>
                                </li>
                                <li class="meta-author-affiliation">
                                        <div class="meta-author-name"><sup>39</sup>ClinicalTrials.gov, National Library of Medicine, National Institutes of Health, Bethesda, Maryland</div>
                                </li>
                                <li class="meta-author-affiliation">
                                        <div class="meta-author-name"><sup>40</sup>Centre for Health Research and Development, Society for Applied Studies, New Delhi, India</div>
                                </li>
                                <li class="meta-author-affiliation">
                                        <div class="meta-author-name"><sup>41</sup>Applied Health Research Centre, St Michael’s Hospital, University of Toronto, Toronto, Ontario, Canada</div>
                                </li>
                                <li class="meta-author-affiliation">
                                        <div class="meta-author-name"><sup>42</sup>Women’s College Research Institute, Department of Medicine, University of Toronto, Toronto, Ontario, Canada</div>
                                </li>
                        </ul>



                </div>
            </div>
        <div class="meta-citation-wrap">
            <span class="meta-citation-journal-name">JAMA. </span><span class="meta-citation"> 2021;326(3):257-265. doi:10.1001/jama.2021.9941</span>
        </div>

 
    </div>
    <div class="widget-EditorsChoice widget-instance-AMA_EditorsChoice_Links">
        
 
    </div>
    <div class="widget-LinkedContentToolbar widget-instance-AMA_LinkedContentToolbar">
        
<div class="linked-content-toolbar">
    
    <div class="hidden js-search-open-multimedia-by-default" showContentByDefault="False"></div>
    <div class="linked-content-controls">
        <a class="linked-content-trigger td-n stats-graphical-abstract" href="#graphical-abstract-tab">
            <i class="icon-visual-abstract"><span class="sr-t">visual abstract icon</span></i>
            <div class="trigger-text d-ib va-m ta-l fw-5">Visual <div>Abstract</div></div>
        </a>
        <a class="linked-content-trigger td-n stats-editorial-comment" href="#editorial-comment-tab">
            <i class="icon-document"><span class="sr-t">editorial comment icon</span></i>
            <div class="trigger-text d-ib va-m ta-l fw-5">Editorial <div>Comment</div></div>
        </a>
        <a class="linked-content-trigger td-n stats-related-articles" href="#related-articles-tab">
            <i class="icon-related"><span class="sr-t">related articles icon</span></i>
            <div class="trigger-text d-ib va-m ta-l fw-5">Related <div>Articles</div></div>
        </a>
        <a class="linked-content-trigger td-n stats-author-interviews" href="#author-interviews-tab">
            <i class="icon-author_interview"><span class="sr-t">author interview icon</span></i>
            <div class="trigger-text d-ib va-m ta-l fw-5">Interviews</div>
        </a>
        <a class="linked-content-trigger td-n stats-more-multimedia" href="#more-multimedia-tab">
            <i class="icon-multimedia"><span class="sr-t">multimedia icon</span></i>
            <div class="trigger-text d-ib va-m ta-l fw-5">Multimedia</div>
        </a>
        <a class="linked-content-trigger td-n stats-listen-to-this-article" href="#listen-to-this-article-tab">
            <i class="icon-audio"><span class="sr-t">audio icon</span></i>
            <div class="trigger-text d-ib va-m ta-l fw-5">Listen to <div>this article</div></div>
        </a>
    </div>

    
<div class="linked-content-tabs">
    <div id="graphical-abstract-tab" class="linked-content-tab graphical-abstract-tab">
    <div class="widget-SectionDisplay widget-instance-AMA_GraphicalAbstract_Tab">
        
 
    </div>

    </div>

    
    <div id="editorial-comment-tab" class="linked-content-tab editorial-comment-tab">
    <div class="widget-ArticleLinks widget-instance-AMA_LinkedContentToolbar_EditorialComments">
        
 
    </div>

    </div>

    
    <div id="related-articles-tab" class="linked-content-tab related-article-tab">
    <div class="widget-ArticleLinks widget-instance-AMA_LinkedContentToolbar_RelatedArticle">
        
    <ul class="article-abstract-links related-abstract-content">
            <li class="article-link related-abstract-article">

                    <a class="related-article-title" href="https://jamanetwork.com/journals/jama/fullarticle/1487502">
                            <div class="related-article-type">Special Communication</div>
                        <div class="related-article-title sb-tc">Reporting of Noninferiority and Equivalence Randomized Trials<span class="subtitle"><span class="colon-for-citation-subtitle">: </span>Extension of the CONSORT 2010 Statement</span></div>
                    </a>
                    <div class="related-article-authors">Gilda Piaggio, PhD; Diana R. Elbourne, PhD; Stuart J. Pocock, PhD; Stephen J. W. Evans, MSc; Douglas G. Altman, DSc; for the CONSORT Group</div>
                                    <div class="related-article-journal-name">JAMA</div>
            </li>
            <li class="article-link related-abstract-article">

                    <a class="related-article-title" href="https://jamanetwork.com/journals/jama/fullarticle/1656259">
                            <div class="related-article-type">Special Communication</div>
                        <div class="related-article-title sb-tc">Reporting of Patient-Reported Outcomes in Randomized Trials<span class="subtitle"><span class="colon-for-citation-subtitle">: </span>The CONSORT PRO Extension</span></div>
                    </a>
                    <div class="related-article-authors">Melanie Calvert, PhD; Jane Blazeby, MD; Douglas G. Altman, DSc; Dennis A. Revicki, PhD; David Moher, PhD; Michael D. Brundage, MD; for the CONSORT PRO Group</div>
                                    <div class="related-article-journal-name">JAMA</div>
            </li>
            <li class="article-link related-abstract-article">

                    <a class="related-article-title" href="https://jamanetwork.com/journals/jama/fullarticle/2731183">
                            <div class="related-article-type">Special Communication</div>
                        <div class="related-article-title sb-tc">CONSORT Extension for Reporting Multi-Arm Parallel Group Randomized Trials</div>
                    </a>
                    <div class="related-article-authors">Edmund Juszczak, MSc; Douglas G. Altman, DSc; Sally Hopewell, DPhil; Kenneth Schulz, PhD</div>
                                    <div class="related-article-journal-name">JAMA</div>
            </li>
            <li class="article-link related-abstract-article">

                    <a class="related-article-title" href="https://jamanetwork.com/journals/jama/fullarticle/2789561">
                            <div class="related-article-type">JAMA Guide to Statistics and Methods</div>
                        <div class="related-article-title sb-tc">CONSERVE Guideline for Modified Trials</div>
                    </a>
                    <div class="related-article-authors">Maria Mori Brooks, PhD; Stephen R. Wisniewski, PhD</div>
                                    <div class="related-article-journal-name">JAMA</div>
            </li>
            <li class="article-link related-abstract-article">

                    <a class="related-article-title" href="https://jamanetwork.com/journals/jama/fullarticle/2799401">
                            <div class="related-article-type">Special Communication</div>
                        <div class="related-article-title sb-tc">Guidelines for Reporting Outcomes in Trial Reports</div>
                    </a>
                    <div class="related-article-authors">Nancy J. Butcher, PhD; Andrea Monsour, MPH; Emma J. Mew, MPH, MPhil; An-Wen Chan, MD, DPhil; David Moher, PhD; Evan Mayo-Wilson, DPhil; Caroline B. Terwee, PhD; Alyssandra Chee-A-Tow, MPH; Ami Baba, MRes; Frank Gavin, MA; Jeremy M. Grimshaw, MBCHB, PhD; Lauren E. Kelly, PhD; Leena Saeed, BSc, BEd; Lehana Thabane, PhD; Lisa Askie, PhD; Maureen Smith, MEd; Mufiza Farid-Kapadia, MD, PhD; Paula R. Williamson, PhD; Peter Szatmari, MD; Peter Tugwell, MD; Robert M. Golub, MD; Suneeta Monga, MD; Sunita Vohra, MD; Susan Marlin, MSc; Wendy J. Ungar, MSc, PhD; Martin Offringa, MD, PhD</div>
                                    <div class="related-article-journal-name">JAMA</div>
            </li>
    </ul>
 
    </div>
    <div class="widget-ArticleLinks widget-instance-AMA_LinkedContentToolbar_RelatedEditorsChoices">
        
 
    </div>

    </div>

    
    <div id="author-interviews-tab" class="linked-content-tab linked-author-interviews-tab">
    <div class="widget-AudioPlayer widget-instance-AMA_LinkedContentToolbar_PlatformAudioPlayer_AuthorInterviews">
         
    </div>

    </div>

    
    <div id="listen-to-this-article-tab" class="linked-content-tab linked-listen-to-this-article-tab">
    <div class="widget-AudioPlayer widget-instance-AMA_LinkedContentToolbar_PlatformAudioPlayer_ListenToThisArticle">
         
    </div>

    </div>

    
    <div id="more-multimedia-tab" class="linked-content-tab more-multimedia-tab">

    </div>
</div>
</div> 
    </div>

            <div class="widget-ArticleFulltext widget-instance-AMA_Article_FullText_Widget">
        <div class="article-full-text" data-userHasAccess="True">
    

            <a class="article-section-id-anchor" id="247891022"></a>
<span class="heading-text thm-col h3 cb section-type-keyPoints decorated-hed sb-sc ">Key Points</span><p><strong>Question</strong> 
    <span>What information should be included in a trial protocol or completed trial article when the study had to undergo important modifications in response to extenuating circumstances such as COVID-19?</span></p><p><strong>Findings</strong> 
    <span>Developed using a consensus process, a rapid review, and a survey of the international trials community, CONSERVE (CONSORT and SPIRIT Extension for RCTs Revised in Extenuating Circumstances) offers guidance for reporting trials and trial protocols that undergo important modifications in response to extenuating circumstances such as the COVID-19 pandemic.</span></p><p><strong>Meaning</strong> 
    <span>CONSERVE offers guidance that could help improve the transparency, quality, and completeness of reporting important modifications to trials in extenuating circumstances.</span></p>            <a class="article-section-id-anchor" id="247891023"></a>
                        <div class="h3 cb section-type-abstract decorated-hed ">

                            <div class="heading-text thm-col sb-sc">
                                Abstract
                            </div>
                        </div>
<p><strong>Importance</strong> 
    <span>Extenuating circumstances can trigger unplanned changes to randomized trials and introduce methodological, ethical, feasibility, and analytical challenges that can potentially compromise the validity of findings. Numerous randomized trials have required changes in response to the COVID-19 pandemic, but guidance for reporting such modifications is incomplete.</span></p><p><strong>Objective</strong> 
    <span>As a joint extension for the CONSORT and SPIRIT reporting guidelines, CONSERVE (CONSORT and SPIRIT Extension for RCTs Revised in Extenuating Circumstances) aims to improve reporting of trial protocols and completed trials that undergo important modifications in response to extenuating circumstances.</span></p><p><strong>Evidence</strong> 
    <span>A panel of 37 international trial investigators, patient representatives, methodologists and statisticians, ethicists, funders, regulators, and journal editors convened to develop the guideline. The panel developed CONSERVE following an accelerated, iterative process between June 2020 and February 2021 involving (1) a rapid literature review of multiple databases (OVID Medline, OVID EMBASE, and EBSCO CINAHL) and gray literature sources from 2003 to March 2021; (2) consensus-based panelist meetings using a modified Delphi process and surveys; and (3) a global survey of trial stakeholders.</span></p><p><strong>Findings</strong> 
    <span>The rapid review yielded 41 673 citations, of which 38 titles were relevant, including emerging guidance from regulatory and funding agencies for managing the effects of the COVID-19 pandemic on trials. However, no generalizable guidance for all circumstances in which trials and trial protocols might face unanticipated modifications were identified. The CONSERVE panel used these findings to develop a consensus reporting guidelines following 4 rounds of meetings and surveys. Responses were received from 198 professionals from 34 countries, of whom 90% (n = 178) indicated that they understood the concept definitions and 85.4% (n = 169) indicated that they understood and could use the implementation tool. Feedback from survey respondents was used to finalize the guideline and confirm that the guideline’s core concepts were applicable and had utility for the trial community. CONSERVE incorporates an implementation tool and checklists tailored to trial reports and trial protocols for which extenuating circumstances have resulted in important modifications to the intended study procedures. The checklists include 4 sections capturing extenuating circumstances, important modifications, responsible parties, and interim data analyses.</span></p><p><strong>Conclusions and Relevance</strong> 
    <span>CONSERVE offers an extension to CONSORT and SPIRIT that could improve the transparency, quality, and completeness of reporting important modifications to trials in extenuating circumstances such as COVID-19.</span></p>            <div class="movable-ad-target bta"> </div>
            <a class="article-section-id-anchor" id="247891028"></a>
                        <div class="h3 cb section-type-section  ">

                            <div class="heading-text thm-col sb-sc">
                                Introduction
                            </div>
                        </div>
            <a class="article-section-id-anchor" id="247891029"></a>
<p class="para">Randomized trials are an essential tool to inform health care, policy, and regulatory decisions concerning the effects of medical interventions. Forethought and diligence in trial design, statistical approaches, implementation, and analysis are necessary to minimize trial modifications after participant enrollment, which can introduce methodological, ethical, feasibility, and analytical challenges. Amendments to trial procedures are common, and circumstances such as new safety or efficacy information, regulatory requirements, or changes in the standard of care can make those changes unavoidable.<sup><a href="#jsc210001r1" class="ref-link section-jump-link" data-tab-toggle=".tab-nav-references">1</a></sup> Modifications can also introduce biases, raising doubts about the validity of the conclusion of a clinical trial.<sup><a href="#jsc210001r2" class="ref-link section-jump-link" data-tab-toggle=".tab-nav-references">2</a></sup><sup>,<a href="#jsc210001r3" class="ref-link section-jump-link" data-tab-toggle=".tab-nav-references">3</a></sup></p>            <a class="article-section-id-anchor" id="247891030"></a>
<p class="para">COVID-19 has fundamentally changed everyday life, patient care, and health research. Numerous trials that were underway prior to the COVID-19 pandemic faced unavoidable modifications in response to the pandemic, such as changes to methods of recruitment, intervention delivery, outcome assessment (eg, substituting virtual visits for in-person ones), statistical analysis, and sometimes study design. As of January 29, 2021, 2043 trials registered with ClinicalTrials.gov had been terminated, withdrawn, or suspended because of COVID-19, affecting more than 129 000 participants and interrupting plans to recruit more than 4 million future participants.<sup><a href="#jsc210001r4" class="ref-link section-jump-link" data-tab-toggle=".tab-nav-references">4</a></sup> Although some health regulatory agencies released guidance on trial modifications due to the COVID-19 pandemic, no consensus exists on how such changes and their implications should be reported.<sup><a href="#jsc210001r5" class="ref-link section-jump-link" data-tab-toggle=".tab-nav-references">5</a></sup><sup>-<a href="#jsc210001r5" class="ref-link section-jump-link" data-tab-toggle=".tab-nav-references">8</a></sup></p>            <a class="article-section-id-anchor" id="247891031"></a>
<p class="para">Reporting guidelines can improve the completeness and transparency of research reports by defining a minimum set of items to address. While CONSORT (Consolidated Standards of Reporting Trials) 2010 and SPIRIT (Standard Protocol Items: Recommendations for Interventional Trials) 2013 guide reporting for completed trials and trial protocols, respectively, there is limited guidance for reporting trial modifications.<sup><a href="#jsc210001r9" class="ref-link section-jump-link" data-tab-toggle=".tab-nav-references">9</a></sup><sup>,<a href="#jsc210001r10" class="ref-link section-jump-link" data-tab-toggle=".tab-nav-references">10</a></sup> Thorough and consistent reporting of trials that undergo modifications could enhance trial interpretation and transparency, reduce research waste, and facilitate understanding of how trialists respond and adjust to unforeseen circumstances related to major disruptions, such as the COVID-19 pandemic. As a joint extension for CONSORT and SPIRIT, CONSERVE (CONSORT and SPIRIT Extension for RCTs Revised in Extenuating Circumstances) aims to provide guidance to improve the reporting of trials and trial protocols that undergo important modifications in response to extenuating circumstances.</p>            <a class="article-section-id-anchor" id="247891032"></a>
                        <div class="h3 cb section-type-section  ">

                            <div class="heading-text thm-col sb-sc">
                                Methods
                            </div>
                        </div>
            <a class="article-section-id-anchor" id="247891033"></a>
                        <div class="h4 cb section-type-section  ">

                            <div class="heading-text ">
                                CONSERVE Guideline Development Procedure and Panel
                            </div>
                        </div>
            <a class="article-section-id-anchor" id="247891034"></a>
<p class="para">The CONSERVE Panel that convened to develop the guideline was composed of 37 trial investigators, trial methodologists, patient representatives, ethicists, funders, regulators, and journal editors, including CONSORT and SPIRIT executive committee members. Panelists were recruited through professional networks to ensure global and interprofessional representation. CONSERVE was developed between June 2020 and February 2021 following a process adapted from the reporting guideline development procedure of Moher et al,<sup><a href="#jsc210001r11" class="ref-link section-jump-link" data-tab-toggle=".tab-nav-references">11</a></sup> modified to replace face-to-face meetings with virtual meetings and emphasizing rapid completion given the unprecedented disruption of trials in the context of the COVID-19 pandemic. The panel wrote and registered a protocol (available through the Open Science Framework at <a href="https://osf.io/ms8bz">https://osf.io/ms8bz</a>)<sup><a href="#jsc210001r12" class="ref-link section-jump-link" data-tab-toggle=".tab-nav-references">12</a></sup> for the guideline development process involving 3 main elements: (1) rapid review, (2) consensus-based meetings and surveys, and (3) a global survey of the trials community. Although the guideline development timeline was extended, the guideline development process proceeded per protocol. The guideline development process did not involve human subjects research as defined by the Tri-Council Policy Statement (Canada) and therefore was outside the scope of research ethics committee review.<sup><a href="#jsc210001r13" class="ref-link section-jump-link" data-tab-toggle=".tab-nav-references">13</a></sup></p>            <a class="article-section-id-anchor" id="247891035"></a>
                        <div class="h5 cb section-type-section  ">

                            <div class="heading-text ">
                                Rapid Review
                            </div>
                        </div>
            <a class="article-section-id-anchor" id="247891036"></a>
<p class="para">Panelists conducted a rapid review of guidance on modifications to trials.<sup><a href="#jsc210001r14" class="ref-link section-jump-link" data-tab-toggle=".tab-nav-references">14</a></sup> A review protocol and search strategy was registered through the Open Science Framework.<sup><a href="#jsc210001r15" class="ref-link section-jump-link" data-tab-toggle=".tab-nav-references">15</a></sup></p>            <a class="article-section-id-anchor" id="247891037"></a>
<p class="para">In brief, a search was conducted for guidance and processes for reporting on modifications to trials and trial protocols, including any type of document from 2003 through August 2020 indexed in the OVID Medline, OVID EMBASE, or EBSCO CINAHL databases and gray literature sources including the US Food and Drug Administration (FDA), the UK National Health Service’s Health Research Authority, the US National Institutes of Health, and the UK National Institute for Health Research in any language. Reference lists of included articles were manually screened to identify additional documents. Searches were conducted by a health research librarian and peer reviewed using the Peer Review of Electronic Search Strategies (PRESS) guideline.<sup><a href="#jsc210001r16" class="ref-link section-jump-link" data-tab-toggle=".tab-nav-references">16</a></sup></p>            <a class="article-section-id-anchor" id="247891038"></a>
<p class="para">Reports on circumstances in which modifications had been prespecified in the protocol, such as adaptive trial designs, were excluded. Reports that involved analysis techniques for missing data were also excluded. Database searches were updated on February 26, 2021; gray literature searches were updated to March 10, 2021 (<a class="supplement-link section-jump-link" data-tab-toggle=".tab-nav-supplemental" href="#note-JSC210001-1">Supplement 1</a>). The search yielded 41 673 citations, of which 3735 were duplicates, and panelists conducted independent and duplicate screening of titles and abstracts using Covidence software, yielding 38 relevant titles (<a class="supplement-link section-jump-link" data-tab-toggle=".tab-nav-supplemental" href="#note-JSC210001-1">Supplement 1</a>). The rapid review identified no comprehensive guidance overlapping with the purpose and intent of CONSERVE. All searches are available in <a class="supplement-link section-jump-link" data-tab-toggle=".tab-nav-supplemental" href="#note-JSC210001-1">Supplement 1</a>.</p>            <a class="article-section-id-anchor" id="247891039"></a>
                        <div class="h5 cb section-type-section  ">

                            <div class="heading-text ">
                                Consensus-Based Meetings and Surveys
                            </div>
                        </div>
            <a class="article-section-id-anchor" id="247891040"></a>
<p class="para">Since CONSERVE was envisioned as a joint extension of the CONSORT 2010 and SPIRIT 2013, the first meeting was a virtual gathering of panelists drawn from the SPIRIT-CONSORT executive committee to develop a prototype for CONSERVE. This prototype offered definitions of key concepts, items from the CONSORT and SPIRIT checklists that would require refinement when trials undergo important modifications, and an implementation tool to be used to report on these modifications.</p>            <a class="article-section-id-anchor" id="247891041"></a>
<p class="para">The entire CONSERVE panel convened through a series of 4 virtual meetings to revise this prototype and build consensus. These meetings were intended to integrate and accelerate the Delphi processes and replace in-person meetings conventionally used to develop reporting guidelines.<sup><a href="#jsc210001r11" class="ref-link section-jump-link" data-tab-toggle=".tab-nav-references">11</a></sup> Consensus was defined as being achieved when no panelist called for further revisions.</p>            <a class="article-section-id-anchor" id="247891042"></a>
<p class="para">Online surveys conducted using Google Forms presented the evolving CONSERVE prototypes in between meetings and sought dissenting views, gaps, and revisions. Survey results structured discussions at the subsequent virtual meetings, where panelists proposed and discussed solutions to problems prior to developing a new prototype. The panel achieved consensus following 3 meetings. Through a fourth, final meeting, the panel refined the resulting guideline and checklists by incorporating the results of the rapid literature review and survey of the global trials community.</p>            <a class="article-section-id-anchor" id="247891043"></a>
                        <div class="h5 cb section-type-section  ">

                            <div class="heading-text ">
                                Global Survey of Trials Community
                            </div>
                        </div>
            <a class="article-section-id-anchor" id="247891044"></a>
<p class="para">The panel developed an online survey targeting an international group of trial stakeholders including trial investigators, trial methodologists, trial staff, funders, regulators, ethicists, patient and patient organization representatives, journal publishers, and editors. The survey was conducted to gather feedback to refine the emerging draft guideline; to determine whether it was appropriate and operable for people who are engaged with trials and trial reporting, including public-facing patient representatives; and to identify case studies. The survey was sent by email to a sample of 113 investigators listed as primary contacts for trials registered as ongoing in April 2020, as identified from the search portal of the World Health Organization’s International Clinical Trials Registry Platform. CONSERVE panelists also distributed the survey widely by email within their professional networks. The panel planned to continue distributing the survey until responses were received from all geographic regions and all target stakeholder groups, including investigators, methodologists and statisticians, trial staff, ethicists, editors and publishers, sponsors, regulators, and funders.</p>            <a class="article-section-id-anchor" id="247891045"></a>
<p class="para">Responses were received from 198 professionals from 34 countries, including 61 respondents from low- and middle-income countries. The top 5 represented countries were the United Kingdom (n = 59), Canada (n = 24), India (n = 15), United States (n = 11), and Australia (n = 9). Briefly, 90% (178/198) of respondents indicated that they understood the CONSERVE concept definitions and 85.4% (169/198) indicated that they understood and could use the CONSERVE implementation tool. Survey questions and response summaries are included in <a class="supplement-link section-jump-link" data-tab-toggle=".tab-nav-supplemental" href="#note-JSC210001-1">Supplement 1</a>. Feedback from survey respondents was used to finalize the guideline and confirm that the core concepts were suited for widespread implementation.</p>            <a class="article-section-id-anchor" id="247891046"></a>
                        <div class="h3 cb section-type-section  ">

                            <div class="heading-text thm-col sb-sc">
                                Results
                            </div>
                        </div>
            <a class="article-section-id-anchor" id="247891047"></a>
                        <div class="h4 cb section-type-section  ">

                            <div class="heading-text ">
                                Scope of CONSERVE
                            </div>
                        </div>
            <a class="article-section-id-anchor" id="247891048"></a>
<p class="para">CONSERVE is an extension to the core CONSORT 2010 and SPIRIT 2013 statements and should be used in conjunction with these statements and their explanatory materials.<sup><a href="#jsc210001r9" class="ref-link section-jump-link" data-tab-toggle=".tab-nav-references">9</a></sup><sup>,<a href="#jsc210001r10" class="ref-link section-jump-link" data-tab-toggle=".tab-nav-references">10</a>,<a href="#jsc210001r17" class="ref-link section-jump-link" data-tab-toggle=".tab-nav-references">17</a></sup><sup>,<a href="#jsc210001r18" class="ref-link section-jump-link" data-tab-toggle=".tab-nav-references">18</a></sup> CONSERVE is designed to guide reporting for trials that have undergone important modifications in extenuating circumstances (<a href="#jsc210001f1" class="figure-link section-jump-link" data-tab-toggle=".tab-nav-figure-table">Figure</a>). The concept of extenuating circumstances is intended to limit the scope of CONSERVE to circumstances in which changes to a trial were prompted by unavoidable situations beyond the control of study investigators, sponsors, or funders. The concept of important modifications is intended to limit the scope of CONSERVE to cases for which those modifications have substantive implications for the study at a scientific, ethical, feasibility, inferential, or analytical level. Although the COVID-19 pandemic is the exemplar that prompted the development of CONSERVE, the approach is applicable to other extenuating circumstances that result in important modifications to a trial, such as natural disaster, strikes and other personnel disruptions, regulatory changes, or changes to the clinical standard of care.</p>            <a class="article-section-id-anchor" id="247891050"></a>
<p class="para">CONSERVE is not a mechanism to redress poor trial design, and it does not encourage unwarranted trial modifications, especially post hoc changes to favor positive results based on accumulating trial data. CONSERVE is based on the observations that protocol amendments are common and that in some circumstances important modifications can be necessary, unavoidable, or beneficial.<sup><a href="#jsc210001r1" class="ref-link section-jump-link" data-tab-toggle=".tab-nav-references">1</a></sup> Rather than abandoning trial data and the investments that contributed to data collection, it is better to report the unanticipated circumstances and trial modifications rigorously and transparently.<sup><a href="#jsc210001r19" class="ref-link section-jump-link" data-tab-toggle=".tab-nav-references">19</a></sup> CONSERVE provides guidance to support that rigor and transparency.</p>            <a class="article-section-id-anchor" id="247891051"></a>
<p class="para">The CONSERVE implementation tool (<a href="#jsc210001f1" class="figure-link section-jump-link" data-tab-toggle=".tab-nav-figure-table">Figure</a>) provides a pathway to determine when CONSERVE should be used to report on trials and trial protocols and provides guidance for its application.</p>            <a class="article-section-id-anchor" id="247891052"></a>
                        <div class="h4 cb section-type-section  ">

                            <div class="heading-text ">
                                CONSERVE Checklists
                            </div>
                        </div>
            <a class="article-section-id-anchor" id="247891053"></a>
<p class="para">The CONSERVE checklists are summarized in the implementation tool and provided in <a class="supplement-link section-jump-link" data-tab-toggle=".tab-nav-supplemental" href="#note-JSC210001-1">Supplement 2</a>. The CONSERVE checklists consist of 4 sections: (1) extenuating circumstances, (2) important modifications including impacts and mitigating strategies, (3) responsible parties, and (4) interim data. The <a href="#jsc210001t1" class="table-link section-jump-link" data-tab-toggle=".tab-nav-figure-table">Table</a> provides narrative case studies of trials<sup><a href="#jsc210001r20" class="ref-link section-jump-link" data-tab-toggle=".tab-nav-references">20</a></sup><sup>-<a href="#jsc210001r20" class="ref-link section-jump-link" data-tab-toggle=".tab-nav-references">23</a></sup> that included important modifications in extenuating circumstances and samples of CONSERVE checklist items that might be addressed in a trial report concerning these types of studies.</p>            <a class="article-section-id-anchor" id="247891055"></a>
<p class="para">CONSERVE provides 2 checklists to support authors in reporting how their trial addressed important modifications in extenuating circumstances. CONSERVE-CONSORT is designed for reporting completed trial results, while CONSERVE-SPIRIT is for reporting trial protocols. Both checklists (<a class="supplement-link section-jump-link" data-tab-toggle=".tab-nav-supplemental" href="#note-JSC210001-1">Supplement 2</a>) share a common format. The first section of each checklist refers to the extenuating circumstances, responsible parties, interim data, and important modifications. The second section provides an itemized list with rows for each item from the core CONSORT or SPIRIT checklists. The columns offer checkboxes to indicate if that item was unaffected, was directly affected by the extenuating circumstances, or was modified by the study team as a mitigating strategy in response to the extenuating circumstances. A completed checklist should be made available whenever CONSERVE is used for reporting a trial or trial protocol. Because extenuating circumstances can potentially lead to modifications in any aspect of a trial, the CONSERVE checklists incorporate a list of all items from the SPIRIT and CONSORT statements.<sup><a href="#jsc210001r9" class="ref-link section-jump-link" data-tab-toggle=".tab-nav-references">9</a></sup><sup>,<a href="#jsc210001r10" class="ref-link section-jump-link" data-tab-toggle=".tab-nav-references">10</a></sup></p>            <a class="article-section-id-anchor" id="247891056"></a>
<p class="para">CONSERVE-CONSORT or CONSERVE-SPIRIT should be used instead of CONSORT or SPIRIT when reporting on trials or trial protocols that have undergone important modifications. Authors may add items from other SPIRIT or CONSORT extensions as applicable. Investigators should ensure that the trial registry record is updated to reflect any changes to registered information. Authors should report the items listed in the CONSERVE checklists as applicable throughout the completed trial or protocol. In some circumstances, more limited modifications may be reported with a concise statement or paragraph in the study article’s methods section, whereas in more complex cases modifications may appear throughout the various sections of the article. In cases in which reporting the requisite details requires more space than journal word counts allow, a supplement can be provided to outline the effects of the extenuating circumstances on the trial.</p>            <a class="article-section-id-anchor" id="247891057"></a>
                        <div class="h5 cb section-type-section  ">

                            <div class="heading-text ">
                                Extenuating Circumstances
                            </div>
                        </div>
            <a class="article-section-id-anchor" id="247891058"></a>
<p class="para">Authors should describe the circumstances that led to the trial modifications, including how the circumstances are extenuating. Extenuating circumstances refer to unavoidable situations that prompt modifications to a trial and that are not usually under the control of study investigators, sponsors, or funders (<a href="#jsc210001f1" class="figure-link section-jump-link" data-tab-toggle=".tab-nav-figure-table">Figure</a>). Extenuating circumstances share elements with the contract law concept of force majeure, referring to external events such as wars, strikes, riots, or epidemics that prevent parties from fulfilling their contractual obligations.<sup><a href="#jsc210001r8" class="ref-link section-jump-link" data-tab-toggle=".tab-nav-references">8</a></sup> Similarly, extenuating circumstances are unavoidable external events that would prevent trial investigators or participants from adhering to a trial protocol or would necessitate protocol modifications. This is not to suggest that extenuating circumstances must be universally external, unpredictable, and unavoidable but rather that the circumstances would not have been reasonably foreseen or incorporated as part of the study protocol.<sup><a href="#jsc210001r24" class="ref-link section-jump-link" data-tab-toggle=".tab-nav-references">24</a></sup> Generally, extenuating circumstances would not include resources shortages, insufficient enrollment to complete the trial as planned, or other factors that might be addressed in a pilot or feasibility study.<sup><a href="#jsc210001r25" class="ref-link section-jump-link" data-tab-toggle=".tab-nav-references">25</a></sup></p>            <a class="article-section-id-anchor" id="247891059"></a>
<p class="para">Circumstances that are extenuating for one trial may not be extenuating for another. For example, while many trials would approach war or an act of terrorism as an extenuating circumstance, trials concerning combat injuries would likely not.<sup><a href="#jsc210001r26" class="ref-link section-jump-link" data-tab-toggle=".tab-nav-references">26</a></sup> Therefore, it is important that authors consider and explain how modifications to the study were prompted by unavoidable situations beyond the control of investigators, sponsors, or funders and why those modifications were important from a scientific, ethical, pragmatic, or analytical perspective.</p>            <a class="article-section-id-anchor" id="247891060"></a>
                        <div class="h5 cb section-type-section  ">

                            <div class="heading-text ">
                                Important Modifications
                            </div>
                        </div>
            <a class="article-section-id-anchor" id="247891061"></a>
<p class="para">Important modifications incorporate 2 concepts. First, <i>modification</i> refers to any change to a trial. The term <i>modification</i> is used rather than <i>amendment</i> because a modification can be any kind of revision to the anticipated or ongoing trial, regardless of whether it triggers a formal protocol amendment and regardless of whether it represents a change to the trial itself or the context in which the trial occurs. For example, the study by Siegal et al<sup><a href="#jsc210001r21" class="ref-link section-jump-link" data-tab-toggle=".tab-nav-references">21</a></sup> conducted in critical care units encountered changes in the populations and underlying conditions of patients admitted to these settings due to the COVID-19 pandemic. The investigators modified their analysis plan to mitigate the effect of these changes (<a href="#jsc210001t1" class="table-link section-jump-link" data-tab-toggle=".tab-nav-figure-table">Table</a>). This could represent an important modification to trials conducted in critical care settings regardless of whether such a change triggered an amendment to the study protocol. Second, “important” refers to the subset of modifications that could have a potentially meaningful effect on the study objectives or research question, ethical acceptability (including benefits and harms to participants), internal validity, generalizability, feasibility, or analytical methods and statistical power. Many trials undergo amendments for a range of pragmatic and administrative reasons that do not necessarily constitute important modifications, for example, adding a recruitment site to an existing multicenter trial without modifying the study in any other way. Authors should report the rationale for important modifications and the associated implications for the trial.</p>            <a class="article-section-id-anchor" id="247891062"></a>
<p class="para">Important modifications can manifest as impacts on the trial or as mitigating strategies. <i>Impacts</i> refer to aspects of the trial that are directly affected or changed by the extenuating circumstance and that are not under the control of investigators, sponsors, or funders. For example, a rotavirus vaccine trial conducted in Niger by Isanaka et al<sup><a href="#jsc210001r22" class="ref-link section-jump-link" data-tab-toggle=".tab-nav-references">22</a></sup> was affected by extenuating circumstances when the threat of local terrorism prevented participants from being transported to regional health centers for outcome assessments, precluding some follow-up visits from occurring per protocol (<a href="#jsc210001t1" class="table-link section-jump-link" data-tab-toggle=".tab-nav-figure-table">Table</a>). In this case, the extenuating circumstance was terrorism, which affected the outcomes, data collection methods, and participant flow (SPIRIT items 12 and 18; CONSORT items 13 and 17). The trial by Vaillancourt et al<sup><a href="#jsc210001r20" class="ref-link section-jump-link" data-tab-toggle=".tab-nav-references">20</a></sup> on out-of-hospital cervical spine immobilization was stopped early when regional authorities enacted a new policy mandating a modified immobilization rule and adopting many aspects of the trial’s experimental intervention as standard of care (<a href="#jsc210001t1" class="table-link section-jump-link" data-tab-toggle=".tab-nav-figure-table">Table</a>). In this example, the extenuating circumstance was regional policy change, and the impacts affected both the interventions (SPIRIT item 11; CONSORT item 5) and the numbers analyzed (SPIRIT item 20; CONSORT item 16).</p>            <a class="article-section-id-anchor" id="247891063"></a>
<p class="para"><i>Mitigating strategies</i> refer to the aspects of the trial that are modified by the study investigators, sponsor, or funder in response to the extenuating circumstances or to manage the impacts on the trial. For example, in the rotavirus vaccine trial,<sup><a href="#jsc210001r22" class="ref-link section-jump-link" data-tab-toggle=".tab-nav-references">22</a></sup> investigators were unable to implement mitigating strategies that would enable data collection and therefore reported the cases in which participants could not access outcome assessments or laboratories as protocol deviations (<a href="#jsc210001t1" class="table-link section-jump-link" data-tab-toggle=".tab-nav-figure-table">Table</a>). Had security concerns worsened, alternative mitigating strategies might have included revised sample size calculations (SPIRIT item 14; CONSORT item 7), revised outcome assessment procedures for participants facing security concerns (SPIRIT item 18A; CONSORT item 6), or changes to the analysis plan including new ancillary analyses (SPIRIT item 20; CONSORT items 16 and 18). In a trial by James et al<sup><a href="#jsc210001r23" class="ref-link section-jump-link" data-tab-toggle=".tab-nav-references">23</a></sup> involving celecoxib for hormone-sensitive prostate cancer, investigators were unable to implement the intended intervention because of unanticipated regulatory changes concerning the use of celecoxib in trials (<a href="#jsc210001t1" class="table-link section-jump-link" data-tab-toggle=".tab-nav-figure-table">Table</a>). The investigators’ mitigating strategies included new exclusion criteria for patients with contraindications to celecoxib use (SPIRIT item 10; CONSORT item 4), changes in the intervention duration (SPIRIT item 11; CONSORT item 5), and revisions to the consent materials (SPIRIT item 26).</p>            <a class="article-section-id-anchor" id="247891064"></a>
<p class="para">Authors should provide a modification timeline, including the dates when extenuating circumstances were identified, the dates when those circumstances took effect on the trial, and the numbers of participants or clusters who had enrolled and completed the trial before and after extenuating circumstances prompted modifications to the trial.<sup><a href="#jsc210001r8" class="ref-link section-jump-link" data-tab-toggle=".tab-nav-references">8</a></sup></p>            <a class="article-section-id-anchor" id="247891065"></a>
                        <div class="h5 cb section-type-section  ">

                            <div class="heading-text ">
                                Responsible Parties
                            </div>
                        </div>
            <a class="article-section-id-anchor" id="247891066"></a>
<p class="para">Authors should report the parties responsible for planning, reviewing, and approving modifications as well as the responsibilities of each of these parties. Depending on the specifics of the trial, investigators, study staff, participants, regulators, research ethics committees, data monitoring committees, sponsors, and funders may all be involved in planning, reviewing, and approving trial modifications.</p>            <a class="article-section-id-anchor" id="247891067"></a>
                        <div class="h5 cb section-type-section  ">

                            <div class="heading-text ">
                                Interim Data
                            </div>
                        </div>
            <a class="article-section-id-anchor" id="247891068"></a>
<p class="para">Authors should report whether accumulating trial data were used to inform modifications, especially if interim examination of those data had the potential to introduce bias. For example, using data concerning recruitment rate or adherence would not generally introduce bias, whereas using outcome data by study group would have a greater potential to bias the choice of mitigating strategies used to respond to extenuating circumstances. Authors should report who accessed and reviewed the data and should describe how the study data were used. It is also important to report whether data were examined by study group and whether decision-makers were blinded to the intervention allocation. In addition, authors should report whether accumulating data were used in an ad hoc manner or according to an analysis plan.</p>            <a class="article-section-id-anchor" id="247891069"></a>
<p class="para">Examining interim outcome data can bias trial results and interpretation and introduce analytical and ethical challenges when interim analyses are not prespecified or lead to early study termination.<sup><a href="#jsc210001r27" class="ref-link section-jump-link" data-tab-toggle=".tab-nav-references">27</a></sup><sup>-<a href="#jsc210001r27" class="ref-link section-jump-link" data-tab-toggle=".tab-nav-references">32</a></sup> Similar concerns arise if interim data are used to inform unplanned revisions to study procedures. When trials are affected by extenuating circumstances, however, it may be reasonable in some instances to use outcome data to plan and implement mitigating strategies.</p>            <a class="article-section-id-anchor" id="247891070"></a>
<p class="para">Rather than conducting ad hoc interim analyses in a fully ad hoc manner, trialists can reduce the chance of introducing bias by creating a plan for these interim analyses a priori and detailing how the findings will inform further decisions. These previously unanticipated analyses can be conducted in a planned manner by documenting the intended analysis in the protocol and determining how those analyses will inform modifications a priori.</p>            <a class="article-section-id-anchor" id="247891071"></a>
                        <div class="h3 cb section-type-section  ">

                            <div class="heading-text thm-col sb-sc">
                                Discussion
                            </div>
                        </div>
            <a class="article-section-id-anchor" id="247891072"></a>
<p class="para">CONSERVE aims to provide guidance to help improve the quality, completeness, and transparency of reporting of important modifications due to extenuating circumstances for completed trials and trial protocols. The guidance is designed to be a practical resource for investigators and methodologists, ethicists, editors and publishers, sponsors, regulators and funders, study participants, and the public as they navigate trial reporting in extenuating circumstances, such as the COVID-19 pandemic. The evolving pandemic with its varied global disease burden and government responses has continued to affect clinical trials in diverse ways. CONSERVE discourages unnecessary modifications to trials but acknowledges that managing unanticipated events is an inherent part of the scientific enterprise.</p>            <a class="article-section-id-anchor" id="247891073"></a>
<p class="para">Although CONSERVE was developed in the context of the COVID-19 pandemic, it applies to reporting on other important modifications to trials. This could help address a gap in existing trial reporting guidance that predates the COVID-19 pandemic and will persist beyond the pandemic. For example, CONSERVE might have enhanced reporting on trials modified by public health emergencies such as the 2014-2016 Ebola virus epidemic, natural disasters, or other unavoidable logistical and ethical concerns.<sup><a href="#jsc210001r33" class="ref-link section-jump-link" data-tab-toggle=".tab-nav-references">33</a></sup><sup>-<a href="#jsc210001r33" class="ref-link section-jump-link" data-tab-toggle=".tab-nav-references">37</a></sup> By promoting complete and transparent reporting of trial modifications, CONSERVE also allows the research community to learn from how extenuating circumstances have been managed, examine the overall impact of those circumstances, and take modifications into account when interpreting trial results. While the COVID-19 pandemic continues to cause disruption to trials worldwide, it provides an opportunity to assess the manner in which important clinical trial modifications are made in response to a variety of extenuating circumstances. The international survey yielded examples of trials that encountered extenuating circumstances including regulatory changes, new standards of care, and security threats (<a href="#jsc210001t1" class="table-link section-jump-link" data-tab-toggle=".tab-nav-figure-table">Table</a>).<sup><a href="#jsc210001r20" class="ref-link section-jump-link" data-tab-toggle=".tab-nav-references">20</a></sup><sup>-<a href="#jsc210001r20" class="ref-link section-jump-link" data-tab-toggle=".tab-nav-references">23</a></sup></p>            <a class="article-section-id-anchor" id="247891074"></a>
<p class="para">CONSERVE may help to reduce the publication biases and wasted research investments that can occur when trials deviate from their protocols.<sup><a href="#jsc210001r3" class="ref-link section-jump-link" data-tab-toggle=".tab-nav-references">3</a></sup> By supporting transparency, CONSERVE may also promote public trust in science when studies encounter unanticipated circumstances.<sup><a href="#jsc210001r38" class="ref-link section-jump-link" data-tab-toggle=".tab-nav-references">38</a></sup> Consistent reporting of trials that encounter extenuating circumstances could also prompt trialists to develop plans for a wider range of potential disruptions in trial protocols.</p>            <a class="article-section-id-anchor" id="247891075"></a>
<p class="para">CONSERVE complements regulatory guidance on modifying trials in the context of the COVID-19 pandemic. For example, the UK Medicines and Healthcare Products Regulatory Agency set guidance for trial investigators to assess the risks and benefits of ongoing trials during COVID-19 and to consider options including halting recruitment, adapting delivery processes, stopping or suspending the trial, or mitigating risks as the trial proceeds.<sup><a href="#jsc210001r39" class="ref-link section-jump-link" data-tab-toggle=".tab-nav-references">39</a></sup> Guidance from the FDA on trials during the COVID-19 pandemic recommended that trialists describe the contingency measures implemented, list how and which participants were affected including how participation was altered, and provide analyses and discussions that address the effect on safety and efficacy.<sup><a href="#jsc210001r5" class="ref-link section-jump-link" data-tab-toggle=".tab-nav-references">5</a></sup> Similar recommendations were made by the Norwegian Medicines Agency and the South African Health Products Regulatory Authority, while the European Medicines Agency (EMA) provided guidance on the methodological aspects of ongoing clinical trials.<sup><a href="#jsc210001r6" class="ref-link section-jump-link" data-tab-toggle=".tab-nav-references">6</a></sup><sup>-<a href="#jsc210001r6" class="ref-link section-jump-link" data-tab-toggle=".tab-nav-references">8</a></sup> The EMA guidance outlined the importance of describing specific dates and durations of issues external to the trial (eg, lockdowns and travel restrictions) and discussed when data review may be warranted to inform study decisions. Guidance from the FDA also addressed statistical methodology as it relates to meeting trial objectives during the pandemic.<sup><a href="#jsc210001r40" class="ref-link section-jump-link" data-tab-toggle=".tab-nav-references">40</a></sup> However, existing guidelines did not describe the connections among modifications to the conduct of trials, statistical analysis, and reporting. Other reports have provided analyses on the management of missing data in trials due to COVID-19,<sup><a href="#jsc210001r41" class="ref-link section-jump-link" data-tab-toggle=".tab-nav-references">41</a></sup> ethical dimensions of conducting trials during public health emergencies,<sup><a href="#jsc210001r33" class="ref-link section-jump-link" data-tab-toggle=".tab-nav-references">33</a></sup><sup>,<a href="#jsc210001r42" class="ref-link section-jump-link" data-tab-toggle=".tab-nav-references">42</a></sup><sup>,<a href="#jsc210001r43" class="ref-link section-jump-link" data-tab-toggle=".tab-nav-references">43</a></sup> and the challenges of trial sponsorship during a pandemic.<sup><a href="#jsc210001r44" class="ref-link section-jump-link" data-tab-toggle=".tab-nav-references">44</a></sup><sup>-<a href="#jsc210001r44" class="ref-link section-jump-link" data-tab-toggle=".tab-nav-references">46</a></sup></p>            <a class="article-section-id-anchor" id="247891076"></a>
<p class="para">Clinical and research specialty societies have also provided guidance on conducting trials during the pandemic, including in oncology, cardiovascular disease and heart failure, and hepatology.<sup><a href="#jsc210001r46" class="ref-link section-jump-link" data-tab-toggle=".tab-nav-references">46</a></sup><sup>-<a href="#jsc210001r46" class="ref-link section-jump-link" data-tab-toggle=".tab-nav-references">50</a></sup> These resources provide methodological guidance, while CONSERVE delivers a framework for reporting what decisions were made, why they were made, and the corresponding impact. Some journals have provided reporting recommendations to authors regarding trials directly affected by the COVID-19 pandemic. Editorials have called on trial authors to describe pandemic-related issues in the methods sections of articles, including changes in study protocol, trial delays or interruptions, issues with missing data, and effects on statistical power.<sup><a href="#jsc210001r51" class="ref-link section-jump-link" data-tab-toggle=".tab-nav-references">51</a></sup><sup>-<a href="#jsc210001r51" class="ref-link section-jump-link" data-tab-toggle=".tab-nav-references">53</a></sup></p>            <a class="article-section-id-anchor" id="247891077"></a>
<p class="para">The CONSERVE statement has limitations. First, CONSERVE was developed rapidly using a modified process to engage rapidly with a global community of trial investigators, methodologists, ethicists, funders, regulators, journal editors, and patient representatives. Unlike prior reporting guidelines, this process adapted the conventional Delphi process and incorporated several steps to solicit detailed feedback and achieve consensus with a large group of trial professionals and public representatives who refined the process, but substituted in-person discussions with virtual meetings to ensure that dissenting views could be addressed. Second, given that many ongoing trials affected by the pandemic have not yet been published, only a few reports have described how investigators have responded to the extenuating circumstances, limiting the examples available about COVID-19. Third, the global survey sought to capture a large, international body of interdisciplinary persons working on and with trials, and those respondents provided examples and feedback about how CONSERVE could be used. Despite its international representation, including respondents from low- and middle-income countries, CONSERVE may not have captured all relevant perspectives.</p>            <a class="article-section-id-anchor" id="247891078"></a>
<p class="para">Implementation will be supported by making CONSERVE widely available, including through the SPIRIT and CONSORT websites and other reporting guideline resources such as the Enhancing the Quality and Transparency of Health Research (EQUATOR) Network (<a href="https://www.equator-network.org/">https://www.equator-network.org/</a>). The CONSERVE panel will also work with all trial stakeholders including investigators, journals, regulators, and funders to disseminate and endorse the statement. To reach a larger audience, the panel also encourages translation of the CONSERVE checklists to other languages.</p>            <a class="article-section-id-anchor" id="247891079"></a>
                        <div class="h4 cb section-type-section  ">

                            <div class="heading-text ">
                                Conclusions
                            </div>
                        </div>
            <a class="article-section-id-anchor" id="247891080"></a>
<p class="para">CONSERVE offers an extension to CONSORT and SPIRIT that could improve the transparency, quality, and completeness of reporting important modifications to trials in extenuating circumstances such as COVID-19.</p>            <a class="article-section-id-anchor" id="247891081"></a>
                        <div class="h3 cb section-type-acknowledgements  has-back-to-top">
                                <a href="#top" class="section-jump-link back-to-top" data-tab-toggle=".tab-nav-full-text">Back to top</a>

                            <div class="heading-text thm-col sb-sc">
                                Article Information
                            </div>
                        </div>
<p class="authorInfoSection"><strong>Corresponding Author:</strong> Aaron M. Orkin, MD, MSc, MPH, Division of Emergency Medicine, Department of Family and Community Medicine, University of Toronto, 500 University Ave, Toronto, ON M5G 1V7, Canada (<a href="mailto:aaron.orkin@utoronto.ca" target="_blank">aaron.orkin@utoronto.ca</a>).</p><p class="para"><strong>Accepted for Publication:</strong> June 1, 2021.</p><p class="parapublished-online"><strong>Published Online:</strong> June 21, 2021. doi:10.1001/jama.2021.9941</p><p class="paraauthor-contributions"><strong>Author Contributions:</strong> Drs Orkin and Gill had full access to all of the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis. All authors contributed to developing the guideline protocol and participated in the guideline development process as members of the CONSERVE Working Group. Drs Orkin, Gill, Ghersi, Jüni, and Chan conceived of the project and coordinated its implementation. All other authors appear in random order generated by <a href="http://www.random.org">www.random.org</a>. Drs Orkin, Gill, Ghersi, and Chan prepared the original draft of the manuscript and all authors revised and approved the final draft for submission.</p><p class="para"><i>Concept and design:</i> Orkin, Gill, Ghersi, Campbell, Sugarman, Steg, Simes, H. C. Williams, Wittes, Moher, Getz, Hopewell, Schulz, Boutron, Ross, Golub, Khan, Mulrow, Heber, Lee, Hróbjartsson, Jüni, Chan.</p><p class="para"><i>Acquisition, analysis, or interpretation of data:</i> Orkin, Gill, Ghersi, Emsley, Steg, Weijer, Simes, Rombey, H. C. Williams, Moher, Richards, Kasamon, Dickersin, Wu, Ayala, Calleja, Golub, Khan, Siegfried, Kearney, Wanyenze, Hróbjartsson, R. Williams, Bhandari, Jüni, Chan.</p><p class="para"><i>Drafting of the manuscript:</i> Orkin, Gill, Ghersi, Emsley, Moher, Kasamon, Hopewell, Khan, Heber, Kearney, Jüni.</p><p class="para"><i>Critical revision of the manuscript for important intellectual content:</i> All authors.</p><p class="para"><i>Statistical analysis:</i> Orkin, Gill, Jüni.</p><p class="para"><i>Administrative, technical, or material support:</i> Orkin, Gill, Moher, Getz, Schulz, Khan, Siegfried, Lee, Wanyenze, Chan.</p><p class="para"><i>Supervision:</i> Orkin, Gill, Chan.</p><p class="parafinancial-disclosure"><strong>Conflict of Interest Disclosures:</strong> Dr Gill reported grants from the Physicians’ Services Incorporated Foundation, the Canadian Institutes of Health Research (CIHR), and the Hospital for Sick Children and expenses to attend conferences and meetings reimbursed by the EBMLive Steering Committee and the CIHR Institute of Human Development, Child and Youth Health Institute Advisory Board. Dr Sugarman reported receipt of personal fees from Merck, IQVIA, Aspen Neurosciences, Biogen, and Portola Pharmaceuticals; in addition, he receives stock options not yet exercised from Aspen Neurosciences and nonfinancial support from Merck KGaA and IQVIA. Dr Steg reported receipt of grants and personal fees from Amarin, Bayer, Servier and Sanofi/Regeneron; personal fees from Amgen, Bristol Myers Squibb, Boehringer Ingelheim, Idorsia, Novartis, Novo Nordisk, Pfizer, Sanofi/Lexicon, and Myokardia; and personal fees and nonfinancial support from AstraZeneca. In addition, Dr Steg has a patent issued to Sanofi. Dr Weijer reported receipt of consulting income from Cardialen, Eli Lilly &amp; Co, and RTI International. Dr Simes reported receipt of grants from the National Health and Medical Research Council of Australia, the Cancer Institute of New South Wales, Australia, Cancer Australia, Bayer, Roche, Pfizer, AstraZeneca, and Bristol Myers Squibb. Dr Wittes reported involvement in many studies that have been affected by COVID-19; the company for which she works, WCG Statistics Collaborative, has received consulting fees for those consultations. Dr Richards reported receipt of personal fees from Merck, Eli Lilly &amp; Co, Novo Nordisk, and Innomar; consulting fees from Janssen and the CIHR Institute of Musculoskeletal Health and Arthritis; and being volunteer vice president of the Canadian Arthritis Patient Alliance, for which her efforts are supported via independent grants by pharmaceutical firms. Dr Ross reported receipt of grants from Johnson &amp; Johnson, the FDA, the Agency for Healthcare Research and Quality, the Laura and John Arnold Foundation, the National Institutes of Health/National Heart, Lung, and Blood Institute, and the Medical Devices Innovation Consortium and being a current US research and outreach editor at <i>The BMJ</i>. Dr Khan reported being scientific director of the CIHR Institute of Musculoskeletal Health and Arthritis. Dr Jüni reported serving as unpaid member of the steering group of trials funded by Appili Therapeutics, Astra Zeneca, Biotronik, Biosensors, St Jude Medical, and The Medicines Company; receiving research grants to his institution from AstraZeneca, Biotronik, Biosensors International, Eli Lilly &amp; Co, and The Medicines Company; and receiving honoraria to his institution for participation in advisory boards and/or consulting from Amgen, Ava, and Fresenius; he has not received personal payments from any pharmaceutical company or device manufacturer. No other disclosures were reported.</p><p class="parafunding-statement"><strong>Funding/Support:</strong> Dr Orkin receives salary support from the University of Toronto Department of Family and Community Medicine and the CIHR Postdoctoral Fellowship Program. Dr Emsley is supported by grant NIHR300051 from the National Institute of Health Research. Dr R. Williams’ work was supported by the Intramural Research Program of the National Center for Biotechnology Information, National Library of Medicine, National Institutes of Health.</p><p class="para"><strong>Role of the Funder/Sponsor:</strong> The supporting organizations had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; or decision to submit the manuscript for publication.</p><p class="para"><strong>Disclaimer:</strong> The views expressed in this article do not necessarily reflect the views or policies of the National Institutes of Health. This article represents the views and findings of the authors and not necessarily of the institutions with which they are affiliated. Dr Golub is Deputy Editor of <i>JAMA</i> but was not involved in any of the decisions regarding review of the manuscript or its acceptance.</p><p class="para"><strong>Group Information:</strong> The CONSERVE Group members appear in <a class="supplement-link section-jump-link" data-tab-toggle=".tab-nav-supplemental" href="#note-JSC210001-1">Supplement 3</a>.</p><p class="para"><strong>Additional Contributions:</strong> We thank all of the respondents to the CONSERVE survey and acknowledge in particular Christian Vaillancourt, MD, MSc (University of Ottawa), Monica Taljaard, PhD (University of Ottawa), Jennifer Brunet, MA, PhD (University of Ottawa), Rebecca Grais, PhD (Médecins Sans Frontières), and Matthew Sydes, MSc, CStat (University College London), for contributing case studies to the project. We thank Joanne Roberti (Unity Health Toronto) and Arani Muthuraja (Women’s College Hospital, Toronto) for administrative support. Dr Orkin acknowledges Ross Upshur, MA, MD, MSc (University of Toronto), for enabling him to pursue this initiative and the SOONER Project Investigators for prompting this work. None of these individuals received compensation for their contributions to this work.</p>            <a class="article-section-id-anchor" id="247891082"></a>
                        <div class="h3 cb section-type-references  ">

                            <div class="heading-text thm-col sb-sc">
                                References
                            </div>
                        </div>
<div class="references"><div class="reference"><a class="reference-number" id="jsc210001r1">1.</a><div class="reference-content">Getz
         KA﻿, Zuckerman
         R﻿, Cropp
         AB﻿, 
     et al.  Measuring the incidence, causes, and repercussions of protocol amendments. ﻿ <i xmlns:helper="urn:XsltStringHelper"> Ther Innov Regul Sci</i>. 2011;45(3):265-275. doi:<a href="http://dx.doi.org/10.1177/009286151104500307">10.1177/009286151104500307</a><a class="google-scholar-ref-link" href="https://scholar.google.com/scholar_lookup?title=Measuring%20the%20incidence%2C%20causes%2C%20and%20repercussions%20of%20protocol%20amendments.&amp;author=KA%20Getz&amp;author=R%20Zuckerman&amp;author=AB%20Cropp&amp;publication_year=2011&amp;journal=Ther%20Innov%20Regul%20Sci&amp;volume=45&amp;pages=265-275" target="_blank" xmlns:helper="urn:XsltStringHelper">Google Scholar</a></div></div><div class="reference"><a class="reference-number" id="jsc210001r2">2.</a><div class="reference-content">Altman
         DG﻿.  The scandal of poor medical research. ﻿ <i xmlns:helper="urn:XsltStringHelper"> BMJ</i>. 1994;308(6924):283-284. doi:<a href="http://dx.doi.org/10.1136/bmj.308.6924.283">10.1136/bmj.308.6924.283</a><a class="pubmed-link" href="https://www.ncbi.nlm.nih.gov/pubmed/8124111" target="_blank" xmlns:helper="urn:XsltStringHelper">PubMed</a><a class="google-scholar-ref-link" href="https://scholar.google.com/scholar_lookup?title=The%20scandal%20of%20poor%20medical%20research.&amp;author=DG%20Altman&amp;publication_year=1994&amp;journal=BMJ&amp;volume=308&amp;pages=283-284" target="_blank" xmlns:helper="urn:XsltStringHelper">Google Scholar</a><a href="https://doi.org/10.1136/bmj.308.6924.283" class="crossref-doi" target="_blank" xmlns:helper="urn:XsltStringHelper">Crossref</a><span class="inst-open-url-holders" data-targetId="10.1136/bmj.308.6924.283" xmlns:helper="urn:XsltStringHelper"> </span></div></div><div class="reference"><a class="reference-number" id="jsc210001r3">3.</a><div class="reference-content">Macleod
         MR﻿, Michie
         S﻿, Roberts
         I﻿, 
     et al.  Biomedical research: increasing value, reducing waste. ﻿ <i xmlns:helper="urn:XsltStringHelper"> Lancet</i>. 2014;383(9912):101-104. doi:<a href="http://dx.doi.org/10.1016/S0140-6736(13)62329-6">10.1016/S0140-6736(13)62329-6</a><a class="pubmed-link" href="https://www.ncbi.nlm.nih.gov/pubmed/24411643" target="_blank" xmlns:helper="urn:XsltStringHelper">PubMed</a><a class="google-scholar-ref-link" href="https://scholar.google.com/scholar_lookup?title=Biomedical%20research%3A%20increasing%20value%2C%20reducing%20waste.&amp;author=MR%20Macleod&amp;author=S%20Michie&amp;author=I%20Roberts&amp;publication_year=2014&amp;journal=Lancet&amp;volume=383&amp;pages=101-104" target="_blank" xmlns:helper="urn:XsltStringHelper">Google Scholar</a><a href="https://doi.org/10.1016/S0140-6736(13)62329-6" class="crossref-doi" target="_blank" xmlns:helper="urn:XsltStringHelper">Crossref</a><span class="inst-open-url-holders" data-targetId="10.1016/S0140-6736(13)62329-6" xmlns:helper="urn:XsltStringHelper"> </span></div></div><div class="reference"><a class="reference-number" id="jsc210001r4">4.</a><div class="reference-content">Carlisle
         BG﻿. Clinical trials stopped by COVID-19. Updated January 29, 2021. Accessed May 31, 2021. <a href="https://covid19.bgcarlisle.com/">https://covid19.bgcarlisle.com/</a></div></div><div class="reference"><a class="reference-number" id="jsc210001r5">5.</a><div class="reference-content">US Food and Drug Administration. FDA guidance on conduct of clinical trials of medical products during the COVID-19 public health emergency. Published March 2020. Accessed February 5, 2021. <a href="https://www.fda.gov/regulatory-information/search-fda-guidance-documents/fda-guidance-conduct-clinical-trials-medical-products-during-covid-19-public-health-emergency">https://www.fda.gov/regulatory-information/search-fda-guidance-documents/fda-guidance-conduct-clinical-trials-medical-products-during-covid-19-public-health-emergency</a></div></div><div class="reference"><a class="reference-number" id="jsc210001r6">6.</a><div class="reference-content">South African Health Products Regulatory Authority. SAHPRA policy on conduct of clinical trials of health products during the current COVID-19 pandemic. Published March 25, 2020. Accessed February 5, 2021. <a href="http://www.sahpra.org.za/wp-content/uploads/2020/03/SAHPRA-Communication_COVID_19-Final-25032020.pdf">http://www.sahpra.org.za/wp-content/uploads/2020/03/SAHPRA-Communication_COVID_19-Final-25032020.pdf</a></div></div><div class="reference"><a class="reference-number" id="jsc210001r7">7.</a><div class="reference-content">Norwegian Medicines Agency. Management of clinical trials in relation to COVID-19. Updated May 20, 2020. Accessed February 5, 2021. <a href="https://legemiddelverket.no/english/clinical-trials/management-of-clinical-trials-in-relation-to-covid-19">https://legemiddelverket.no/english/clinical-trials/management-of-clinical-trials-in-relation-to-covid-19</a></div></div><div class="reference"><a class="reference-number" id="jsc210001r8">8.</a><div class="reference-content">European Medicines Agency. Implications of coronavirus disease (COVID-19) on methodological aspects of ongoing clinical trials. Published June 29, 2020. Accessed February 5, 2021. <a href="https://www.ema.europa.eu/en/implications-coronavirus-disease-covid-19-methodological-aspects-ongoing-clinical-trials">https://www.ema.europa.eu/en/implications-coronavirus-disease-covid-19-methodological-aspects-ongoing-clinical-trials</a></div></div><div class="reference"><a class="reference-number" id="jsc210001r9">9.</a><div class="reference-content">Schulz
         KF﻿, Altman
         DG﻿, Moher
         D﻿; CONSORT Group.  CONSORT 2010 statement. ﻿ <i xmlns:helper="urn:XsltStringHelper"> PLoS Med</i>. 2010;7(3):e1000251. doi:<a href="http://dx.doi.org/10.1371/journal.pmed.1000251">10.1371/journal.pmed.1000251</a><a class="pubmed-link" href="https://www.ncbi.nlm.nih.gov/pubmed/20352064" target="_blank" xmlns:helper="urn:XsltStringHelper">PubMed</a><a class="google-scholar-ref-link" href="https://scholar.google.com/scholar_lookup?title=CONSORT%202010%20statement.&amp;author=KF%20Schulz&amp;author=DG%20Altman&amp;author=D%20Moher&amp;publication_year=2010&amp;journal=PLoS%20Med&amp;volume=7&amp;pages=" target="_blank" xmlns:helper="urn:XsltStringHelper">Google Scholar</a></div></div><div class="reference"><a class="reference-number" id="jsc210001r10">10.</a><div class="reference-content">Chan
         A-W﻿, Tetzlaff
         JM﻿, Altman
         DG﻿, 
     et al.  SPIRIT 2013 statement. ﻿ <i xmlns:helper="urn:XsltStringHelper"> Ann Intern Med</i>. 2013;158(3):200-207. doi:<a href="http://dx.doi.org/10.7326/0003-4819-158-3-201302050-00583">10.7326/0003-4819-158-3-201302050-00583</a><a class="pubmed-link" href="https://www.ncbi.nlm.nih.gov/pubmed/23295957" target="_blank" xmlns:helper="urn:XsltStringHelper">PubMed</a><a class="google-scholar-ref-link" href="https://scholar.google.com/scholar_lookup?title=SPIRIT%202013%20statement.&amp;author=A-W%20Chan&amp;author=JM%20Tetzlaff&amp;author=DG%20Altman&amp;publication_year=2013&amp;journal=Ann%20Intern%20Med&amp;volume=158&amp;pages=200-207" target="_blank" xmlns:helper="urn:XsltStringHelper">Google Scholar</a><a href="https://doi.org/10.7326/0003-4819-158-3-201302050-00583" class="crossref-doi" target="_blank" xmlns:helper="urn:XsltStringHelper">Crossref</a><span class="inst-open-url-holders" data-targetId="10.7326/0003-4819-158-3-201302050-00583" xmlns:helper="urn:XsltStringHelper"> </span></div></div><div class="reference"><a class="reference-number" id="jsc210001r11">11.</a><div class="reference-content">Moher
         D﻿, Schulz
         KF﻿, Simera
         I﻿, Altman
         DG﻿.  Guidance for developers of health research reporting guidelines. ﻿ <i xmlns:helper="urn:XsltStringHelper"> PLoS Med</i>. 2010;7(2):e1000217. doi:<a href="http://dx.doi.org/10.1371/journal.pmed.1000217">10.1371/journal.pmed.1000217</a><a class="pubmed-link" href="https://www.ncbi.nlm.nih.gov/pubmed/20169112" target="_blank" xmlns:helper="urn:XsltStringHelper">PubMed</a><a class="google-scholar-ref-link" href="https://scholar.google.com/scholar_lookup?title=Guidance%20for%20developers%20of%20health%20research%20reporting%20guidelines.&amp;author=D%20Moher&amp;author=KF%20Schulz&amp;author=I%20Simera&amp;author=DG%20Altman&amp;publication_year=2010&amp;journal=PLoS%20Med&amp;volume=7&amp;pages=" target="_blank" xmlns:helper="urn:XsltStringHelper">Google Scholar</a></div></div><div class="reference"><a class="reference-number" id="jsc210001r12">12.</a><div class="reference-content">Orkin
         A﻿, Gill
         P﻿, Jüni
         P﻿, 
     et al. Development protocol: CONSORT and SPIRIT extension for RCTs revised in extenuating circumstances. Open Science Framework. Published 2020. Accessed February 7, 2021. <a href="https://osf.io/ms8bz">https://osf.io/ms8bz</a></div></div><div class="reference"><a class="reference-number" id="jsc210001r13">13.</a><div class="reference-content">Canadian Institutes of Health Research; Natural Sciences and Engineering Research Council of Canada; Social Sciences and Humanities Research Council. <i>Tri-council Policy Statement: Ethical Conduct for Research Involving Humans (TCPS2)</i>. Government of Canada; 2014.</div></div><div class="reference"><a class="reference-number" id="jsc210001r14">14.</a><div class="reference-content">Khangura
         S﻿, Konnyu
         K﻿, Cushman
         R﻿, 
     et al.  Evidence summaries: the evolution of a rapid review approach. ﻿ <i xmlns:helper="urn:XsltStringHelper"> Syst Rev</i>. 2012;1(1):10. doi:<a href="http://dx.doi.org/10.1186/2046-4053-1-10">10.1186/2046-4053-1-10</a><a class="pubmed-link" href="https://www.ncbi.nlm.nih.gov/pubmed/22587960" target="_blank" xmlns:helper="urn:XsltStringHelper">PubMed</a><a class="google-scholar-ref-link" href="https://scholar.google.com/scholar_lookup?title=Evidence%20summaries%3A%20the%20evolution%20of%20a%20rapid%20review%20approach.&amp;author=S%20Khangura&amp;author=K%20Konnyu&amp;author=R%20Cushman&amp;publication_year=2012&amp;journal=Syst%20Rev&amp;volume=1&amp;pages=10" target="_blank" xmlns:helper="urn:XsltStringHelper">Google Scholar</a><a href="https://doi.org/10.1186/2046-4053-1-10" class="crossref-doi" target="_blank" xmlns:helper="urn:XsltStringHelper">Crossref</a><span class="inst-open-url-holders" data-targetId="10.1186/2046-4053-1-10" xmlns:helper="urn:XsltStringHelper"> </span></div></div><div class="reference"><a class="reference-number" id="jsc210001r15">15.</a><div class="reference-content">Ayala
         A﻿, Orkin
         A﻿, Rombey
         T﻿, 
     et al. Managing and reporting major modifications to trial protocols and trial conduct due to extenuating circumstances: a rapid review protocol. Open Science Framework. Published 2020. Accessed February 7, 2021. <a href="https://osf.io/t49ev/">https://osf.io/t49ev/</a></div></div><div class="reference"><a class="reference-number" id="jsc210001r16">16.</a><div class="reference-content">McGowan
         J﻿, Sampson
         M﻿, Salzwedel
         DM﻿, 
     et al.  PRESS Peer Review of Electronic Search Strategies. ﻿ <i xmlns:helper="urn:XsltStringHelper"> J Clin Epidemiol</i>. 2016;75:40-46. doi:<a href="http://dx.doi.org/10.1016/j.jclinepi.2016.01.021">10.1016/j.jclinepi.2016.01.021</a><a class="pubmed-link" href="https://www.ncbi.nlm.nih.gov/pubmed/27005575" target="_blank" xmlns:helper="urn:XsltStringHelper">PubMed</a><a class="google-scholar-ref-link" href="https://scholar.google.com/scholar_lookup?title=PRESS%20Peer%20Review%20of%20Electronic%20Search%20Strategies.&amp;author=J%20McGowan&amp;author=M%20Sampson&amp;author=DM%20Salzwedel&amp;publication_year=2016&amp;journal=J%20Clin%20Epidemiol&amp;volume=75&amp;pages=40-46" target="_blank" xmlns:helper="urn:XsltStringHelper">Google Scholar</a><a href="https://doi.org/10.1016/j.jclinepi.2016.01.021" class="crossref-doi" target="_blank" xmlns:helper="urn:XsltStringHelper">Crossref</a><span class="inst-open-url-holders" data-targetId="10.1016/j.jclinepi.2016.01.021" xmlns:helper="urn:XsltStringHelper"> </span></div></div><div class="reference"><a class="reference-number" id="jsc210001r17">17.</a><div class="reference-content">Moher
         D﻿, Hopewell
         S﻿, Schulz
         KF﻿, 
     et al; CONSORT.  CONSORT 2010 explanation and elaboration. ﻿ <i xmlns:helper="urn:XsltStringHelper"> Int J Surg</i>. 2012;10(1):28-55. doi:<a href="http://dx.doi.org/10.1016/j.ijsu.2011.10.001">10.1016/j.ijsu.2011.10.001</a><a class="pubmed-link" href="https://www.ncbi.nlm.nih.gov/pubmed/22036893" target="_blank" xmlns:helper="urn:XsltStringHelper">PubMed</a><a class="google-scholar-ref-link" href="https://scholar.google.com/scholar_lookup?title=CONSORT%202010%20explanation%20and%20elaboration.&amp;author=D%20Moher&amp;author=S%20Hopewell&amp;author=KF%20Schulz&amp;publication_year=2012&amp;journal=Int%20J%20Surg&amp;volume=10&amp;pages=28-55" target="_blank" xmlns:helper="urn:XsltStringHelper">Google Scholar</a><a href="https://doi.org/10.1016/j.ijsu.2011.10.001" class="crossref-doi" target="_blank" xmlns:helper="urn:XsltStringHelper">Crossref</a><span class="inst-open-url-holders" data-targetId="10.1016/j.ijsu.2011.10.001" xmlns:helper="urn:XsltStringHelper"> </span></div></div><div class="reference"><a class="reference-number" id="jsc210001r18">18.</a><div class="reference-content">Chan
         A-W﻿, Tetzlaff
         JM﻿, Gøtzsche
         PC﻿, 
     et al.  SPIRIT 2013 explanation and elaboration. ﻿ <i xmlns:helper="urn:XsltStringHelper"> BMJ</i>. 2013;346:e7586. doi:<a href="http://dx.doi.org/10.1136/bmj.e7586">10.1136/bmj.e7586</a><a class="pubmed-link" href="https://www.ncbi.nlm.nih.gov/pubmed/23303884" target="_blank" xmlns:helper="urn:XsltStringHelper">PubMed</a><a class="google-scholar-ref-link" href="https://scholar.google.com/scholar_lookup?title=SPIRIT%202013%20explanation%20and%20elaboration.&amp;author=A-W%20Chan&amp;author=JM%20Tetzlaff&amp;author=PC%20Gøtzsche&amp;publication_year=2013&amp;journal=BMJ&amp;volume=346&amp;pages=" target="_blank" xmlns:helper="urn:XsltStringHelper">Google Scholar</a></div></div><div class="reference"><a class="reference-number" id="jsc210001r19">19.</a><div class="reference-content">Getz
         KA﻿, Stergiopoulos
         S﻿, Short
         M﻿, 
     et al.  The impact of protocol amendments on clinical trial performance and cost. ﻿ <i xmlns:helper="urn:XsltStringHelper"> Ther Innov Regul Sci</i>. 2016;50(4):436-441. doi:<a href="http://dx.doi.org/10.1177/2168479016632271">10.1177/2168479016632271</a><a class="pubmed-link" href="https://www.ncbi.nlm.nih.gov/pubmed/30227022" target="_blank" xmlns:helper="urn:XsltStringHelper">PubMed</a><a class="google-scholar-ref-link" href="https://scholar.google.com/scholar_lookup?title=The%20impact%20of%20protocol%20amendments%20on%20clinical%20trial%20performance%20and%20cost.&amp;author=KA%20Getz&amp;author=S%20Stergiopoulos&amp;author=M%20Short&amp;publication_year=2016&amp;journal=Ther%20Innov%20Regul%20Sci&amp;volume=50&amp;pages=436-441" target="_blank" xmlns:helper="urn:XsltStringHelper">Google Scholar</a><a href="https://doi.org/10.1177/2168479016632271" class="crossref-doi" target="_blank" xmlns:helper="urn:XsltStringHelper">Crossref</a><span class="inst-open-url-holders" data-targetId="10.1177/2168479016632271" xmlns:helper="urn:XsltStringHelper"> </span></div></div><div class="reference"><a class="reference-number" id="jsc210001r20">20.</a><div class="reference-content">Vaillancourt
         C﻿, Charette
         M﻿, Taljaard
         M﻿, 
     et al.  Pragmatic strategy empowering paramedics to assess low-risk trauma patients with the Canadian C-Spine Rule and selectively transport them without immobilization. ﻿ <i xmlns:helper="urn:XsltStringHelper"> JMIR Res Protoc</i>. 2020;9(6):e16966. doi:<a href="http://dx.doi.org/10.2196/16966">10.2196/16966</a><a class="pubmed-link" href="https://www.ncbi.nlm.nih.gov/pubmed/32348267" target="_blank" xmlns:helper="urn:XsltStringHelper">PubMed</a><a class="google-scholar-ref-link" href="https://scholar.google.com/scholar_lookup?title=Pragmatic%20strategy%20empowering%20paramedics%20to%20assess%20low-risk%20trauma%20patients%20with%20the%20Canadian%20C-Spine%20Rule%20and%20selectively%20transport%20them%20without%20immobilization.&amp;author=C%20Vaillancourt&amp;author=M%20Charette&amp;author=M%20Taljaard&amp;publication_year=2020&amp;journal=JMIR%20Res%20Protoc&amp;volume=9&amp;pages=" target="_blank" xmlns:helper="urn:XsltStringHelper">Google Scholar</a></div></div><div class="reference"><a class="reference-number" id="jsc210001r21">21.</a><div class="reference-content">Siegal
         DM﻿, Belley-Cote
         E﻿, Arnold
         DM﻿, 
     et al.  Small-Volume Tubes to Reduce Anemia and Transfusion (STRATUS). ﻿ <i xmlns:helper="urn:XsltStringHelper"> Blood</i>. 2019;134(suppl 1):3685. doi:<a href="http://dx.doi.org/10.1182/blood-2019-130257">10.1182/blood-2019-130257</a><a class="google-scholar-ref-link" href="https://scholar.google.com/scholar_lookup?title=Small-Volume%20Tubes%20to%20Reduce%20Anemia%20and%20Transfusion%20%28STRATUS%29.&amp;author=DM%20Siegal&amp;author=E%20Belley-Cote&amp;author=DM%20Arnold&amp;publication_year=2019&amp;journal=Blood&amp;volume=134&amp;pages=3685" target="_blank" xmlns:helper="urn:XsltStringHelper">Google Scholar</a><a href="https://doi.org/10.1182/blood-2019-130257" class="crossref-doi" target="_blank" xmlns:helper="urn:XsltStringHelper">Crossref</a><span class="inst-open-url-holders" data-targetId="10.1182/blood-2019-130257" xmlns:helper="urn:XsltStringHelper"> </span></div></div><div class="reference"><a class="reference-number" id="jsc210001r22">22.</a><div class="reference-content">Isanaka
         S﻿, Guindo
         O﻿, Langendorf
         C﻿, 
     et al.  Efficacy of a low-cost, heat-stable oral rotavirus vaccine in Niger. ﻿ <i xmlns:helper="urn:XsltStringHelper"> N Engl J Med</i>. 2017;376(12):1121-1130. doi:<a href="http://dx.doi.org/10.1056/NEJMoa1609462">10.1056/NEJMoa1609462</a><a class="pubmed-link" href="https://www.ncbi.nlm.nih.gov/pubmed/28328346" target="_blank" xmlns:helper="urn:XsltStringHelper">PubMed</a><a class="google-scholar-ref-link" href="https://scholar.google.com/scholar_lookup?title=Efficacy%20of%20a%20low-cost%2C%20heat-stable%20oral%20rotavirus%20vaccine%20in%20Niger.&amp;author=S%20Isanaka&amp;author=O%20Guindo&amp;author=C%20Langendorf&amp;publication_year=2017&amp;journal=N%20Engl%20J%20Med&amp;volume=376&amp;pages=1121-1130" target="_blank" xmlns:helper="urn:XsltStringHelper">Google Scholar</a><a href="https://doi.org/10.1056/NEJMoa1609462" class="crossref-doi" target="_blank" xmlns:helper="urn:XsltStringHelper">Crossref</a><span class="inst-open-url-holders" data-targetId="10.1056/NEJMoa1609462" xmlns:helper="urn:XsltStringHelper"> </span></div></div><div class="reference"><a class="reference-number" id="jsc210001r23">23.</a><div class="reference-content">James
         ND﻿, Sydes
         MR﻿, Mason
         MD﻿, 
     et al.  Celecoxib plus hormone therapy versus hormone therapy alone for hormone-sensitive prostate cancer. ﻿ <i xmlns:helper="urn:XsltStringHelper"> Lancet Oncol</i>. 2012;13(5):549-558. doi:<a href="http://dx.doi.org/10.1016/S1470-2045(12)70088-8">10.1016/S1470-2045(12)70088-8</a><a class="pubmed-link" href="https://www.ncbi.nlm.nih.gov/pubmed/22452894" target="_blank" xmlns:helper="urn:XsltStringHelper">PubMed</a><a class="google-scholar-ref-link" href="https://scholar.google.com/scholar_lookup?title=Celecoxib%20plus%20hormone%20therapy%20versus%20hormone%20therapy%20alone%20for%20hormone-sensitive%20prostate%20cancer.&amp;author=ND%20James&amp;author=MR%20Sydes&amp;author=MD%20Mason&amp;publication_year=2012&amp;journal=Lancet%20Oncol&amp;volume=13&amp;pages=549-558" target="_blank" xmlns:helper="urn:XsltStringHelper">Google Scholar</a><a href="https://doi.org/10.1016/S1470-2045(12)70088-8" class="crossref-doi" target="_blank" xmlns:helper="urn:XsltStringHelper">Crossref</a><span class="inst-open-url-holders" data-targetId="10.1016/S1470-2045(12)70088-8" xmlns:helper="urn:XsltStringHelper"> </span></div></div><div class="reference"><a class="reference-number" id="jsc210001r24">24.</a><div class="reference-content">Morse
         SS﻿, Mazet
         JA﻿, Woolhouse
         M﻿, 
     et al.  Prediction and prevention of the next pandemic zoonosis. ﻿ <i xmlns:helper="urn:XsltStringHelper"> Lancet</i>. 2012;380(9857):1956-1965. doi:<a href="http://dx.doi.org/10.1016/S0140-6736(12)61684-5">10.1016/S0140-6736(12)61684-5</a><a class="pubmed-link" href="https://www.ncbi.nlm.nih.gov/pubmed/23200504" target="_blank" xmlns:helper="urn:XsltStringHelper">PubMed</a><a class="google-scholar-ref-link" href="https://scholar.google.com/scholar_lookup?title=Prediction%20and%20prevention%20of%20the%20next%20pandemic%20zoonosis.&amp;author=SS%20Morse&amp;author=JA%20Mazet&amp;author=M%20Woolhouse&amp;publication_year=2012&amp;journal=Lancet&amp;volume=380&amp;pages=1956-1965" target="_blank" xmlns:helper="urn:XsltStringHelper">Google Scholar</a><a href="https://doi.org/10.1016/S0140-6736(12)61684-5" class="crossref-doi" target="_blank" xmlns:helper="urn:XsltStringHelper">Crossref</a><span class="inst-open-url-holders" data-targetId="10.1016/S0140-6736(12)61684-5" xmlns:helper="urn:XsltStringHelper"> </span></div></div><div class="reference"><a class="reference-number" id="jsc210001r25">25.</a><div class="reference-content">Lancaster
         GA﻿, Dodd
         S﻿, Williamson
         PR﻿.  Design and analysis of pilot studies. ﻿ <i xmlns:helper="urn:XsltStringHelper"> J Eval Clin Pract</i>. 2004;10(2):307-312. doi:<a href="http://dx.doi.org/10.1111/j..2002.384.doc.x">10.1111/j..2002.384.doc.x</a><a class="pubmed-link" href="https://www.ncbi.nlm.nih.gov/pubmed/15189396" target="_blank" xmlns:helper="urn:XsltStringHelper">PubMed</a><a class="google-scholar-ref-link" href="https://scholar.google.com/scholar_lookup?title=Design%20and%20analysis%20of%20pilot%20studies.&amp;author=GA%20Lancaster&amp;author=S%20Dodd&amp;author=PR%20Williamson&amp;publication_year=2004&amp;journal=J%20Eval%20Clin%20Pract&amp;volume=10&amp;pages=307-312" target="_blank" xmlns:helper="urn:XsltStringHelper">Google Scholar</a><a href="https://doi.org/10.1111/jep.2004.10.issue-2" class="crossref-doi" target="_blank" xmlns:helper="urn:XsltStringHelper">Crossref</a><span class="inst-open-url-holders" data-targetId="10.1111/jep.2004.10.issue-2" xmlns:helper="urn:XsltStringHelper"> </span></div></div><div class="reference"><a class="reference-number" id="jsc210001r26">26.</a><div class="reference-content">Martinaud
         C﻿, Tiberghien
         P﻿, Bégué
         S﻿, 
     et al.  Rational and design of the T-STORHM study. ﻿ <i xmlns:helper="urn:XsltStringHelper"> Transfus Clin Biol</i>. 2019;26(4):198-201. doi:<a href="http://dx.doi.org/10.1016/j.tracli.2019.09.004">10.1016/j.tracli.2019.09.004</a><a class="pubmed-link" href="https://www.ncbi.nlm.nih.gov/pubmed/31645305" target="_blank" xmlns:helper="urn:XsltStringHelper">PubMed</a><a class="google-scholar-ref-link" href="https://scholar.google.com/scholar_lookup?title=Rational%20and%20design%20of%20the%20T-STORHM%20study.&amp;author=C%20Martinaud&amp;author=P%20Tiberghien&amp;author=S%20Bégué&amp;publication_year=2019&amp;journal=Transfus%20Clin%20Biol&amp;volume=26&amp;pages=198-201" target="_blank" xmlns:helper="urn:XsltStringHelper">Google Scholar</a><a href="https://doi.org/10.1016/j.tracli.2019.09.004" class="crossref-doi" target="_blank" xmlns:helper="urn:XsltStringHelper">Crossref</a><span class="inst-open-url-holders" data-targetId="10.1016/j.tracli.2019.09.004" xmlns:helper="urn:XsltStringHelper"> </span></div></div><div class="reference"><a class="reference-number" id="jsc210001r27">27.</a><div class="reference-content">Schulz
         KF﻿, Grimes
         DA﻿.  Multiplicity in randomised trials, II. ﻿ <i xmlns:helper="urn:XsltStringHelper"> Lancet</i>. 2005;365(9471):1657-1661. doi:<a href="http://dx.doi.org/10.1016/S0140-6736(05)66516-6">10.1016/S0140-6736(05)66516-6</a><a class="pubmed-link" href="https://www.ncbi.nlm.nih.gov/pubmed/15885299" target="_blank" xmlns:helper="urn:XsltStringHelper">PubMed</a><a class="google-scholar-ref-link" href="https://scholar.google.com/scholar_lookup?title=Multiplicity%20in%20randomised%20trials%2C%20II.&amp;author=KF%20Schulz&amp;author=DA%20Grimes&amp;publication_year=2005&amp;journal=Lancet&amp;volume=365&amp;pages=1657-1661" target="_blank" xmlns:helper="urn:XsltStringHelper">Google Scholar</a><a href="https://doi.org/10.1016/S0140-6736(05)66516-6" class="crossref-doi" target="_blank" xmlns:helper="urn:XsltStringHelper">Crossref</a><span class="inst-open-url-holders" data-targetId="10.1016/S0140-6736(05)66516-6" xmlns:helper="urn:XsltStringHelper"> </span></div></div><div class="reference"><a class="reference-number" id="jsc210001r28">28.</a><div class="reference-content">Bassler
         D﻿, Montori
         VM﻿, Briel
         M﻿, 
     et al.  Early stopping of randomized clinical trials for overt efficacy is problematic. ﻿ <i xmlns:helper="urn:XsltStringHelper"> J Clin Epidemiol</i>. 2008;61(3):241-246. doi:<a href="http://dx.doi.org/10.1016/j.jclinepi.2007.07.016">10.1016/j.jclinepi.2007.07.016</a><a class="pubmed-link" href="https://www.ncbi.nlm.nih.gov/pubmed/18226746" target="_blank" xmlns:helper="urn:XsltStringHelper">PubMed</a><a class="google-scholar-ref-link" href="https://scholar.google.com/scholar_lookup?title=Early%20stopping%20of%20randomized%20clinical%20trials%20for%20overt%20efficacy%20is%20problematic.&amp;author=D%20Bassler&amp;author=VM%20Montori&amp;author=M%20Briel&amp;publication_year=2008&amp;journal=J%20Clin%20Epidemiol&amp;volume=61&amp;pages=241-246" target="_blank" xmlns:helper="urn:XsltStringHelper">Google Scholar</a><a href="https://doi.org/10.1016/j.jclinepi.2007.07.016" class="crossref-doi" target="_blank" xmlns:helper="urn:XsltStringHelper">Crossref</a><span class="inst-open-url-holders" data-targetId="10.1016/j.jclinepi.2007.07.016" xmlns:helper="urn:XsltStringHelper"> </span></div></div><div class="reference"><a class="reference-number" id="jsc210001r29">29.</a><div class="reference-content">Mueller
         PS﻿, Montori
         VM﻿, Bassler
         D﻿, 
     et al.  Ethical issues in stopping randomized trials early because of apparent benefit. ﻿ <i xmlns:helper="urn:XsltStringHelper"> Ann Intern Med</i>. 2007;146(12):878-881. doi:<a href="http://dx.doi.org/10.7326/0003-4819-146-12-200706190-00009">10.7326/0003-4819-146-12-200706190-00009</a><a class="pubmed-link" href="https://www.ncbi.nlm.nih.gov/pubmed/17577007" target="_blank" xmlns:helper="urn:XsltStringHelper">PubMed</a><a class="google-scholar-ref-link" href="https://scholar.google.com/scholar_lookup?title=Ethical%20issues%20in%20stopping%20randomized%20trials%20early%20because%20of%20apparent%20benefit.&amp;author=PS%20Mueller&amp;author=VM%20Montori&amp;author=D%20Bassler&amp;publication_year=2007&amp;journal=Ann%20Intern%20Med&amp;volume=146&amp;pages=878-881" target="_blank" xmlns:helper="urn:XsltStringHelper">Google Scholar</a><a href="https://doi.org/10.7326/0003-4819-146-12-200706190-00009" class="crossref-doi" target="_blank" xmlns:helper="urn:XsltStringHelper">Crossref</a><span class="inst-open-url-holders" data-targetId="10.7326/0003-4819-146-12-200706190-00009" xmlns:helper="urn:XsltStringHelper"> </span></div></div><div class="reference"><a class="reference-number" id="jsc210001r30">30.</a><div class="reference-content">Montori
         VM﻿, Devereaux
         PJ﻿, Adhikari
         NKJ﻿, 
     et al.  Randomized trials stopped early for benefit. ﻿ <i xmlns:helper="urn:XsltStringHelper"> JAMA</i>. 2005;294(17):2203-2209. doi:<a href="http://jamanetwork.com/article.aspx?doi=10.1001/jama.294.17.2203">10.1001/jama.294.17.2203</a><a class="pubmed-link" href="https://www.ncbi.nlm.nih.gov/pubmed/16264162" target="_blank" xmlns:helper="urn:XsltStringHelper">PubMed</a><a class="google-scholar-ref-link" href="https://scholar.google.com/scholar_lookup?title=Randomized%20trials%20stopped%20early%20for%20benefit.&amp;author=VM%20Montori&amp;author=PJ%20Devereaux&amp;author=NKJ%20Adhikari&amp;publication_year=2005&amp;journal=JAMA&amp;volume=294&amp;pages=2203-2209" target="_blank" xmlns:helper="urn:XsltStringHelper">Google Scholar</a><a href="https://doi.org/10.1001/jama.294.17.2203" class="crossref-doi" target="_blank" xmlns:helper="urn:XsltStringHelper">Crossref</a><span class="inst-open-url-holders" data-targetId="10.1001/jama.294.17.2203" xmlns:helper="urn:XsltStringHelper"> </span></div></div><div class="reference"><a class="reference-number" id="jsc210001r31">31.</a><div class="reference-content">Tharmanathan
         P﻿, Calvert
         M﻿, Hampton
         J﻿, Freemantle
         N﻿.  The use of interim data and data monitoring committee recommendations in randomized controlled trial reports. ﻿ <i xmlns:helper="urn:XsltStringHelper"> BMC Med Res Methodol</i>. 2008;8(1):12. doi:<a href="http://dx.doi.org/10.1186/1471-2288-8-12">10.1186/1471-2288-8-12</a><a class="pubmed-link" href="https://www.ncbi.nlm.nih.gov/pubmed/18366697" target="_blank" xmlns:helper="urn:XsltStringHelper">PubMed</a><a class="google-scholar-ref-link" href="https://scholar.google.com/scholar_lookup?title=The%20use%20of%20interim%20data%20and%20data%20monitoring%20committee%20recommendations%20in%20randomized%20controlled%20trial%20reports.&amp;author=P%20Tharmanathan&amp;author=M%20Calvert&amp;author=J%20Hampton&amp;author=N%20Freemantle&amp;publication_year=2008&amp;journal=BMC%20Med%20Res%20Methodol&amp;volume=8&amp;pages=12" target="_blank" xmlns:helper="urn:XsltStringHelper">Google Scholar</a><a href="https://doi.org/10.1186/1471-2288-8-12" class="crossref-doi" target="_blank" xmlns:helper="urn:XsltStringHelper">Crossref</a><span class="inst-open-url-holders" data-targetId="10.1186/1471-2288-8-12" xmlns:helper="urn:XsltStringHelper"> </span></div></div><div class="reference"><a class="reference-number" id="jsc210001r32">32.</a><div class="reference-content">Coskinas
         X﻿, Simes
         J﻿, Schou
         M﻿, Martin
         AJ﻿.  Changes to aspects of ongoing randomised controlled trials with fixed designs. ﻿ <i xmlns:helper="urn:XsltStringHelper"> Trials</i>. 2020;21(1):457. doi:<a href="http://dx.doi.org/10.1186/s13063-020-04374-3">10.1186/s13063-020-04374-3</a><a class="pubmed-link" href="https://www.ncbi.nlm.nih.gov/pubmed/32493444" target="_blank" xmlns:helper="urn:XsltStringHelper">PubMed</a><a class="google-scholar-ref-link" href="https://scholar.google.com/scholar_lookup?title=Changes%20to%20aspects%20of%20ongoing%20randomised%20controlled%20trials%20with%20fixed%20designs.&amp;author=X%20Coskinas&amp;author=J%20Simes&amp;author=M%20Schou&amp;author=AJ%20Martin&amp;publication_year=2020&amp;journal=Trials&amp;volume=21&amp;pages=457" target="_blank" xmlns:helper="urn:XsltStringHelper">Google Scholar</a><a href="https://doi.org/10.1186/s13063-020-04374-3" class="crossref-doi" target="_blank" xmlns:helper="urn:XsltStringHelper">Crossref</a><span class="inst-open-url-holders" data-targetId="10.1186/s13063-020-04374-3" xmlns:helper="urn:XsltStringHelper"> </span></div></div><div class="reference"><a class="reference-number" id="jsc210001r33">33.</a><div class="reference-content">Alirol
         E﻿, Kuesel
         AC﻿, Guraiib
         MM﻿, 
     et al.  Ethics review of studies during public health emergencies—the experience of the WHO ethics review committee during the Ebola virus disease epidemic. ﻿ <i xmlns:helper="urn:XsltStringHelper"> BMC Med Ethics</i>. 2017;18(1):43. doi:<a href="http://dx.doi.org/10.1186/s12910-017-0201-1">10.1186/s12910-017-0201-1</a><a class="pubmed-link" href="https://www.ncbi.nlm.nih.gov/pubmed/28651650" target="_blank" xmlns:helper="urn:XsltStringHelper">PubMed</a><a class="google-scholar-ref-link" href="https://scholar.google.com/scholar_lookup?title=Ethics%20review%20of%20studies%20during%20public%20health%20emergencies%E2%80%94the%20experience%20of%20the%20WHO%20ethics%20review%20committee%20during%20the%20Ebola%20virus%20disease%20epidemic.&amp;author=E%20Alirol&amp;author=AC%20Kuesel&amp;author=MM%20Guraiib&amp;publication_year=2017&amp;journal=BMC%20Med%20Ethics&amp;volume=18&amp;pages=43" target="_blank" xmlns:helper="urn:XsltStringHelper">Google Scholar</a><a href="https://doi.org/10.1186/s12910-017-0201-1" class="crossref-doi" target="_blank" xmlns:helper="urn:XsltStringHelper">Crossref</a><span class="inst-open-url-holders" data-targetId="10.1186/s12910-017-0201-1" xmlns:helper="urn:XsltStringHelper"> </span></div></div><div class="reference"><a class="reference-number" id="jsc210001r34">34.</a><div class="reference-content">Sweetman
         EA﻿, Doig
         GS﻿.  Failure to report protocol violations in clinical trials. ﻿ <i xmlns:helper="urn:XsltStringHelper"> Trials</i>. 2011;12:214. doi:<a href="http://dx.doi.org/10.1186/1745-6215-12-214">10.1186/1745-6215-12-214</a><a class="pubmed-link" href="https://www.ncbi.nlm.nih.gov/pubmed/21955551" target="_blank" xmlns:helper="urn:XsltStringHelper">PubMed</a><a class="google-scholar-ref-link" href="https://scholar.google.com/scholar_lookup?title=Failure%20to%20report%20protocol%20violations%20in%20clinical%20trials.&amp;author=EA%20Sweetman&amp;author=GS%20Doig&amp;publication_year=2011&amp;journal=Trials&amp;volume=12&amp;pages=214" target="_blank" xmlns:helper="urn:XsltStringHelper">Google Scholar</a><a href="https://doi.org/10.1186/1745-6215-12-214" class="crossref-doi" target="_blank" xmlns:helper="urn:XsltStringHelper">Crossref</a><span class="inst-open-url-holders" data-targetId="10.1186/1745-6215-12-214" xmlns:helper="urn:XsltStringHelper"> </span></div></div><div class="reference"><a class="reference-number" id="jsc210001r35">35.</a><div class="reference-content">Girardis
         M﻿, Busani
         S﻿, Damiani
         E﻿, 
     et al.  Effect of conservative vs conventional oxygen therapy on mortality among patients in an intensive care unit. ﻿ <i xmlns:helper="urn:XsltStringHelper"> JAMA</i>. 2016;316(15):1583-1589. doi:<a href="http://jamanetwork.com/article.aspx?doi=10.1001/jama.2016.11993">10.1001/jama.2016.11993</a><a class="pubmed-link" href="https://www.ncbi.nlm.nih.gov/pubmed/27706466" target="_blank" xmlns:helper="urn:XsltStringHelper">PubMed</a><a class="google-scholar-ref-link" href="https://scholar.google.com/scholar_lookup?title=Effect%20of%20conservative%20vs%20conventional%20oxygen%20therapy%20on%20mortality%20among%20patients%20in%20an%20intensive%20care%20unit.&amp;author=M%20Girardis&amp;author=S%20Busani&amp;author=E%20Damiani&amp;publication_year=2016&amp;journal=JAMA&amp;volume=316&amp;pages=1583-1589" target="_blank" xmlns:helper="urn:XsltStringHelper">Google Scholar</a><a href="https://doi.org/10.1001/jama.2016.11993" class="crossref-doi" target="_blank" xmlns:helper="urn:XsltStringHelper">Crossref</a><span class="inst-open-url-holders" data-targetId="10.1001/jama.2016.11993" xmlns:helper="urn:XsltStringHelper"> </span></div></div><div class="reference"><a class="reference-number" id="jsc210001r36">36.</a><div class="reference-content">Eisenberg
         MJ﻿, Hébert-Losier
         A﻿, Windle
         SB﻿, 
     et al.  Effect of e-cigarettes plus counseling vs counseling alone on smoking cessation. ﻿ <i xmlns:helper="urn:XsltStringHelper"> JAMA</i>. 2020;324(18):1844-1854. doi:<a href="http://jamanetwork.com/article.aspx?doi=10.1001/jama.2020.18889">10.1001/jama.2020.18889</a><a class="pubmed-link" href="https://www.ncbi.nlm.nih.gov/pubmed/33170240" target="_blank" xmlns:helper="urn:XsltStringHelper">PubMed</a><a class="google-scholar-ref-link" href="https://scholar.google.com/scholar_lookup?title=Effect%20of%20e-cigarettes%20plus%20counseling%20vs%20counseling%20alone%20on%20smoking%20cessation.&amp;author=MJ%20Eisenberg&amp;author=A%20Hébert-Losier&amp;author=SB%20Windle&amp;publication_year=2020&amp;journal=JAMA&amp;volume=324&amp;pages=1844-1854" target="_blank" xmlns:helper="urn:XsltStringHelper">Google Scholar</a><a href="https://doi.org/10.1001/jama.2020.18889" class="crossref-doi" target="_blank" xmlns:helper="urn:XsltStringHelper">Crossref</a><span class="inst-open-url-holders" data-targetId="10.1001/jama.2020.18889" xmlns:helper="urn:XsltStringHelper"> </span></div></div><div class="reference"><a class="reference-number" id="jsc210001r37">37.</a><div class="reference-content">Tomazini
         BM﻿, Maia
         IS﻿, Cavalcanti
         AB﻿, 
     et al.  Effect of dexamethasone on days alive and ventilator-free in patients with moderate or severe acute respiratory distress syndrome and COVID-19. ﻿ <i xmlns:helper="urn:XsltStringHelper"> JAMA</i>. 2020;324(13):1307-1316. doi:<a href="http://jamanetwork.com/article.aspx?doi=10.1001/jama.2020.17021">10.1001/jama.2020.17021</a><a class="pubmed-link" href="https://www.ncbi.nlm.nih.gov/pubmed/32876695" target="_blank" xmlns:helper="urn:XsltStringHelper">PubMed</a><a class="google-scholar-ref-link" href="https://scholar.google.com/scholar_lookup?title=Effect%20of%20dexamethasone%20on%20days%20alive%20and%20ventilator-free%20in%20patients%20with%20moderate%20or%20severe%20acute%20respiratory%20distress%20syndrome%20and%20COVID-19.&amp;author=BM%20Tomazini&amp;author=IS%20Maia&amp;author=AB%20Cavalcanti&amp;publication_year=2020&amp;journal=JAMA&amp;volume=324&amp;pages=1307-1316" target="_blank" xmlns:helper="urn:XsltStringHelper">Google Scholar</a><a href="https://doi.org/10.1001/jama.2020.17021" class="crossref-doi" target="_blank" xmlns:helper="urn:XsltStringHelper">Crossref</a><span class="inst-open-url-holders" data-targetId="10.1001/jama.2020.17021" xmlns:helper="urn:XsltStringHelper"> </span></div></div><div class="reference"><a class="reference-number" id="jsc210001r38">38.</a><div class="reference-content">Laine
         C﻿, Goodman
         SN﻿, Griswold
         ME﻿, Sox
         HC﻿.  Reproducible research: moving toward research the public can really trust. ﻿ <i xmlns:helper="urn:XsltStringHelper"> Ann Intern Med</i>. 2007;146(6):450-453. doi:<a href="http://dx.doi.org/10.7326/0003-4819-146-6-200703200-00154">10.7326/0003-4819-146-6-200703200-00154</a><a class="pubmed-link" href="https://www.ncbi.nlm.nih.gov/pubmed/17339612" target="_blank" xmlns:helper="urn:XsltStringHelper">PubMed</a><a class="google-scholar-ref-link" href="https://scholar.google.com/scholar_lookup?title=Reproducible%20research%3A%20moving%20toward%20research%20the%20public%20can%20really%20trust.&amp;author=C%20Laine&amp;author=SN%20Goodman&amp;author=ME%20Griswold&amp;author=HC%20Sox&amp;publication_year=2007&amp;journal=Ann%20Intern%20Med&amp;volume=146&amp;pages=450-453" target="_blank" xmlns:helper="urn:XsltStringHelper">Google Scholar</a><a href="https://doi.org/10.7326/0003-4819-146-6-200703200-00154" class="crossref-doi" target="_blank" xmlns:helper="urn:XsltStringHelper">Crossref</a><span class="inst-open-url-holders" data-targetId="10.7326/0003-4819-146-6-200703200-00154" xmlns:helper="urn:XsltStringHelper"> </span></div></div><div class="reference"><a class="reference-number" id="jsc210001r39">39.</a><div class="reference-content">Medicines and Healthcare Products Regulatory Agency. Managing clinical trials during coronavirus (COVID-19): how investigators and sponsors should manage clinical trials during COVID-19. Published 2020. Accessed March 2, 2021. <a href="https://www.gov.uk/guidance/managing-clinical-trials-during-coronavirus-covid-19">https://www.gov.uk/guidance/managing-clinical-trials-during-coronavirus-covid-19</a></div></div><div class="reference"><a class="reference-number" id="jsc210001r40">40.</a><div class="reference-content">US Food and Drug Administration. Statistical considerations for clinical trials during the COVID-19 public health emergency: guidance for industry. Published June 2020. Accessed May 3, 2021. <a href="https://www.fda.gov/regulatory-information/search-fda-guidance-documents/statistical-considerations-clinical-trials-during-covid-19-public-health-emergency-guidance-industry">https://www.fda.gov/regulatory-information/search-fda-guidance-documents/statistical-considerations-clinical-trials-during-covid-19-public-health-emergency-guidance-industry</a></div></div><div class="reference"><a class="reference-number" id="jsc210001r41">41.</a><div class="reference-content">Cro
         S﻿, Morris
         TP﻿, Kahan
         BC﻿, 
     et al.  A four-step strategy for handling missing outcome data in randomised trials affected by a pandemic. ﻿ <i xmlns:helper="urn:XsltStringHelper"> BMC Med Res Methodol</i>. 2020;20(1):208. doi:<a href="http://dx.doi.org/10.1186/s12874-020-01089-6">10.1186/s12874-020-01089-6</a><a class="pubmed-link" href="https://www.ncbi.nlm.nih.gov/pubmed/32787782" target="_blank" xmlns:helper="urn:XsltStringHelper">PubMed</a><a class="google-scholar-ref-link" href="https://scholar.google.com/scholar_lookup?title=A%20four-step%20strategy%20for%20handling%20missing%20outcome%20data%20in%20randomised%20trials%20affected%20by%20a%20pandemic.&amp;author=S%20Cro&amp;author=TP%20Morris&amp;author=BC%20Kahan&amp;publication_year=2020&amp;journal=BMC%20Med%20Res%20Methodol&amp;volume=20&amp;pages=208" target="_blank" xmlns:helper="urn:XsltStringHelper">Google Scholar</a><a href="https://doi.org/10.1186/s12874-020-01089-6" class="crossref-doi" target="_blank" xmlns:helper="urn:XsltStringHelper">Crossref</a><span class="inst-open-url-holders" data-targetId="10.1186/s12874-020-01089-6" xmlns:helper="urn:XsltStringHelper"> </span></div></div><div class="reference"><a class="reference-number" id="jsc210001r42">42.</a><div class="reference-content">Meagher
         KM﻿, Cummins
         NW﻿, Bharucha
         AE﻿, 
     et al.  COVID-19 ethics and research. ﻿ <i xmlns:helper="urn:XsltStringHelper"> Mayo Clin Proc</i>. 2020;95(6):1119-1123. doi:<a href="http://dx.doi.org/10.1016/j.mayocp.2020.04.019">10.1016/j.mayocp.2020.04.019</a><a class="pubmed-link" href="https://www.ncbi.nlm.nih.gov/pubmed/32402511" target="_blank" xmlns:helper="urn:XsltStringHelper">PubMed</a><a class="google-scholar-ref-link" href="https://scholar.google.com/scholar_lookup?title=COVID-19%20ethics%20and%20research.&amp;author=KM%20Meagher&amp;author=NW%20Cummins&amp;author=AE%20Bharucha&amp;publication_year=2020&amp;journal=Mayo%20Clin%20Proc&amp;volume=95&amp;pages=1119-1123" target="_blank" xmlns:helper="urn:XsltStringHelper">Google Scholar</a><a href="https://doi.org/10.1016/j.mayocp.2020.04.019" class="crossref-doi" target="_blank" xmlns:helper="urn:XsltStringHelper">Crossref</a><span class="inst-open-url-holders" data-targetId="10.1016/j.mayocp.2020.04.019" xmlns:helper="urn:XsltStringHelper"> </span></div></div><div class="reference"><a class="reference-number" id="jsc210001r43">43.</a><div class="reference-content">Vissers
         MFJM﻿, Cohen
         AF﻿, Van Gerven
         JMA﻿, Groeneveld
         GJ﻿.  The impact of the global COVID-19 pandemic on the conduct of clinical trials. ﻿ <i xmlns:helper="urn:XsltStringHelper"> Br J Clin Pharmacol</i>. 2021;87(3):837-844. doi:<a href="http://dx.doi.org/10.1111/bcp.14480">10.1111/bcp.14480</a><a class="pubmed-link" href="https://www.ncbi.nlm.nih.gov/pubmed/32668047" target="_blank" xmlns:helper="urn:XsltStringHelper">PubMed</a><a class="google-scholar-ref-link" href="https://scholar.google.com/scholar_lookup?title=The%20impact%20of%20the%20global%20COVID-19%20pandemic%20on%20the%20conduct%20of%20clinical%20trials.&amp;author=MFJM%20Vissers&amp;author=AF%20Cohen&amp;author=JMA%20Van Gerven&amp;author=GJ%20Groeneveld&amp;publication_year=2021&amp;journal=Br%20J%20Clin%20Pharmacol&amp;volume=87&amp;pages=837-844" target="_blank" xmlns:helper="urn:XsltStringHelper">Google Scholar</a><a href="https://doi.org/10.1111/bcp.v87.3" class="crossref-doi" target="_blank" xmlns:helper="urn:XsltStringHelper">Crossref</a><span class="inst-open-url-holders" data-targetId="10.1111/bcp.v87.3" xmlns:helper="urn:XsltStringHelper"> </span></div></div><div class="reference"><a class="reference-number" id="jsc210001r44">44.</a><div class="reference-content">Rusen
         ID﻿.  Challenges in tuberculosis clinical trials in the face of the COVID-19 pandemic. ﻿ <i xmlns:helper="urn:XsltStringHelper"> Trop Med Infect Dis</i>. 2020;5(2):E86. doi:<a href="http://dx.doi.org/10.3390/tropicalmed5020086">10.3390/tropicalmed5020086</a><a class="pubmed-link" href="https://www.ncbi.nlm.nih.gov/pubmed/32471274" target="_blank" xmlns:helper="urn:XsltStringHelper">PubMed</a><a class="google-scholar-ref-link" href="https://scholar.google.com/scholar_lookup?title=Challenges%20in%20tuberculosis%20clinical%20trials%20in%20the%20face%20of%20the%20COVID-19%20pandemic.&amp;author=ID%20Rusen&amp;publication_year=2020&amp;journal=Trop%20Med%20Infect%20Dis&amp;volume=5&amp;pages=" target="_blank" xmlns:helper="urn:XsltStringHelper">Google Scholar</a></div></div><div class="reference"><a class="reference-number" id="jsc210001r45">45.</a><div class="reference-content">Davis
         S﻿, Pai
         S﻿.  Challenges and opportunities for sponsors in conducting clinical trials during a pandemic. ﻿ <i xmlns:helper="urn:XsltStringHelper"> Perspect Clin Res</i>. 2020;11(3):115-120. doi:<a href="http://dx.doi.org/10.4103/picr.PICR_177_20">10.4103/picr.PICR_177_20</a><a class="pubmed-link" href="https://www.ncbi.nlm.nih.gov/pubmed/33033700" target="_blank" xmlns:helper="urn:XsltStringHelper">PubMed</a><a class="google-scholar-ref-link" href="https://scholar.google.com/scholar_lookup?title=Challenges%20and%20opportunities%20for%20sponsors%20in%20conducting%20clinical%20trials%20during%20a%20pandemic.&amp;author=S%20Davis&amp;author=S%20Pai&amp;publication_year=2020&amp;journal=Perspect%20Clin%20Res&amp;volume=11&amp;pages=115-120" target="_blank" xmlns:helper="urn:XsltStringHelper">Google Scholar</a><a href="https://doi.org/10.4103/picr.PICR_177_20" class="crossref-doi" target="_blank" xmlns:helper="urn:XsltStringHelper">Crossref</a><span class="inst-open-url-holders" data-targetId="10.4103/picr.PICR_177_20" xmlns:helper="urn:XsltStringHelper"> </span></div></div><div class="reference"><a class="reference-number" id="jsc210001r46">46.</a><div class="reference-content">Anker
         SD﻿, Butler
         J﻿, Khan
         MS﻿, 
     et al.  Conducting clinical trials in heart failure during (and after) the COVID-19 pandemic. ﻿ <i xmlns:helper="urn:XsltStringHelper"> Eur Heart J</i>. 2020;41(22):2109-2117. doi:<a href="http://dx.doi.org/10.1093/eurheartj/ehaa461">10.1093/eurheartj/ehaa461</a><a class="pubmed-link" href="https://www.ncbi.nlm.nih.gov/pubmed/32498081" target="_blank" xmlns:helper="urn:XsltStringHelper">PubMed</a><a class="google-scholar-ref-link" href="https://scholar.google.com/scholar_lookup?title=Conducting%20clinical%20trials%20in%20heart%20failure%20during%20%28and%20after%29%20the%20COVID-19%20pandemic.&amp;author=SD%20Anker&amp;author=J%20Butler&amp;author=MS%20Khan&amp;publication_year=2020&amp;journal=Eur%20Heart%20J&amp;volume=41&amp;pages=2109-2117" target="_blank" xmlns:helper="urn:XsltStringHelper">Google Scholar</a><a href="https://doi.org/10.1093/eurheartj/ehaa461" class="crossref-doi" target="_blank" xmlns:helper="urn:XsltStringHelper">Crossref</a><span class="inst-open-url-holders" data-targetId="10.1093/eurheartj/ehaa461" xmlns:helper="urn:XsltStringHelper"> </span></div></div><div class="reference"><a class="reference-number" id="jsc210001r47">47.</a><div class="reference-content">de Paula
         BHR﻿, Araújo
         I﻿, Bandeira
         L﻿, 
     et al.  Recommendations from national regulatory agencies for ongoing cancer trials during the COVID-19 pandemic. ﻿ <i xmlns:helper="urn:XsltStringHelper"> Lancet Oncol</i>. 2020;21(5):624-627. doi:<a href="http://dx.doi.org/10.1016/S1470-2045(20)30226-6">10.1016/S1470-2045(20)30226-6</a><a class="pubmed-link" href="https://www.ncbi.nlm.nih.gov/pubmed/32277907" target="_blank" xmlns:helper="urn:XsltStringHelper">PubMed</a><a class="google-scholar-ref-link" href="https://scholar.google.com/scholar_lookup?title=Recommendations%20from%20national%20regulatory%20agencies%20for%20ongoing%20cancer%20trials%20during%20the%20COVID-19%20pandemic.&amp;author=BHR%20de Paula&amp;author=I%20Araújo&amp;author=L%20Bandeira&amp;publication_year=2020&amp;journal=Lancet%20Oncol&amp;volume=21&amp;pages=624-627" target="_blank" xmlns:helper="urn:XsltStringHelper">Google Scholar</a><a href="https://doi.org/10.1016/S1470-2045(20)30226-6" class="crossref-doi" target="_blank" xmlns:helper="urn:XsltStringHelper">Crossref</a><span class="inst-open-url-holders" data-targetId="10.1016/S1470-2045(20)30226-6" xmlns:helper="urn:XsltStringHelper"> </span></div></div><div class="reference"><a class="reference-number" id="jsc210001r48">48.</a><div class="reference-content">Waterhouse
         DM﻿, Harvey
         RD﻿, Hurley
         P﻿, 
     et al.  Early impact of COVID-19 on the conduct of oncology clinical trials and long-term opportunities for transformation. ﻿ <i xmlns:helper="urn:XsltStringHelper"> JCO Oncol Pract</i>. 2020;16(7):417-421. doi:<a href="http://dx.doi.org/10.1200/OP.20.00275">10.1200/OP.20.00275</a><a class="pubmed-link" href="https://www.ncbi.nlm.nih.gov/pubmed/32396491" target="_blank" xmlns:helper="urn:XsltStringHelper">PubMed</a><a class="google-scholar-ref-link" href="https://scholar.google.com/scholar_lookup?title=Early%20impact%20of%20COVID-19%20on%20the%20conduct%20of%20oncology%20clinical%20trials%20and%20long-term%20opportunities%20for%20transformation.&amp;author=DM%20Waterhouse&amp;author=RD%20Harvey&amp;author=P%20Hurley&amp;publication_year=2020&amp;journal=JCO%20Oncol%20Pract&amp;volume=16&amp;pages=417-421" target="_blank" xmlns:helper="urn:XsltStringHelper">Google Scholar</a><a href="https://doi.org/10.1200/OP.20.00275" class="crossref-doi" target="_blank" xmlns:helper="urn:XsltStringHelper">Crossref</a><span class="inst-open-url-holders" data-targetId="10.1200/OP.20.00275" xmlns:helper="urn:XsltStringHelper"> </span></div></div><div class="reference"><a class="reference-number" id="jsc210001r49">49.</a><div class="reference-content">Moskowitz
         CS﻿, Panageas
         KS﻿.  Implications for design and analyses of oncology clinical trials during the COVID-19 pandemic. ﻿ <i xmlns:helper="urn:XsltStringHelper"> JAMA Oncol</i>. 2020;6(9):1326-1327. doi:<a href="http://jamanetwork.com/article.aspx?doi=10.1001/jamaoncol.2020.2370">10.1001/jamaoncol.2020.2370</a><a class="pubmed-link" href="https://www.ncbi.nlm.nih.gov/pubmed/32556067" target="_blank" xmlns:helper="urn:XsltStringHelper">PubMed</a><a class="google-scholar-ref-link" href="https://scholar.google.com/scholar_lookup?title=Implications%20for%20design%20and%20analyses%20of%20oncology%20clinical%20trials%20during%20the%20COVID-19%20pandemic.&amp;author=CS%20Moskowitz&amp;author=KS%20Panageas&amp;publication_year=2020&amp;journal=JAMA%20Oncol&amp;volume=6&amp;pages=1326-1327" target="_blank" xmlns:helper="urn:XsltStringHelper">Google Scholar</a><a href="https://doi.org/10.1001/jamaoncol.2020.2370" class="crossref-doi" target="_blank" xmlns:helper="urn:XsltStringHelper">Crossref</a><span class="inst-open-url-holders" data-targetId="10.1001/jamaoncol.2020.2370" xmlns:helper="urn:XsltStringHelper"> </span></div></div><div class="reference"><a class="reference-number" id="jsc210001r50">50.</a><div class="reference-content">Lau
         G﻿, Sharma
         M﻿; APASL Covid-19 Task Force.  Clinical practice guidance for hepatology and liver transplant providers during the COVID-19 pandemic. ﻿ <i xmlns:helper="urn:XsltStringHelper"> Hepatol Int</i>. 2020;14(4):415-428. doi:<a href="http://dx.doi.org/10.1007/s12072-020-10054-w">10.1007/s12072-020-10054-w</a><a class="pubmed-link" href="https://www.ncbi.nlm.nih.gov/pubmed/32447721" target="_blank" xmlns:helper="urn:XsltStringHelper">PubMed</a><a class="google-scholar-ref-link" href="https://scholar.google.com/scholar_lookup?title=Clinical%20practice%20guidance%20for%20hepatology%20and%20liver%20transplant%20providers%20during%20the%20COVID-19%20pandemic.&amp;author=G%20Lau&amp;author=M%20Sharma&amp;publication_year=2020&amp;journal=Hepatol%20Int&amp;volume=14&amp;pages=415-428" target="_blank" xmlns:helper="urn:XsltStringHelper">Google Scholar</a><a href="https://doi.org/10.1007/s12072-020-10054-w" class="crossref-doi" target="_blank" xmlns:helper="urn:XsltStringHelper">Crossref</a><span class="inst-open-url-holders" data-targetId="10.1007/s12072-020-10054-w" xmlns:helper="urn:XsltStringHelper"> </span></div></div><div class="reference"><a class="reference-number" id="jsc210001r51">51.</a><div class="reference-content">Perlis
         RH﻿, Haneuse
         SJPA﻿, Rubenfeld
         GD﻿, 
     et al.  Reporting clinical studies affected by the COVID-19 pandemic. ﻿ <i xmlns:helper="urn:XsltStringHelper"> JAMA Netw Open</i>. 2021;4(1):e2036155. doi:<a href="http://jamanetwork.com/article.aspx?doi=10.1001/jamanetworkopen.2020.36155">10.1001/jamanetworkopen.2020.36155</a><a class="pubmed-link" href="https://www.ncbi.nlm.nih.gov/pubmed/33443576" target="_blank" xmlns:helper="urn:XsltStringHelper">PubMed</a><a class="google-scholar-ref-link" href="https://scholar.google.com/scholar_lookup?title=Reporting%20clinical%20studies%20affected%20by%20the%20COVID-19%20pandemic.&amp;author=RH%20Perlis&amp;author=SJPA%20Haneuse&amp;author=GD%20Rubenfeld&amp;publication_year=2021&amp;journal=JAMA%20Netw%20Open&amp;volume=4&amp;pages=" target="_blank" xmlns:helper="urn:XsltStringHelper">Google Scholar</a></div></div><div class="reference"><a class="reference-number" id="jsc210001r52">52.</a><div class="reference-content">McDermott
         MM﻿, Newman
         AB﻿.  Preserving clinical trial integrity during the coronavirus pandemic. ﻿ <i xmlns:helper="urn:XsltStringHelper"> JAMA</i>. 2020;323(21):2135-2136. doi:<a href="http://jamanetwork.com/article.aspx?doi=10.1001/jama.2020.4689">10.1001/jama.2020.4689</a><a class="pubmed-link" href="https://www.ncbi.nlm.nih.gov/pubmed/32211830" target="_blank" xmlns:helper="urn:XsltStringHelper">PubMed</a><a class="google-scholar-ref-link" href="https://scholar.google.com/scholar_lookup?title=Preserving%20clinical%20trial%20integrity%20during%20the%20coronavirus%20pandemic.&amp;author=MM%20McDermott&amp;author=AB%20Newman&amp;publication_year=2020&amp;journal=JAMA&amp;volume=323&amp;pages=2135-2136" target="_blank" xmlns:helper="urn:XsltStringHelper">Google Scholar</a><a href="https://doi.org/10.1001/jama.2020.4689" class="crossref-doi" target="_blank" xmlns:helper="urn:XsltStringHelper">Crossref</a><span class="inst-open-url-holders" data-targetId="10.1001/jama.2020.4689" xmlns:helper="urn:XsltStringHelper"> </span></div></div><div class="reference"><a class="reference-number" id="jsc210001r53">53.</a><div class="reference-content">Parikh
         PM﻿, Mehta
         P﻿, Mvt
         KM﻿, 
     et al.  “Serious adverse events” faced by clinical trials. ﻿ <i xmlns:helper="urn:XsltStringHelper"> Indian J Med Paediatr Oncol</i>. 2020;41(2):127. doi:<a href="http://dx.doi.org/10.4103/ijmpo.ijmpo_114_20">10.4103/ijmpo.ijmpo_114_20</a><a class="google-scholar-ref-link" href="https://scholar.google.com/scholar_lookup?title=%E2%80%9CSerious%20adverse%20events%E2%80%9D%20faced%20by%20clinical%20trials.&amp;author=PM%20Parikh&amp;author=P%20Mehta&amp;author=KM%20Mvt&amp;publication_year=2020&amp;journal=Indian%20J%20Med%20Paediatr%20Oncol&amp;volume=41&amp;pages=127" target="_blank" xmlns:helper="urn:XsltStringHelper">Google Scholar</a></div></div></div>

</div>
 
    </div>

        <div class="movable-ad bta">
    <div class="widget-WidgetLoader widget-instance-AMA_AdTag_textbreak_bta_dual">
        
    <div class="SCM-SharedWidgets-AsyncAdLoader" data-url="/AMA/AdTag/AMA_AdTag_textbreak_bta_dual" data-params="{&quot;parameters&quot;:{&quot;siteName&quot;:&quot;jama&quot;,&quot;siteId&quot;:3,&quot;journalId&quot;:67,&quot;adDisplay&quot;:8,&quot;adSection&quot;:&quot;textbreak&quot;,&quot;adPosition&quot;:&quot;bta&quot;,&quot;fromGoogle&quot;:false},&quot;dynamicParameters&quot;:{}}"></div>
 
    </div>

        </div>
    </div> 

</div> 

<div class="hidden-jobs-ad hide">
    <div class="widget-WidgetLoader widget-instance-AMA_JobsAd">
        
<div class="SCM-SharedWidgets-AsyncJobsAdLoader" data-url="/AMA/JobsAd/AMA_JobsAd" data-params="{&quot;parameters&quot;:{&quot;SiteId&quot;:3},&quot;dynamicParameters&quot;:{&quot;localParams&quot;:&quot;[REPLACE_WITH_LOCAL]&quot;}}"></div>
 
    </div>

</div>



<script>
                var App = App || {};
                App.ArticleSplitScreen = App.ArticleSplitScreen || {};
                App.ArticleSplitScreen.siteName = 'jama';
                App.ArticleSplitScreen.siteId = 3;
                App.ArticleSplitScreen.journalId = 67;
                App.ArticleSplitScreen.adDisplay = 'ArticleContentsSkyBox';
                App.ArticleSplitScreen.adSection = "scholarly";
                App.ArticleSplitScreen.adPosition = "contab";
                App.ArticleSplitScreen.controlId = "AMA_AdTag_Contents_Skybox";
                App.ArticleSplitScreen.fromGoogle = "False";
                App.ArticleSplitScreen.slotLocationOverride = "50";

</script> 
    </div>


 
    </div>

    </section>


    <section id="secFooterControl" class="master-footer">
        

        <script>
            var App = App || {};

            function scmByClass(className) {
                return document.getElementsByClassName(className);
            }

            function scmById(id) {
                return document.getElementById(id);
            }

            function scmquery(selector) {
                return document.querySelector(selector);
            }

            function queryAll(selector) {
                return document.querySelectorAll(selector);
            }

            function isTrueString(string) {
                if (typeof string === 'string') {
                    return string.toLowerCase() === 'true';
                }

                return undefined;
            }

            function updateViewportDimensions() {
                var w = window, d = document, e = d.documentElement, g = d.getElementsByTagName('body')[0], x = w.innerWidth || e.clientWidth || g.clientWidth, y = w.innerHeight || e.clientHeight || g.clientHeight;
                return { width: x, height: y };
            }

            var viewport = updateViewportDimensions();

            var debounce = function (func, wait, immediate) {
                var timeout;
                return function () {
                    var context = this, args = arguments;
                    var later = function () {
                        timeout = null;
                        if (!immediate) func.apply(context, args);
                    };
                    var callNow = immediate && !timeout;
                    clearTimeout(timeout);
                    timeout = setTimeout(later, wait);
                    if (callNow) func.apply(context, args);
                };
            };

            (function (App) {
                App.mobileUpperBreakpoint = 767;
                App.mobileAltBreakpoint = 640;
                App.mobileMinBreakpoint = 547;
                App.tabletUpperBreakpoint = 1023;

                function setVariables() {
                    viewport = updateViewportDimensions();
                    App.isMobile = (viewport.width <= App.mobileUpperBreakpoint);
                    App.isMobileAlt = (viewport.width <= App.mobileAltBreakpoint);
                    App.isTablet = (viewport.width > App.mobileUpperBreakpoint && viewport.width <= App.tabletUpperBreakpoint);
                    App.isTabletDown = (viewport.width <= App.tabletUpperBreakpoint);
                    App.isDesktop = (viewport.width > App.tabletUpperBreakpoint);
                    App.activeViewport = App.isMobile ? 'small' : App.isTablet ? 'med' : 'large';
                }

                setVariables();

                App.cachedViewport = App.isMobile ? 'small' : App.isTablet ? 'med' : 'large';
                App.isAnyArticle = !!(scmByClass('widget-ArticleFullView').length || scmByClass('pg_abstract').length
                    || scmByClass('widget-MagazineView').length || scmByClass('widget-ChannelsMagazineView').length);
                App.isSplitScreen = !!scmByClass('widget-ArticleFullView').length;
                App.isAbstract = !!scmByClass('pg_abstract').length;
                App.isMag = !!(scmByClass('widget-MagazineView').length);
                App.isChannel = !!(scmByClass('channel-site').length);
                App.isChannelMag = !!(scmByClass('widget-ChannelsMagazineView').length);
                App.isFreeArticle = !!(scmquery('.widget-ArticleTopInfo .free-access') ||
                                        scmquery('.widget-ArticleTopInfo .open-access') ||
                                        scmquery('.widget-ArticleTopInfo .icon-free') || 
                                        scmquery('.widget-ChannelsMagazineView .free-access'));
                App.isTollFreeAccess = false;
                App.isIssue = !!scmByClass('pg_issue').length || !!scmByClass('pg_newonline').length || !!scmByClass('pg_currentissue').length || !!scmByClass('pg_pastissues').length;
                App.isNewOnline = !!scmByClass('pg_newonline').length;
                App.isCurrentIssue = !!scmByClass('pg_currentissue').length;
                App.isPastIssues = !!scmByClass('pg_pastissues').length;
                App.isJournal = !!scmByClass('pg_journal').length;
                App.isNetworkHome = !!scmByClass('pg_index').length;
                App.isSearch = !!scmByClass('pg_searchresults').length;
                App.isAdvancedSearch = !!scmByClass('pg_advancedsearch').length;
                App.isPlayer= !!scmByClass('pg_multimediaplayer').length;
                App.isSelfServe = !!scmByClass('pg_sspage').length;
                App.isCmsPage = !!scmByClass('pg_cmspage').length; 
                App.isMyAccount = !!scmByClass('pg_myaccount').length;
                App.supportsFlexbox = !!scmByClass('flexbox').length;
                App.isCollection = !!scmByClass('pg_collection').length;
                App.isPaidUser = isTrueString(scmById('hfAppIsPaidUser').getAttribute('value'));
                App.isMember = isTrueString(scmById('hfAppIsMember').getAttribute('value'));
                App.isIndividual = isTrueString(scmById('hfAppIsIndividual').getAttribute('value'));
                App.hasAccess = isTrueString(scmById('hfAppHasAccess').getAttribute('value'));
                App.isReferredFromGoogle = isTrueString(scmById('hfAppIsReferredFromGoogle').getAttribute('value'));
                var subscribedTo = scmById('hfAppSubscribedTo').getAttribute('value');
                App.userSubscribedTo = subscribedTo ? subscribedTo.split(',') : undefined;
                App.isLucy = isTrueString(scmById('hfAppIsLucy').getAttribute('value'));
                App.currentJournalCount = 26;
                App.isChannelPage = !!(scmByClass('channels-page'));
                App.updateAppVariables = debounce(function () {
                    setVariables();
                }, 50, false);
            })(App);
        </script>
        

        
<div class="footer-ad-wrapper">
    <div id="BodyContent_Footer_divAds" class="footer-ad desktop-only">
        
            <div class="widget-WidgetLoader widget-instance-AMA_AdTag_AnchorboardAd_btf">
        
    <div class="SCM-SharedWidgets-AsyncAdLoader" data-url="/AMA/AdTag/AMA_AdTag_AnchorboardAd_btf" data-params="{&quot;parameters&quot;:{&quot;siteName&quot;:&quot;jama&quot;,&quot;siteId&quot;:3,&quot;journalId&quot;:67,&quot;adDisplay&quot;:11,&quot;adSection&quot;:&quot;scholarly&quot;,&quot;adPosition&quot;:&quot;btf&quot;,&quot;fromGoogle&quot;:false},&quot;dynamicParameters&quot;:{&quot;localParams&quot;:&quot;[REPLACE_WITH_LOCAL]&quot;}}"></div>
 
    </div>
</div>
</div>

 
 <div class="ad-riser-wrap desktop-only">
     <div class="ad-riser--dismiss t-c">X</div>
         <div class="widget-WidgetLoader widget-instance-AMA_AdTag_Riser">
        
    <div class="SCM-SharedWidgets-AsyncAdLoader" data-url="/AMA/AdTag/AMA_AdTag_Riser" data-params="{&quot;parameters&quot;:{&quot;siteName&quot;:&quot;jama&quot;,&quot;siteId&quot;:3,&quot;journalId&quot;:67,&quot;adDisplay&quot;:12,&quot;adSection&quot;:&quot;scholarly&quot;,&quot;adPosition&quot;:&quot;Riser&quot;,&quot;fromGoogle&quot;:false},&quot;dynamicParameters&quot;:{&quot;localParams&quot;:&quot;[REPLACE_WITH_LOCAL]&quot;}}"></div>
 
    </div>

 </div>


<div class="footer-wrap">
    
    <footer class="footer" id="footer">
        
        <div id="footer-microsite" class="footer-microsite">
            



    <input type="hidden" class="SelfServeContentId" value="v2_Footer_Left" />
    <input type="hidden" class="SelfServeVersionId" value="0" />

<style type="text/css">
    @media (min-width: 1024px) {.split-screen .footer-microsite-contents {border-bottom:0 !important;}}
    .footer-microsite-contents {margin-bottom:1em;width:100%;}
    .footer-network-other .link-apps:before {width: 23px;}
    .footer-network-other .link-institutions-librarians:before {width: 23px;}
    .jn-ss-footer-border-top {border-top:1px solid #555;padding-top:15px;}
    .jn-ss-footer-border-bottom {border-bottom:1px solid #555;padding-bottom:10px;padding-right:3px;}
</style>
<div class="footer-heading-wrap">
<h3 id="BodyContent_Footer_h3SiteName" class="footer-heading is-b footer-microsite-heading" data-mobile-tog-target=".footer-microsite-links-wrap">JAMA</h3>
</div>
<div class="footer-microsite-links-wrap">
<div class="footer-microsite-contents  jn-ss-footer-border-bottom">
<h4 id="BodyContent_Footer_ContentHeader" class="footer-subheading">Content</h4>
<a href="/journals/jama">Home</a>
<a href="/journals/jama/newonline">New Online</a>
<a href="/journals/jama/currentissue">Current Issue</a>
</div>
<div class="footer-microsite-contents  jn-ss-footer-border-bottom">
<h4 class="footer-subheading">Podcasts</h4>
<a href="/journals/jama/pages/covid-19-interviews#audio">Coronavirus (COVID-19)&nbsp;Q&amp;A</a>
<a href="/journals/jama/pages/jama-clinical-reviews">Clinical Reviews</a>
<a href="/journals/jama/pages/jama-editors-summary">Editors' Summary</a>
<a href="/journals/jama/pages/jama-medical-news">Medical News</a>
<a href="/journals/jama/pages/jama-author-interviews">Author Interviews</a>
<a href="/journals/jama/pages/jamaevidence-jama-guide-to-statistics-and-methods">JAMAevidence: <em>JAMA Guide to Statistics and Methods</em></a>
<a href="/journals/jama/pages/jamaevidence-the-rational-clinical-examination">JAMAevidence: The Rational Clinical Examination</a>
<a href="/journals/jama/pages/jamaevidence-users-guides-to-the-medical-literature">JAMAevidence: Users' Guides to the Medical Literature</a>
</div>
<div class="footer-microsite-services cf">
<h4 id="BodyContent_Footer_ServiceHeader" class="footer-subheading">Journal Information</h4>
<a href="/journals/jama/pages/for-authors">For Authors</a>
<a href="/journals/jama/pages/jama-editors">JAMA Editors</a>
<a href="/journals/jama/editors-and-publishers">Editors &amp; Publishers</a>
<a href="/pages/rss">RSS</a>
<a href="/journals/jama/pages/contact-us">Contact Us</a>
</div>
<div class="footer-network-other  jn-ss-footer-border-bottom">
<a href="https://edhub.ama-assn.org/jn-learning" class="link-network-other is-b link-learning">JN Learning / CME</a>
<a href="https://store.jamanetwork.com" class="link-network-other is-b link-store" target="_blank">Store</a>
<a href="/pages/apps" class="link-network-other is-b link-mobile" target="_blank">Apps</a>
<a href="https://careers.jamanetwork.com/" class="link-network-other is-b link-jobs" target="_blank">Jobs</a>
<a href="/pages/resources-for-librarians" class="link-network-other is-b link-institutions-librarians" target="_blank">Institutions</a>
<a href="/pages/reprints-and-permissions" class="link-network-other is-b link-reprints-permissions">Reprints &amp; Permissions</a>
</div>
<div id="BodyContent_Footer_divSubscribe" class="footer-microsite-subscribe">
<img src="//cdn.jamanetwork.com/UI/app/img/covers/jama.jpg" class="subscribe-image" alt="Journal Cover">
<div class="subscribe-meta">
<h4 class="subscribe-heading footer-subheading">Subscribe</h4>
<a href="https://store.jamanetwork.com/productDetails.aspx?productcodeID=64" class="subscribe-submit btn">Go</a>
</div>
</div>
</div>





        </div>

        
        <div id="footer-network" class="footer-network">
            



    <input type="hidden" class="SelfServeContentId" value="v2_Footer_Middle" />
    <input type="hidden" class="SelfServeVersionId" value="0" />

<style type="text/css">
    .footer-network-sites {width: 62.85542%;}
    .footer-network-info {width: 35.93976%}
    .jn-ss-subheading-mt {margin-top: 1.5em;}
    .jn-registered:after {content: "\00AE";font-size: 50%;vertical-align: top;}
    .jn-trademark:after {content: "\2122";font-size: 50%;vertical-align: top;}
</style>
<div class="footer-heading-wrap">
<h3 class="footer-heading is-b jn-registered" data-mobile-tog-target=".footer-network-links-wrap"><strong>JAMA</strong> Network</h3>
</div>
<div class="footer-network-links-wrap">
<div class="footer-network-sites">
<div class="internal">
<h4 id="BodyContent_Footer_JournalHeader" class="footer-subheading">Publications</h4>
<a href="/journals/jama">JAMA</a>
<a href="/journals/jamanetworkopen" target="_blank">JAMA Network Open</a>
<a href="/journals/jamacardiology">JAMA Cardiology</a>
<a href="/journals/jamadermatology">JAMA Dermatology</a>
<a href="/journals/jama-health-forum">JAMA Health Forum</a>
<a href="/journals/jamainternalmedicine">JAMA Internal Medicine</a>
<a href="/journals/jamaneurology">JAMA Neurology</a>
<a href="/journals/jamaoncology">JAMA Oncology</a>
<a href="/journals/jamaophthalmology">JAMA Ophthalmology</a>
<a href="/journals/jamaotolaryngology">JAMA Otolaryngology–Head &amp; Neck Surgery</a>
<a href="/journals/jamapediatrics">JAMA Pediatrics</a>
<a href="/journals/jamapsychiatry">JAMA Psychiatry</a>
<a href="/journals/jamasurgery">JAMA Surgery</a>
<a href="/journals/archneurpsyc">Archives of Neurology &amp; Psychiatry (1919-1959)</a>
</div>
<div class="external">
<h4 class="footer-subheading">Sites</h4>
<div id="BodyContent_Footer_ssFooterSiteMenu">
<div class="selfServe">
<a target="_blank" href="https://sites.jamanetwork.com/art-and-images-in-psychiatry/">Art and Images in Psychiatry</a>
<a target="_blank" href="/channels/ai">Artificial Intelligence (AI) Resource Center</a>
<a target="_blank" href="/journals/jama/pages/2023-most-viewed-jama">Best of the JAMA Network</a>
<a target="_blank" href="/channels/caring-for-the-critically-ill-patient">Caring for the Critically Ill Patient</a>
<a target="_blank" href="/journals/jama/pages/crosswords">Clinical Crosswords from JAMA</a>
<a target="_blank" href="/journals/jama/pages/coronavirus-alert">Coronavirus Resource Center</a>
<a target="_blank" href="https://ebm.jamanetwork.com/index.html">Evidence-Based Medicine: An Oral History</a>
<a target="_blank" href="/pages/fishbein-fellowship">Fishbein Fellowship</a>
<a target="_blank" href="/channels/genomics/">Genomics and Precision Health</a>
<a target="_blank" href="/channels/hypertension">Hypertension</a>
<a target="_blank" href="/channels/health-forum/archive">JAMA Forum Archive</a>
<a target="_blank" href="https://sites.jamanetwork.com/audio">JAMA Network Audio</a>
<a target="_blank" href="/pages/video">JAMA Network Video</a>
<a target="_blank" href="/pages/conferences">JAMA Network Conferences </a>
<a target="_blank" href="/pages/jama-summit">JAMA Summit </a>
<a target="_blank" href="/journals/jamasurgery/pages/statistics-and-methods">JAMA Surgery Guide to Statistics and Methods</a>
<a target="_blank" href="/channels/medical-news">Medical News</a>
<a target="_blank" href="/channels/monkeypox">Mpox (Monkeypox)</a>
<a target="_blank" href="https://sites.jamanetwork.com/research-ethics/">Research Ethics</a>
<a target="_blank" href="/pages/collections">Topics and Collections</a>
<a target="_blank" href="/pages/visual-abstracts">Visual Abstracts</a>
<a target="_blank" href="/channels/war">War and Health</a>
<a target="_blank" href="/channels/womens-health">Women's Health</a>
<h4 class="footer-subheading jn-ss-subheading-mt">Featured Articles</h4>
<a href="/journals/jama/fullarticle/2799240">Antiretroviral Drugs for HIV Treatment and Prevention in Adults - 2022 IAS-USA Recommendations</a>
<a href="/journals/jama/fullarticle/2781397">CONSERVE 2021 Guidelines for Reporting Trials Modified for the COVID-19 Pandemic</a>
<a href="/journals/jama/fullarticle/2808296">Creation and Adoption of Large Language Models in&nbsp;Medicine</a>
<a href="/journals/jamaoncology/fullarticle/2787350">Global Burden of Cancer, 2010-2019</a>
<a href="/journals/jama/fullarticle/2797443">Global Burden of Long COVID</a>
<a href="/journals/jamadermatology/fullarticle/2790344">Global Burden of Melanoma</a>
<a href="/journals/jamadermatology/fullarticle/2787350">Global Burden of Skin Diseases, 1990-2017</a>
<a href="/journals/jamaneurology/fullarticle/2793874">Global Disparities in Parkinson Disease</a>
<a href="/journals/jama/fullarticle/2799547">Guidelines for Reporting Outcomes in Trial Protocols: The SPIRIT-Outcomes 2022 Extension</a>
<a href="/journals/jamapsychiatry/fullarticle/2799486">Mass Violence and the Complex Spectrum of Mental Illness and Mental Functioning</a>
<a href="/journals/jamapsychiatry/fullarticle/2793903">Neuropsychiatry Sequelae of COVID-19</a>
<a href="/journals/jamaneurology/fullarticle/2810313">A New Framework for Dementia Nomenclature</a>
<a href="/journals/jama/fullarticle/2800656">Organization and Performance of US Health Systems</a>
<a href="/journals/jama-health-forum/fullarticle/2791195">Pharmacy Benefit Managers: History, Business Practices, Economics, and Policy</a>
<a href="/journals/jama-health-forum/fullarticle/2791195">Promoting EDI in Genetics Research</a>
<a href="/journals/jamacardiology/fullarticle/2781972">PTSD and Cardiovascular Disease</a>
<a href="/journals/jama/fullarticle/2810754">Red Blood Cell Transfusion: 2023 AABB International Guidelines</a>
<a href="/journals/jamapediatrics/fullarticle/2797600">Reimagining Children’s Rights in the US</a>
<a href="/journals/jama/fullarticle/2794049">Spirituality in Serious Illness and Health</a>
<a href="/journals/jama/fullarticle/2796374">The US Medicaid Program: Coverage, Financing, Reforms, and Implications for Health Equity</a>
<h4 class="footer-subheading jn-ss-subheading-mt">USPSTF Recommendation Statements</h4>
<a href="/journals/jama/fullarticle/2779985">Screening for Colorectal Cancer</a>
<a href="/journals/jama/fullarticle/2779190">Screening for Hypertension</a>
<a href="/journals/jama/fullarticle/2777244">Screening for Lung Cancer</a>
<a href="/journals/jama/fullarticle/2796244">Screening for Prediabetes and Type 2 Diabetes In Children</a>
<a href="/journals/jama/fullarticle/2783414">Screening for Prediabetes and Type 2 Diabetes In Adults</a>
<a href="/journals/jama/fullarticle/2795521">Statins for Primary Prevention of Cardiovascular Disease</a>
<a href="/journals/jama/fullarticle/2793446">Vitamin and Mineral Supplements for Primary Prevention of of Cardiovascular Disease and Cancer</a>
<h4 class="footer-subheading jn-ss-subheading-mt">Blogs</h4>
<a target="_blank" href="https://amastyleinsider.com/">AMA Style Insider</a>
</div>
</div>
</div>
</div>
<div id="footer-network-info" class="footer-network-info">
<div class="information-for-links">
<h4 id="BodyContent_Footer_InfoHeader" class="footer-subheading">Information</h4>
<a href="/pages/for-authors">For Authors</a>
<a href="/pages/resources-for-librarians">For Institutions &amp; Librarians</a>
<a href="/pages/advertisers">For Advertisers</a>
<a href="/pages/subscription-agents">For Subscription Agents</a>
<a href="https://careers.jamanetwork.com/" target="_blank">For Employers &amp; Job Seekers</a>
<a href="https://media.jamanetwork.com" rel="nofollow" target="_blank">For the Media</a>
<a href="/pages/equity-diversity-inclusion">Equity, Diversity, Inclusion</a>
<a href="/pages/commenting-policy">Online Commenting Policy</a>
<a href="/pages/access-at-jama-network">Public Access and Open Access Policy</a>
<a href="/pages/offensive-content-statement">Statement on Potentially Offensive Content</a>
</div>
<div class="services-links">
<h4 id="BodyContent_Footer_JAMANetworkProductsHeader" class="footer-subheading">JAMA Network Products</h4>
<a href="http://www.amamanualofstyle.com/" class="footer-service-link" target="_blank">AMA Manual of Style</a>
<a href="https://jamaevidence.mhmedical.com/" class="footer-service-link" target="_blank"><span class="jn-registered">JAMAevidence</span></a>
<a href="http://www.peerreviewcongress.org/" class="footer-service-link" target="_blank">Peer Review Congress</a>
</div>
<div class="learning-links">
<h4 id="BodyContent_Footer_LearningHeader" class="footer-subheading">JN Learning</h4>
<a href="https://edhub.ama-assn.org/jn-learning">Home</a>
<a href="https://edhub.ama-assn.org/jn-learning/state-cme">State CME</a>
<a href="https://edhub.ama-assn.org/jn-learning/pages/clinical-challenge-courses">Clinical Challenge CME</a>
<a href="https://edhub.ama-assn.org/jn-learning/course/288 ">Atrial Fibrillation Course</a>
<a href="https://edhub.ama-assn.org/jn-learning/course/294 ">Women's Health Course</a>
<a target="_blank" href="https://edhub.ama-assn.org/pages/auto-credit-reporting">CME / MOC Reporting Preferences</a>
<a href="https://edhub.ama-assn.org/jn-learning/pages/about-cme">About CME &amp; MOC</a>
</div>
</div>
</div>





        </div>
        
        <div id="footer-resources-wrap" class="footer-resources-wrap">
            



    <input type="hidden" class="SelfServeContentId" value="v2_Footer_Right" />
    <input type="hidden" class="SelfServeVersionId" value="0" />

<style type="text/css">
    .footer-resources-wrap .footer-subheading {color: grey;display:block !important;font-size: 1.17647em;font-weight: 400;text-transform: uppercase;}
</style>
<div class="footer-heading-wrap">
<h3 class="footer-heading is-b footer-resources-heading" data-mobile-tog-target=".footer-resources">Help</h3>
</div>
<div class="footer-resources">
<a href="https://store.jamanetwork.com" class="footer-service-link" target="_blank">Subscriptions &amp; Renewals</a>
<a href="https://jamanetwork.com/oauthsignin?return_url=http%3A%2F%2Fjamanetwork.com%2Fmyaccount%23my-alerts" class="footer-service-link" rel="nofollow">Manage Emails</a>
<a href="https://jamanetwork.com/oauthsignin?return_url=http%3A%2F%2Fjamanetwork.com%2Fmyaccount%23my-profile" class="footer-service-link" rel="nofollow">Update My Address</a>
<a href="https://support.jamanetwork.com/hc/en-us" class="footer-service-link">Support Center</a>
<a href="/myaccount " class="footer-service-link">My Account</a>
<h4 class="footer-subheading jn-ss-subheading-mt">JAMA Career Center</h4>
<a href="https://careers.jamanetwork.com/" class="footer-service-link" target="_blank">Physician Job Listings</a>
</div>








    <input type="hidden" class="SelfServeContentId" value="v2_Footer_Socials" />
    <input type="hidden" class="SelfServeVersionId" value="0" />

<style type="text/css">
    .widget-instance-AMA_Journal_Home_Socials .iconsocial {display: inline-block !important;width: 34px;height: 34px;min-width: unset !important;margin: 0 2px !important;background-color: #fff;border-radius: 20px;border: 1px solid #191919;vertical-align: middle;}
    .widget-instance-AMA_Journal_Home_Socials .iconsocial.instagram {background-image: url(https://cdn.jamanetwork.com/ImageLibrary/JamaNetwork/social/instagram-icon-black.svg);background-position: 7px 7px;background-repeat: no-repeat;background-size: 18px;}
    .widget-instance-AMA_Journal_Home_Socials .iconsocial.instagram:hover, .widget-instance-AMA_Journal_Home_Socials .iconsocial.instagram:focus {background-image: url(https://cdn.jamanetwork.com/ImageLibrary/JamaNetwork/social/instagram-icon-fill.png);border-color: #C13584;}
    .footer-resources-wrap .iconsocial {display: inline-block !important;width: 32px;height: 32px;min-width: unset !important;margin: 0 2px 0 3px !important;background-color: #fff;border-radius: 20px;border: 1px solid #191919;vertical-align: middle;}
    .footer-resources-wrap .iconsocial.instagram {background-image: url(https://cdn.jamanetwork.com/ImageLibrary/JamaNetwork/social/instagram-icon-black.svg);background-position: 6px 6px;background-repeat: no-repeat;background-size: 18px;}
    .footer-resources-wrap .iconsocial.instagram:hover, .footer-resources-wrap .iconsocial.instagram:focus {background-color: #C13584;border-color: #191919;}
    #load-instagram-image { background: url(https://cdn.jamanetwork.com/ImageLibrary/JamaNetwork/social/instagram-icon-fill.png) no-repeat -9999px -9999px; }
</style>
<div id="BodyContent_Footer_divSocial" class="social-links footer-social-links">
<a target="_blank" rel="nofollow" data-emailid="6d35777a-fc12-4d2d-9b49-81d031835d91" href="https://www.facebook.com/JAMAJournal/" class="social-link is-b facebook"></a>
<a target="_blank" rel="nofollow" data-emailid="6d35777a-fc12-4d2d-9b49-81d031835d91" href="https://twitter.com/JAMA_current" class="social-link is-b twitter"></a>
<a target="_blank" rel="nofollow" data-emailid="6d35777a-fc12-4d2d-9b49-81d031835d91" href="https://www.instagram.com/jamanetwork/?hl=en" class="iconsocial instagram"></a>
<a target="_blank" rel="nofollow" data-emailid="6d35777a-fc12-4d2d-9b49-81d031835d91" href="https://www.linkedin.com/company/jamanetwork/" class="social-link is-b linked-in"></a>
<a target="_blank" rel="nofollow" data-emailid="6d35777a-fc12-4d2d-9b49-81d031835d91" href="https://www.youtube.com/jamanetwork" class="social-link is-b you-tube"></a>
<a target="_blank" rel="nofollow" data-emailid="6d35777a-fc12-4d2d-9b49-81d031835d91" href="https://www.pinterest.com/jamanetwork/" class="social-link is-b pinterest"></a>
<a target="_blank" rel="nofollow" data-emailid="6d35777a-fc12-4d2d-9b49-81d031835d91" href="/rss/site_3/67.xml" class="social-link is-b rss"></a>
<a target="_blank" rel="nofollow" data-emailid="6d35777a-fc12-4d2d-9b49-81d031835d91" href="https://jamanetwork.com/journals/jama/pages/jama-editors-summary" class="social-link is-b podcast"></a>
<div id="load-instagram-image">&nbsp;</div>
</div>




<div id="BodyContent_Footer_divEmailUpdate" class="footer-email-updates">
                
                    <div class="widget-EmailListSignUp widget-instance-AMAv2_EmailListSignUp_Footer">
        <div class="email-signup">
    
    <div class="email-signup--text sb-pc">Get the latest from JAMA</div>
    <div class="email-signup--input-wrap is-b">
        <input type="text" name="email" class="email-signup--input" placeholder="Email address" title="Email address" />
        <a rel="nofollow" href="javascript:;" class="email-signup--submit sb-sc btn">Sign Up</a>
    </div>
    <div class="email-signup--link"> <a class="email-signup--privacy" href="/pages/privacy-policy">Privacy Policy</a> | <a class="email-signup--terms" href="/pages/terms-of-use">Terms of Use</a></div>
    <div class="email-signup--user-message"></div>
</div> 
    </div>
</div>
        </div>

        
        <div class="footer-bar" itemscope itemtype="https://schema.org/Organization">
            



    <input type="hidden" class="SelfServeContentId" value="v2_Footer_Bottom_Bar" />
    <input type="hidden" class="SelfServeVersionId" value="0" />

<style type="text/css">
    .nav-journals a.theme-jama-health-forum:before {background: #133763;}
    .jn-bottom-bar {color: #fff; float: left;font-size: 10px;padding: 13px 20px;width: 33.33%;}
    .jn-bottom-bar p {line-height: 2;}
    @media (max-width: 900px) {.jn-bottom-bar {float: none;width: 100%;}}
    .jn-footer-copyright {font-size:12px;line-height:1.5;margin-bottom:10px;}
    .jn-footer-pipe {margin:0 10px;}
    .footer-bar-jn-logo img {width: 230px;}
    @media (max-width: 900px) {.footer-bar-jn-logo img {width: 200px;}}
    [data-thm=umb] .jobs-ad--text h6 {color: #d71635 !important;}
    [data-thm=jama] .jobs-ad--text h6 {color: #d71635 !important;}
    [data-thm=jaman] .jobs-ad--text h6 {color: #ed0973 !important;}
    [data-thm=cardi] .jobs-ad--text h6 {color: #be1e32 !important;}
    [data-thm=derm] .jobs-ad--text h6 {color: #006f3b !important;}
    [data-thm=faci] .jobs-ad--text h6 {color: #ed1c24 !important;}
    [data-thm=jama-] .jobs-ad--text h6 {color: #fb5252 !important;}
    [data-thm=intem] .jobs-ad--text h6 {color: #006e96 !important;}
    [data-thm=neur] .jobs-ad--text h6 {color: #981b1e !important;}
    [data-thm=oncol] .jobs-ad--text h6 {color: #3b923f !important;}
    [data-thm=ophth] .jobs-ad--text h6 {color: #66bc29 !important;}
    [data-thm=otol] .jobs-ad--text h6 {color: #34b6e4 !important;}
    [data-thm=peds] .jobs-ad--text h6 {color: #0084c0 !important;}
    [data-thm=psych] .jobs-ad--text h6 {color: #005276 !important;}
    [data-thm=surg] .jobs-ad--text h6 {color: #f47920 !important;}
    .blockquote .para {margin: 0 0 1em 1em;}
    .jn-footer-copyright {display: block;}
    .inline-block {display: inline-block;}
    #selfserve-maintenance {display:block;margin:20px 0;max-height:none !important;min-height:200px;visibility:visible;}
</style>
<a class="footer-bar-jn-logo d-b no-mw mb1" href="/" title="JAMA Network Home"><img class="mw-100" src="https://cdn.jamanetwork.com/ImageLibrary/global/jn-signature-reversed-r.svg?versionId=81373" alt="Jama Network Logo"></a>
<div class="jn-bottom-bar">
<p>
<span class="jn-footer-copyright">© 2024 American Medical Association. <span class="inline-block">All rights reserved,</span> including those for text and data mining, AI training, <span class="inline-block">and similar technologies.</span></span>
<span class="inline-block"><a href="https://www.ama-assn.org/about/terms-use" rel="nofollow" class="p0">Terms of Use</a><span class="jn-footer-pipe">|</span></span>
<span class="inline-block"><a href="https://www.ama-assn.org/about/privacy-policy" rel="nofollow" class="p0">Privacy Policy</a><span class="jn-footer-pipe">|</span></span>
<span class="inline-block"><a href="https://www.ama-assn.org/about/accessibility-statement" rel="nofollow" class="p0">Accessibility Statement</a><span class="jn-footer-pipe">|</span></span>
<span class="inline-block"><a onclick="OneTrust.ToggleInfoDisplay()" rel="nofollow" class="p0" id="CookieFooter">Cookie Settings</a></span>
</p>
</div>
<!-- 
	#selfserve-maintenance {display:block;margin:20px 0;max-height:none !important;min-height:200px;visibility:visible;}
	-->





            <a class="footer-bar-sis no-mw relative nudge-down" href="https://www.silverchair.com" target="_blank"><img class="footer-bar-sis-img mt05 mw-100" width="600" height="70" src="//cdn.jamanetwork.com/UI/app/img/powered.png" alt="Silverchair Logo" /></a>
        </div>
    </footer>

</div>
<div class="ss-ui-only">
        <div class="widget-SelfServeContent widget-instance-AMA_SS_UI_Only">
        


<div class="self-serve">
    <input type="hidden" class="SelfServeContentId" value="SsUiOnly" />
    <input type="hidden" class="SelfServeVersionId" value="0" />

.


</div>

 
    </div>

</div>

    </section>


        

        
        
        <div id="revealModal" class="reveal-modal" data-reveal>
            <div id="revealContent"></div>
            <a class="close-reveal-modal icon-close"></a>
        </div>

        
        <div class="artmet-modal" id="MetricsModal">
            <div class="artmet-modal-contents">
                <a class="artmet-close-modal">&#215;</a>
            </div>
        </div>

        
        
    


            <div class="widget-SigninModals widget-instance-AMA_SigninModals">
        <div class="js-modal-no-access-reveal no-access reveal-modal modal tiny" data-reveal>
    <div class="modal--box">
        <div class="modal--title">Access your subscriptions</div>
        <hr />
                <button type="button" role="button" class="modal--btn js-btn-signin-personal" data-oauth-signin-url="https://jamanetwork.com/oauthsignin?return_url=https%3a%2f%2fjamanetwork.com%2fjournals%2fjama%2ffullarticle%2f2781397">
            Sign in<span class="fw-normal"> | personal account</span>
        </button>

            <div class="widget-AmaAdvancedSeamlessAccess widget-instance-AMA_NoAccess_AdvancedSeamlessAccessButton">
        <div class="seamless-access-button--wrap">
    <button class="d-flex sa-button align-items-center" role="button" type="button">
        <div class="sa-button-logo-wrap">
            <img src="//cdn.jamanetwork.com/UI/app/svg/seamless-access.svg" class="sa-button-logo" alt="Seamless Access Logo" />
        </div>
        <div class="d-flex justify-content-center align-items-center sa-button-text text-truncate">
            <div class="sa-button-text-primary text-truncate">Access through your institution</div>
        </div>
    </button>
    <div class="sa-access-text text-truncate hide">
        <div class="sa-cta-access"><span>Add or change institution</span></div>
    </div>
</div>
 
    </div>

    <div class="widget-SelfServeContent widget-instance-AMA_NoAccess_SigninModal_CreateAccount">
        


<div class="self-serve">
    <input type="hidden" class="SelfServeContentId" value="SigninModal_CreateAccount" />
    <input type="hidden" class="SelfServeVersionId" value="0" />

<div class="modal--title">Free access to newly published articles</div>
<hr>
<button class="modal--btn js-btn-create-personal-account" type="button" role="button">
<div class="text-truncate">Create a free personal account</div>
</button>
<div class="modal--btn-desc">To register for email alerts, access free PDF, and more</div>
<!--<div class="jn-selfServe-modal-label">JAMA|SigninModal_CreateAccount</div>-->


</div>

 
    </div>
            <div class="widget-SelfServeContent widget-instance-AMA_NoAccess_SigninModal_PurchaseOptions_NoAccessAndPaidPDF">
        


<div class="self-serve">
    <input type="hidden" class="SelfServeContentId" value="SigninModal_PurchaseOptions_NoAccessAndPaidPDF" />
    <input type="hidden" class="SelfServeVersionId" value="0" />

<div class="modal--title">Purchase access</div>
<hr>
<button class="modal--btn js-btn-subscribe-journal" type="button" role="button">
<div class="text-truncate">Subscribe to journal</div>
</button>
<div class="modal--btn-desc">Get full journal access for 1 year</div>
<button class="modal--btn js-btn-purchase-article" type="button" role="button">
<div class="text-truncate">Buy article</div>
</button>
<div class="modal--btn-desc">Get unlimited access and a printable PDF ($40.00)—<br>
<em>Sign in or create a free account</em></div>
<!--<div class="jn-selfServe-modal-label">JAMA|SigninModal_PurchaseOptions_NoAccessAndPaidPDF</div>-->


</div>

 
    </div>

            <div class="widget-DeepDyve widget-instance-AMA_NoAccess_DeepDyve">
                <button type="button" role="button" class="modal--btn js-deepdyve-link hiddenRentalLink" data-deepdyveurl="https://www.deepdyve.com/doc-view?docId=10.1001/jama.2021.9941&amp;fieldName=journal_doi&amp;affiliateId=JAMA" data-doi="10.1001/jama.2021.9941" data-fieldname="journal_doi" 
                data-issneissn="0098-7484" data-affiliate="JAMA">Rent article</button>
        <div class="modal--btn-desc js-deepdyve-desc hiddenRentalLink">Rent this article from DeepDyve</div>
 
    </div>

    </div>
        <a class="close-reveal-modal icon-close"></a>

</div>

<div class="js-modal-paid-pdf-reveal no-access reveal-modal modal tiny" data-reveal>
    <div class="modal--box">
        <div class="modal--title">Access your subscriptions</div>
        <hr />
                <button type="button" role="button" class="modal--btn js-btn-signin-personal" data-oauth-signin-url="https://jamanetwork.com/oauthsignin?return_url=https%3a%2f%2fjamanetwork.com%2fjournals%2fjama%2ffullarticle%2f2781397">
            Sign in<span class="fw-normal"> | personal account</span>
        </button>

            <div class="widget-AmaAdvancedSeamlessAccess widget-instance-AMA_PaidPdf_AdvancedSeamlessAccessButton">
        <div class="seamless-access-button--wrap">
    <button class="d-flex sa-button align-items-center" role="button" type="button">
        <div class="sa-button-logo-wrap">
            <img src="//cdn.jamanetwork.com/UI/app/svg/seamless-access.svg" class="sa-button-logo" alt="Seamless Access Logo" />
        </div>
        <div class="d-flex justify-content-center align-items-center sa-button-text text-truncate">
            <div class="sa-button-text-primary text-truncate">Access through your institution</div>
        </div>
    </button>
    <div class="sa-access-text text-truncate hide">
        <div class="sa-cta-access"><span>Add or change institution</span></div>
    </div>
</div>
 
    </div>

    <div class="widget-SelfServeContent widget-instance-AMA_PaidPdf_SigninModal_CreateAccount">
        


<div class="self-serve">
    <input type="hidden" class="SelfServeContentId" value="SigninModal_CreateAccount" />
    <input type="hidden" class="SelfServeVersionId" value="0" />

<div class="modal--title">Free access to newly published articles</div>
<hr>
<button class="modal--btn js-btn-create-personal-account" type="button" role="button">
<div class="text-truncate">Create a free personal account</div>
</button>
<div class="modal--btn-desc">To register for email alerts, access free PDF, and more</div>
<!--<div class="jn-selfServe-modal-label">JAMA|SigninModal_CreateAccount</div>-->


</div>

 
    </div>
            <div class="widget-SelfServeContent widget-instance-AMA_PaidPdf_SigninModal_PurchaseOptions_NoAccessAndPaidPDF">
        


<div class="self-serve">
    <input type="hidden" class="SelfServeContentId" value="SigninModal_PurchaseOptions_NoAccessAndPaidPDF" />
    <input type="hidden" class="SelfServeVersionId" value="0" />

<div class="modal--title">Purchase access</div>
<hr>
<button class="modal--btn js-btn-subscribe-journal" type="button" role="button">
<div class="text-truncate">Subscribe to journal</div>
</button>
<div class="modal--btn-desc">Get full journal access for 1 year</div>
<button class="modal--btn js-btn-purchase-article" type="button" role="button">
<div class="text-truncate">Buy article</div>
</button>
<div class="modal--btn-desc">Get unlimited access and a printable PDF ($40.00)—<br>
<em>Sign in or create a free account</em></div>
<!--<div class="jn-selfServe-modal-label">JAMA|SigninModal_PurchaseOptions_NoAccessAndPaidPDF</div>-->


</div>

 
    </div>

            <div class="widget-DeepDyve widget-instance-AMA_PaidPDF_DeepDyve">
                <button type="button" role="button" class="modal--btn js-deepdyve-link hiddenRentalLink" data-deepdyveurl="https://www.deepdyve.com/doc-view?docId=10.1001/jama.2021.9941&amp;fieldName=journal_doi&amp;affiliateId=JAMA" data-doi="10.1001/jama.2021.9941" data-fieldname="journal_doi" 
                data-issneissn="0098-7484" data-affiliate="JAMA">Rent article</button>
        <div class="modal--btn-desc js-deepdyve-desc hiddenRentalLink">Rent this article from DeepDyve</div>
 
    </div>

    </div>
        <a class="close-reveal-modal icon-close"></a>

</div>

<div class="js-modal-free-pdf-reveal no-access reveal-modal modal tiny" data-reveal>
    <div class="modal--box">
        <div class="modal--title">Sign in to access free PDF</div>
        <hr />
                <button type="button" role="button" class="modal--btn js-btn-signin-personal" data-oauth-signin-url="https://jamanetwork.com/oauthsignin?return_url=https%3a%2f%2fjamanetwork.com%2fjournals%2fjama%2ffullarticle%2f2781397">
            Sign in<span class="fw-normal"> | personal account</span>
        </button>

            <div class="widget-AmaAdvancedSeamlessAccess widget-instance-AMA_FreePdf_AdvancedSeamlessAccessButton">
        <div class="seamless-access-button--wrap">
    <button class="d-flex sa-button align-items-center" role="button" type="button">
        <div class="sa-button-logo-wrap">
            <img src="//cdn.jamanetwork.com/UI/app/svg/seamless-access.svg" class="sa-button-logo" alt="Seamless Access Logo" />
        </div>
        <div class="d-flex justify-content-center align-items-center sa-button-text text-truncate">
            <div class="sa-button-text-primary text-truncate">Access through your institution</div>
        </div>
    </button>
    <div class="sa-access-text text-truncate hide">
        <div class="sa-cta-access"><span>Add or change institution</span></div>
    </div>
</div>
 
    </div>

    <div class="widget-SelfServeContent widget-instance-AMA_FreePdf_SigninModal_CreateAccount">
        


<div class="self-serve">
    <input type="hidden" class="SelfServeContentId" value="SigninModal_CreateAccount" />
    <input type="hidden" class="SelfServeVersionId" value="0" />

<div class="modal--title">Free access to newly published articles</div>
<hr>
<button class="modal--btn js-btn-create-personal-account" type="button" role="button">
<div class="text-truncate">Create a free personal account</div>
</button>
<div class="modal--btn-desc">To register for email alerts, access free PDF, and more</div>
<!--<div class="jn-selfServe-modal-label">JAMA|SigninModal_CreateAccount</div>-->


</div>

 
    </div>
    </div>
        <a class="close-reveal-modal icon-close"></a>

</div>

<div class="js-modal-save-search-reveal no-access reveal-modal modal tiny" data-reveal>
    <div class="modal--box">
        <div class="modal--title">Save your search</div>
        <hr />
                <button type="button" role="button" class="modal--btn js-btn-signin-personal" data-oauth-signin-url="https://jamanetwork.com/oauthsignin?return_url=https%3a%2f%2fjamanetwork.com%2fjournals%2fjama%2ffullarticle%2f2781397">
            Sign in<span class="fw-normal"> | personal account</span>
        </button>

    <div class="widget-SelfServeContent widget-instance-AMA_SaveSearch_SigninModal_CreateAccount">
        


<div class="self-serve">
    <input type="hidden" class="SelfServeContentId" value="SigninModal_CreateAccount" />
    <input type="hidden" class="SelfServeVersionId" value="0" />

<div class="modal--title">Free access to newly published articles</div>
<hr>
<button class="modal--btn js-btn-create-personal-account" type="button" role="button">
<div class="text-truncate">Create a free personal account</div>
</button>
<div class="modal--btn-desc">To register for email alerts, access free PDF, and more</div>
<!--<div class="jn-selfServe-modal-label">JAMA|SigninModal_CreateAccount</div>-->


</div>

 
    </div>
            <div class="widget-SelfServeContent widget-instance-AMA_SigninModal_PurchaseOptions_SaveSearch">
        


<div class="self-serve">
    <input type="hidden" class="SelfServeContentId" value="SigninModal_PurchaseOptions_SaveSearch" />
    <input type="hidden" class="SelfServeVersionId" value="0" />

<div class="modal--title">Purchase access</div>
		<hr />
		<button class="modal--btn js-btn-subscribe-now">Subscribe now</button>
		<!--<div class="jn-selfServe-modal-label">JAMA|SigninModal_PurchaseOptions_SaveSearch</div>-->


</div>

 
    </div>

    </div>
        <a class="close-reveal-modal icon-close"></a>

</div>

<div class="js-modal-follow-collection-reveal no-access reveal-modal modal tiny" data-reveal>
    <div class="modal--box">
        <div class="modal--title">Customize your interests</div>
        <hr />
                <button type="button" role="button" class="modal--btn js-btn-signin-personal" data-oauth-signin-url="https://jamanetwork.com/oauthsignin?return_url=https%3a%2f%2fjamanetwork.com%2fjournals%2fjama%2ffullarticle%2f2781397">
            Sign in<span class="fw-normal"> | personal account</span>
        </button>

    <div class="widget-SelfServeContent widget-instance-AMA_FollowCollection_SigninModal_CreateAccount">
        


<div class="self-serve">
    <input type="hidden" class="SelfServeContentId" value="SigninModal_CreateAccount" />
    <input type="hidden" class="SelfServeVersionId" value="0" />

<div class="modal--title">Free access to newly published articles</div>
<hr>
<button class="modal--btn js-btn-create-personal-account" type="button" role="button">
<div class="text-truncate">Create a free personal account</div>
</button>
<div class="modal--btn-desc">To register for email alerts, access free PDF, and more</div>
<!--<div class="jn-selfServe-modal-label">JAMA|SigninModal_CreateAccount</div>-->


</div>

 
    </div>
            <div class="widget-SelfServeContent widget-instance-AMA_SigninModal_PurchaseOptions_FollowCollection">
        


<div class="self-serve">
    <input type="hidden" class="SelfServeContentId" value="SigninModal_PurchaseOptions_FollowCollection" />
    <input type="hidden" class="SelfServeVersionId" value="0" />

<div class="modal--sub-title">Create a personal account or sign in to:</div>
		<ul>
			<li>Register for email alerts with links to free full-text articles</li>
			<li>Access PDFs of free articles</li>
			<li>Manage your interests</li>
			<li>Save searches and receive search alerts</li>
		<ul>
		<!--<div class="jn-selfServe-modal-label">JAMA|SigninModal_PurchaseOptions_FollowCollection</div>-->


</div>

 
    </div>

            <div class="modal--link-wrap">
        <a class="modal--link" href="/pages/privacy-policy" rel="nofollow">Privacy Policy</a>
    </div>

    </div>
        <a class="close-reveal-modal icon-close"></a>

</div>

<div class="js-modal-user-comment-reveal no-access reveal-modal modal tiny" data-reveal>
    <div class="modal--box">
        <div class="modal--title">Make a comment</div>
        <hr />
                <button type="button" role="button" class="modal--btn js-btn-signin-personal" data-oauth-signin-url="https://jamanetwork.com/oauthsignin?return_url=https%3a%2f%2fjamanetwork.com%2fjournals%2fjama%2ffullarticle%2f2781397">
            Sign in<span class="fw-normal"> | personal account</span>
        </button>

    <div class="widget-SelfServeContent widget-instance-AMA_UserComment_SigninModal_CreateAccount">
        


<div class="self-serve">
    <input type="hidden" class="SelfServeContentId" value="SigninModal_CreateAccount" />
    <input type="hidden" class="SelfServeVersionId" value="0" />

<div class="modal--title">Free access to newly published articles</div>
<hr>
<button class="modal--btn js-btn-create-personal-account" type="button" role="button">
<div class="text-truncate">Create a free personal account</div>
</button>
<div class="modal--btn-desc">To register for email alerts, access free PDF, and more</div>
<!--<div class="jn-selfServe-modal-label">JAMA|SigninModal_CreateAccount</div>-->


</div>

 
    </div>
            <div class="widget-SelfServeContent widget-instance-AMA_SigninModal_PurchaseOptions_UserComment">
        


<div class="self-serve">
    <input type="hidden" class="SelfServeContentId" value="SigninModal_PurchaseOptions_UserComment" />
    <input type="hidden" class="SelfServeVersionId" value="0" />

<div class="modal--sub-title">Create a personal account or sign in to:</div>
		<ul>
			<li>Register for email alerts with links to free full-text articles</li>
			<li>Access PDFs of free articles</li>
			<li>Manage your interests</li>
			<li>Save searches and receive search alerts</li>
		<ul>
		<!--<div class="jn-selfServe-modal-label">JAMA|SigninModal_PurchaseOptions_UserComment</div>-->


</div>

 
    </div>

            <div class="modal--link-wrap">
        <a class="modal--link" href="/pages/privacy-policy" rel="nofollow">Privacy Policy</a>
    </div>

    </div>
        <a class="close-reveal-modal icon-close"></a>

</div>

<div class="hidden-true js-modal-page-data"
     data-store-url="https://store.jamanetwork.com"
     data-store-purchase-url="https://jamanetwork.com/oauthsignin?return_url=https://store.jamanetwork.com"
     data-store-subscribe-url="https://store.jamanetwork.com/index.aspx?productcode=64">
</div>






 
    </div>

        

        
        <script src="//cdn.jamanetwork.com/UI/app/vendor/jquery-2.2.4.min.js?v=638473295270790799"></script>
        <script>window.jQuery || document.write('<script src="/UI/app/vendor/jquery-2.2.4.min.js">\x3C/script>')</script>

        <script src="//cdn.jamanetwork.com/UI/app/dist/app.min.js?v=638488852374030681"></script>
        
    
    
    <script src="//cdn.jsdelivr.net/chartist.js/latest/chartist.min.js" type="text/javascript"></script>

    
    
        <script src="//d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script>
    
    <script defer src='//js.trendmd.com/trendmd.min.js' data-trendmdconfig='{"element":"#trendmd-suggestions"}'></script>
        <script type='text/javascript' src='https://platform-api.sharethis.com/js/sharethis.js#property=643701de45aa460012e1032e&amp;product=sop' async='async'></script>


    <script>
        var App = App || {};
        App.showCmePromo = false;
    </script>


    </form>
    

    
    
    <link rel="stylesheet" href="//cdn.jamanetwork.com/UI/app/scss/modules/_trendMD.css">
</body>
</html>

 contentType 9 text/html url 61 https://jamanetwork.com:443/journals/jama/fullarticle/2781397 responseCode 3 200 